FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,O,N,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature1122,α-Lactose,C12 H22 O11,342.11629,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak2,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,381460320.94968665,216819550.85690933,0.5683934578493345,-0.8150381454837253,0.3992872193705448,0.7873878775042317,Downregulated
Feature1121,Phenacetin,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak3,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,5623479.9360757265,4901841.43386752,0.8716740327321604,-0.19813936272933308,0.37823217675447385,0.7829565408883704,Downregulated
Feature1120,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21535,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Phenol,1419775.0307866267,1741187.9967430134,1.226383024765767,0.29440963288579797,0.4909130943100128,0.7998439321266281,Upregulated
Feature1119,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak3",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,1939945.0784148024,1518108.94031157,0.7825525357408935,-0.35374048596202856,0.6409055553997649,0.8329695325287205,Downregulated
Feature1118,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,1175035.1991176321,1658646.7251880332,1.4115719481710496,0.4973026651844831,0.5806357201657449,0.820796478981062,Upregulated
Feature1117,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,881598040.494218,767723135.3509424,0.8708312633278562,-0.1995348928752176,0.7043260457073928,0.8608429447534801,Downregulated
Feature1116,NA,C30 H32 O10,552.19968,NA,NA,Feature1116,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Phenol,2516132.0979702133,2048757.34370915,0.8142487214251991,-0.2964585456576149,0.35649716546829796,0.7829565408883704,Downregulated
Feature1115,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,NA,Choline O-Sulfate,5,13,4,1,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,256669315.255487,286686631.893168,1.1169493774813009,0.1595638012987017,0.7469222461460532,0.8847091047453014,Upregulated
Feature1114,NA,C9 H16 O7,236.0896,NA,NA,Feature1114,9,16,7,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,363415983.2368768,33895076.311268665,0.09326798455415111,-3.4224742475128718,0.22834973584521007,0.7829565408883704,Downregulated
Feature1113,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak2,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,756203288.4034864,1061498229.2988876,1.4037207263934899,0.48925593655121463,0.10364220454255119,0.7829565408883704,Upregulated
Feature1112,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,NA,L-alpha-Glycerylphosphorylcholine-peak2,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,1117665234.5214992,861424866.822687,0.7707360309829131,-0.37569125809212317,0.16953067249765139,0.7829565408883704,Downregulated
Feature1111,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,L-Glutamic acid,5,9,4,1,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,478260440.94052935,595742822.352417,1.2456451994667406,0.31689320009430805,0.2068931467880602,0.7829565408883704,Upregulated
Feature1110,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,57971319.46533397,59854601.355516836,1.0324864417017288,0.046122836736140094,0.857004593197475,0.9344598188217366,Upregulated
Feature1109,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,651366702.833723,774416254.8174247,1.188909797581583,0.24963926216662366,0.011044962604581257,0.7829565408883704,Upregulated
Feature1108,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08991,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak2,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,69989516.59390303,57166814.604214296,0.8167911051009351,-0.2919609396126908,0.5734297945258295,0.820796478981062,Downregulated
Feature1107,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak2,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Phenol,6573246.25980719,7812558.62541954,1.1885388614131585,0.24918907555755418,0.13768196700850588,0.7829565408883704,Upregulated
Feature1106,Choline,C5 H13 N O,103.09967,NA,NA,Choline,5,13,1,1,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,712591226.904913,887352219.414269,1.2452471850775058,0.3164321497542762,0.14610913557191738,0.7829565408883704,Upregulated
Feature1105,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,60173171.2393584,69302575.46196833,1.1517188480277156,0.20378857610254505,0.5409895414260154,0.8116192259717375,Upregulated
Feature1104,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,DL-Carbidopa,10,14,4,2,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Phenol,980039953.186361,1075541936.6622024,1.0974470307718986,0.134151308519747,0.2647265225784715,0.7829565408883704,Upregulated
Feature1103,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.1057,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,12938215.599931587,6779228.601192653,0.5239693641547062,-0.9324456332661641,0.19250313133854424,0.7829565408883704,Downregulated
Feature1102,Maltotriose,C18 H32 O16,504.16909,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak2,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,90458144.71914963,77777689.2267329,0.8598196377806947,-0.21789403387379547,0.13440223397204878,0.7829565408883704,Downregulated
Feature1101,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,Other,L-Iditol,6,14,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,880747483.1953499,789400580.2119137,0.8962847981670866,-0.15797086749568268,0.5115762369628372,0.8027811718493753,Downregulated
Feature1100,NA,C32 H36 O10,580.23111,NA,NA,Feature1100,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Phenol,1397367.9474576784,1630659.7229920335,1.166950856400276,0.22274380635762114,0.4280932735212612,0.7913025583045388,Upregulated
Feature1099,Maltotriose,C18 H32 O16,504.16908,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak1,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,18974990.868771773,45441217.126724735,2.394795203907578,1.2599022860491598,0.14980789845711706,0.7829565408883704,Upregulated
Feature1098,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,843639846.0867227,962248828.691833,1.1405919636860273,0.18978277300247937,0.23625210895391627,0.7829565408883704,Upregulated
Feature1097,Dambonitol,C8 H16 O6,208.09467,NA,NA,Dambonitol,8,16,6,0,0,0,2,0.75,-0.5,74.55,1,-5,-2.5,-0.4,-5,Carbohydrate,127938606.01852678,8415527.723366614,0.06577786006319283,-3.9262541157217776,0.2548661094627189,0.7829565408883704,Downregulated
Feature1096,NA,C6 H11 N O7,209.05352,NA,NA,Feature1096,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,235405092.358823,201155715.33044067,0.8545087674816451,-0.22683280048460164,0.5082787197916986,0.7998439321266281,Downregulated
Feature1095,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak2",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,432436992.58979267,514635788.57710004,1.1900827112292882,0.25106184490597827,0.2699961043740488,0.7829565408883704,Upregulated
Feature1094,D-Gluconic acid,C6 H12 O7,196.05831,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Gluconic acid,6,12,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,6958915.329896926,7026375.198271464,1.009694020573108,0.01391816240117902,0.9715624983948417,0.9859603162880705,Upregulated
Feature1093,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Other,Other,Proline,5,9,2,1,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,139756922.975066,226627039.479287,1.621580059541805,0.6974002533050734,0.1628969433239552,0.7829565408883704,Upregulated
Feature1092,N-Acetylneuraminic acid,C11 H19 N O9,309.10605,Metabolic pathways;Other,Other,N-Acetylneuraminic acid,11,19,9,1,0,0,1.7272727272727273,0.8181818181818182,0.18181818181818168,55.11818181818182,3,-6,-7,-0.4545454545454546,-7,Carbohydrate,26276613.087375835,24251025.524001066,0.9229129128385298,-0.11573357501584897,0.23596115042889756,0.7829565408883704,Downregulated
Feature1091,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16789,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak3",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,728320.615332342,805578.630074486,1.106076929741842,0.14545173123022787,0.5905618134526787,0.820796478981062,Upregulated
Feature1090,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,2893434.3741580863,9959955.789193103,3.442260822691439,1.7833564156080215,0.2811789447300614,0.7829565408883704,Upregulated
Feature1089,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13223,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak7,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,3140093.7751261103,2675661.8219908634,0.8520961517728576,-0.23091185943739095,0.73585782680414,0.8792678186094197,Downregulated
Feature1088,NA,C16 H29 N O12,427.16894,NA,NA,Feature1088,16,29,12,1,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,5962213.38245727,6066797.7984330105,1.01754120647266,0.02508721922865131,0.9363421297710501,0.9691719887335095,Upregulated
Feature1087,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13226,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak6,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,5857747.209973247,7095282.909784763,1.2112647841314355,0.2765142746087274,0.12948437338909377,0.7829565408883704,Upregulated
Feature1086,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,NP-019445,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,141905378.9538151,240732291.85748366,1.6964282371271706,0.7625004019731211,0.5211133488953795,0.8083677301524742,Upregulated
Feature1085,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,DL-Tryptophan,11,12,2,2,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Phenol,307302823.17543435,465854940.064982,1.5159474789433767,0.6002197711999663,0.11403795455159169,0.7829565408883704,Upregulated
Feature1084,Beauvericin,C45 H57 N3 O9,783.40966,NA,NA,Beauvericin,45,57,9,3,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Phenol,1003119.7129663967,1312805.0920930568,1.3087222543068837,0.38815895148412444,0.16978098407393433,0.7829565408883704,Upregulated
Feature1083,1-Linoleoyl glycerol,C21 H38 O4,354.27701,NA,NA,1-Linoleoyl glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,259540309.60929933,495610551.59415966,1.9095706263902905,0.9332482797188644,0.016896315750325276,0.7829565408883704,Upregulated
Feature1082,α-Lactose,C12 H22 O11,342.11628,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak1,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,37701615.385787435,35640589.301290736,0.945333215476129,-0.08110514800834077,0.8313570956371967,0.9217219973368921,Downregulated
Feature1081,g-Butyrobetaine,C7 H15 N O2,145.1103,NA,NA,g-Butyrobetaine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,2709733.793858956,676056.406580359,0.24949181654393476,-2.0029355996659315,0.20171739226858174,0.7829565408883704,Downregulated
Feature1080,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,NA,DL-Stachydrine,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,89174746.42393766,111883563.81386954,1.2546552505119994,0.3272910002693199,0.2979491708480235,0.7829565408883704,Upregulated
Feature1079,trans-3-Indoleacrylic acid,C11 H9 N O2,187.06331,Microbial metabolism in diverse environments;Other,NA,trans-3-Indoleacrylic acid,11,9,2,1,0,0,0.8181818181818182,0.18181818181818185,-0.18181818181818168,65.48181818181817,8,6,0.625,0.6666666666666666,5,Phenol,280027721.6533033,422307203.3944333,1.5080907022386996,0.592723200314014,0.11294445920383364,0.7829565408883704,Upregulated
Feature1078,Crotonic acid,C4 H6 O2,86.03675,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak3,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,69440066.0982279,72466826.56800672,1.0435880989153619,0.061552396859331185,0.9072300455774158,0.9563272387951537,Upregulated
Feature1077,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15209,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,12,6,2,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,1379230.026514269,157157.95290410033,0.11394615102840094,-3.133575902061446,0.2901746345640608,0.7829565408883704,Downregulated
Feature1076,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03787,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,2,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Phenol,820634.0216315957,904434.630155725,1.1021169075558381,0.14027726656359593,0.5174205277977226,0.8069818060683912,Upregulated
Feature1075,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Lysine degradation;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,6,2,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,353133226.159715,276510269.7852563,0.7830196914413156,-0.3528795059055059,0.41595205456675854,0.7873878775042317,Downregulated
Feature1074,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",C20 H34 O4,338.24575,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",20,34,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,3094796.8362434767,3226406.740498313,1.0425261854715435,0.06008362076873834,0.8209652744941942,0.916540336300981,Upregulated
Feature1073,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,L-Tyrosine,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,243373482.58666167,334465652.488534,1.3742896265185167,0.4586860789081709,0.07472957911999069,0.7829565408883704,Upregulated
Feature1072,NA,C9 H17 N O6,235.10555,NA,NA,Feature1072,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,348099632.9854613,275583237.97617435,0.7916791971673361,-0.3370121524799576,0.42332526725533887,0.7873878775042317,Downregulated
Feature1071,NA,C74 H117 N10 O14 P3,1462.79612,Other,NA,Feature1071,74,117,14,10,0,3,1.5810810810810811,0.1891891891891892,-1,88.8,23,9,-0.0851063829787234,0.05555555555555555,-4,Lipid,159783.31103547732,183296.78613627332,1.1471585170467222,0.19806476010342736,0.484813062602941,0.7998439321266281,Upregulated
Feature1070,L-Glutamine,C5 H10 N2 O3,146.06916,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Glutamine,5,10,3,2,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,163089668.549052,199367412.47756898,1.2224404786107332,0.2897642211663438,0.3609523833420476,0.7829565408883704,Upregulated
Feature1069,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak2,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,8907881.799718827,6957194.555847433,0.7810155895947153,-0.3565767490725844,0.5687244511611578,0.820796478981062,Downregulated
Feature1068,Acetylagmatine,C7 H16 N4 O,172.13243,NA,NA,Acetylagmatine,7,16,1,4,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,84196.88395271944,91646.9655553139,1.0884840537184017,0.1223202722115604,0.6462372611441436,0.8343822865405398,Upregulated
Feature1067,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,362091.92751918634,444501.23032830865,1.2275922122145506,0.2958313985587056,0.2696977652004779,0.7829565408883704,Upregulated
Feature1066,NA,C29 H30 O10,538.18407,NA,NA,Feature1066,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,617993.8381513903,689339.2181454033,1.1154467497725042,0.1576216425171957,0.48144107378022627,0.7998439321266281,Upregulated
Feature1065,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,NA,Tris(hydroxymethyl)aminomethane,4,11,3,1,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,68931326.74707873,64084113.606402,0.9296805477361256,-0.10519302530018253,0.8433423282149766,0.9276765610364743,Downregulated
Feature1064,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak2,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,23066107.7241352,18183081.185143165,0.7883029682601072,-0.34317788804562577,0.37677282349092,0.7829565408883704,Downregulated
Feature1063,L-Pyroglutamic acid,C5 H7 N O3,129.0426,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Phenol,155328205.19747433,205094548.559055,1.3203947621638383,0.4009693206988034,0.21964256799469586,0.7829565408883704,Upregulated
Feature1062,2-Hydroxy-N-(2-hydroxyethyl)propionamide,C5 H11 N O3,133.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Hydroxy-N-(2-hydroxyethyl)propionamide,5,11,3,1,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-2,-3,-0.6,-3,Amino Sugar,51263220.708418965,43567978.737284765,0.8498876608845138,-0.2346559381025615,0.16042480799468606,0.7829565408883704,Downregulated
Feature1061,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10046,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,4328889.699525436,1990023.4127675167,0.45970758113464455,-1.1212116367483707,0.30980740276544794,0.7829565408883704,Downregulated
Feature1060,NA,C9 H19 N O7,253.11617,NA,NA,Feature1060,9,19,7,1,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,53888767.933246806,2502450.9945737803,0.04643733918121158,-4.428570880362958,0.2112036194788036,0.7829565408883704,Downregulated
Feature1059,hercynine,C9 H15 N3 O2,197.1165,NA,NA,hercynine,9,15,2,3,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,82792232.73025207,51660988.1740494,0.6239835123467157,-0.6804201859438874,0.5178595584872284,0.8069818060683912,Downregulated
Feature1058,NA,C6 H14 O4,150.08923,NA,NA,Feature1058,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,307938170.2185107,377617398.4930417,1.2262766847808673,0.29428453100691765,0.19550672277627737,0.7829565408883704,Upregulated
Feature1057,NA,C75 H119 N10 O14 P3,1476.81198,NA,NA,Feature1057,75,119,14,10,0,3,1.586666666666667,0.18666666666666668,-1.0133333333333336,89.18,23,9,-0.08333333333333333,0.05454545454545454,-4,Lipid,175590.7577705,192817.03930698065,1.0981047166445723,0.13501563811386033,0.6304432186007343,0.8293364212030647,Upregulated
Feature1056,NA,C23 H33 N3 O5,431.24199,NA,NA,Feature1056,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Phenol,38095682.3000742,38254056.078174435,1.0041572631998752,0.005985230515124512,0.9856257031393205,0.9944892436351777,Upregulated
Feature1055,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.09171,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Phenol,178958060.261837,203505521.87827733,1.137168795753175,0.1854464166942055,0.3218795135551855,0.7829565408883704,Upregulated
Feature1054,L-glycero-Î±-D-manno-Heptopyranose,C7 H14 O7,210.07395,Metabolic pathways;Other,NA,L-glycero-Î±-D-manno-Heptopyranose,7,14,7,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,1483321.0505763076,2330182.03872981,1.570922247631068,0.6516117766009096,0.23876489002771775,0.7829565408883704,Upregulated
Feature1053,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",C9 H12 N2 O6,244.06954,Metabolic pathways;ABC transporters;Other,Other,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,55901983.86684847,51056118.93903287,0.9133149739487271,-0.13081560818427002,0.6589495016194672,0.8363589828247083,Downregulated
Feature1052,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10013,NA,NA,N-(Carboxymethyl)norleucine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,1546943.6871439593,1149373.7062304076,0.7429964747795285,-0.4285727291169732,0.47465336916839596,0.7998439321266281,Downregulated
Feature1051,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,7073970.065893884,42340694.1500535,5.985421730039966,2.581452902373786,0.004170164750596051,0.7829565408883704,Upregulated
Feature1050,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",C12 H12 O5,236.06846,NA,NA,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",12,12,5,0,0,0,1,0.4166666666666667,-0.16666666666666696,65.05000000000001,7,2,0.2857142857142857,0.47368421052631576,2,Phenol,493421.142350191,586066.7308815416,1.187761691949548,0.24824540825126967,0.3661977904456097,0.7829565408883704,Upregulated
Feature1049,2-Acetamido-2-deoxy-D-gluconolactone,C8 H13 N O6,219.07432,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,2-Acetamido-2-deoxy-D-gluconolactone,8,13,6,1,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,24985989.245242734,25786036.57392283,1.0320198380311247,0.04547070327477784,0.8601119259741179,0.936028691506266,Upregulated
Feature1048,NA,C6 H15 N O7,213.0849,NA,NA,Feature1048,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,6811622.304104997,6501667.385297246,0.9544961677307097,-0.0671886896174993,0.8164503166590881,0.9142978308596724,Downregulated
Feature1047,NA,C10 H20 O7,252.12091,NA,NA,Feature1047,10,20,7,0,0,0,2,0.7,-0.5999999999999996,77.39999999999999,1,-6,-2,-0.38461538461538464,-6,Amino Sugar,1996714.462050357,1959446.9519404299,0.9813355836208757,-0.027181521097674945,0.9753272756372395,0.9885430923802915,Downregulated
Feature1046,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,162647464.235339,148847401.832788,0.9151535348710798,-0.12791429092755519,0.4009559715004385,0.7873878775042317,Downregulated
Feature1045,NA,C12 H18 O9,306.09515,NA,NA,Feature1045,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,4180694.20336399,3212467.168737653,0.7684052007804698,-0.3800608112889186,0.43633248487235865,0.7974180334973026,Downregulated
Feature1044,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,NA,Acetyl-L-carnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,359651.0243001353,628493.0284542197,1.7475079618561877,0.8052990287075908,0.23145469792998707,0.7829565408883704,Upregulated
Feature1043,3-Deoxy-D-glycero-hexitol,C6 H14 O5,166.08414,NA,NA,3-Deoxy-D-glycero-hexitol,6,14,5,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,257014807.125892,282452357.591176,1.0989730932226953,0.13615606440417344,0.5645620931348467,0.820796478981062,Upregulated
Feature1042,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",C21 H22 O6,370.14172,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Phenol,575398.1765689506,694729.4355151193,1.2073890113064498,0.2718905760613266,0.3838957747634483,0.7829565408883704,Upregulated
Feature1041,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,7301116.903780793,15647001.950837167,2.1430970298167065,1.0996971702507645,0.09343661831497617,0.7829565408883704,Upregulated
Feature1040,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,39938125.75096373,8658316.00650623,0.2167932481482885,-2.2056082690750296,0.28644499953799735,0.7829565408883704,Downregulated
Feature1039,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,Other,(+)-Piperitol,20,20,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Phenol,610906.8182584806,533853.1855007263,0.8738700723992375,-0.19450930010359033,0.35987037356674617,0.7829565408883704,Downregulated
Feature1038,5-Aminolevulinic acid,C5 H9 N O3,131.05823,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,5-Aminolevulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1269250.67880766,1370504.07433277,1.0797741511710104,0.11072958548217365,0.6705077645732247,0.8383146233448654,Upregulated
Feature1037,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12595,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak2",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,322061.58169343235,413549.7727343747,1.28407048912785,0.36072440146635076,0.1429237856167943,0.7829565408883704,Upregulated
Feature1036,.alpha.-Glucoheptitol,C7 H16 O7,212.08964,NA,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,14256018.034291632,14405478.355784366,1.0104840160227926,0.015046501146611114,0.9549744565714074,0.976397314763342,Upregulated
Feature1035,NA,C9 H17 N O6,235.10557,NA,NA,Feature1035,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,79084460.141933,119984328.4390965,1.517166940556469,0.6013798404049036,0.34314974107881857,0.7829565408883704,Upregulated
Feature1034,diphthinate,C13 H22 N4 O4,298.16416,NA,NA,diphthinate,13,22,4,4,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,111725.0230608379,72889260.99984741,652.3987107181606,9.349610120747952,0.27611876331921115,0.7829565408883704,Upregulated
Feature1033,NA,C62 H107 N2 O15 P3,1212.68834,NA,NA,Feature1033,62,107,15,2,0,3,1.7258064516129032,0.24193548387096775,-1.387096774193548,99.83225806451613,12,-3,-0.1904761904761905,-0.0101010101010101,-8,Lipid,11810585.03366318,15917764.420911033,1.3477541015573187,0.4305573000623515,0.19202611028147346,0.7829565408883704,Upregulated
Feature1032,Inosine,C10 H12 N4 O5,268.08079,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Inosine,10,12,5,4,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Phenol,5785880.34477042,6322129.907341117,1.0926824494487493,0.12787419225526137,0.8273296524363867,0.9190731386471543,Upregulated
Feature1031,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak2,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,8674945.55253313,7703704.614024363,0.8880406876761137,-0.1713023163257236,0.7523071322223374,0.8847091047453014,Downregulated
Feature1030,2'-Deoxyadenosine,C10 H13 N5 O3,251.10191,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak2,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,206395835.149803,232701494.12040633,1.127452469917867,0.17306661498030088,0.1490605866200742,0.7829565408883704,Upregulated
Feature1029,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Phenol,538708.451115591,586983.3751285163,1.0896123383862917,0.12381494512555472,0.7370070235499784,0.879704128109655,Upregulated
Feature1028,NA,C22 H33 N O6,407.23081,NA,NA,Feature1028,22,33,6,1,0,0,1.5,0.2727272727272727,-0.8181818181818183,83.61818181818182,7,1,0,0.16666666666666666,0,Lipid,632766.3460062731,663794.5834629816,1.0490358528903194,0.06906398573515812,0.8131901698888553,0.9142978308596724,Upregulated
Feature1027,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,NA,N-Caffeoylputrescine,13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,241040.90774990467,288733.3017402387,1.1978601658761505,0.26045950264116396,0.27649225195081484,0.7829565408883704,Upregulated
Feature1026,Succinyl proline,C9 H13 N O5,215.07946,Other,NA,Succinyl proline-peak2,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Phenol,12445950.6629486,16284031.6013739,1.3083798933777882,0.3877814939837706,0.15940619897601466,0.7829565408883704,Upregulated
Feature1025,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13231,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak5,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,13432289.404316343,10889499.912587827,0.8106957484915852,-0.30276751768138427,0.33072955846857205,0.7829565408883704,Downregulated
Feature1024,2-Deoxyhexopyranose,C6 H12 O5,164.0685,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Other,Other,2-Deoxyhexopyranose,6,12,5,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,183384852.38509235,161308963.09246734,0.8796198867817744,-0.18504787332622402,0.3353888652796187,0.7829565408883704,Downregulated
Feature1023,Glutarylcarnitine,C12 H21 N O6,275.13695,NA,NA,Glutarylcarnitine,12,21,6,1,0,0,1.75,0.5,-0.5,74.55,3,-3,-0.8,-0.125,-4,Protein,26097756.4342352,12725005.430269752,0.48759001419666137,-1.036259514902323,0.2525475402350272,0.7829565408883704,Downregulated
Feature1022,NA,C10 H15 N O8,277.07983,NA,NA,Feature1022,10,15,8,1,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,45983422.78136027,37725447.666383035,0.8204140836961649,-0.28557583673096487,0.49541598374010926,0.7998439321266281,Downregulated
Feature1021,NA,C6 H11 N3 O2,157.08515,NA,NA,Feature1021,6,11,2,3,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,153315638.098722,185419693.57486933,1.2093984402000473,0.2742896234132422,0.13034010961678844,0.7829565408883704,Upregulated
Feature1020,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Pinolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,7462099.14753481,8648884.554009156,1.1590417633175532,0.212932551370785,0.5270582035059782,0.8098418097030804,Upregulated
Feature1019,NA,C22 H14 N3 O4 P,415.07208,NA,NA,Feature1019,22,14,4,3,0,1,0.6363636363636364,0.18181818181818185,-0.09090909090909084,62.89090909090909,18,14,0.7142857142857143,0.75,10,Condensed HC,660624.0470667733,720786.0917266126,1.0910685054941065,0.12574168776035688,0.537614840788492,0.8116192259717375,Upregulated
Feature1018,4-Acetamidobutanoic acid,C6 H11 N O3,145.07391,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak2,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,9278428.30361528,5023882.005733229,0.5414582988991472,-0.8850778637722565,0.20004362117026053,0.7829565408883704,Downregulated
Feature1017,Valylproline,C10 H18 N2 O3,214.13174,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Valylproline,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,58918386.6886832,97645762.1908224,1.657305430081944,0.7288395059138396,0.1958831785717142,0.7829565408883704,Upregulated
Feature1016,D-Glucose 6-phosphate,C6 H13 O9 P,260.02974,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,D-Glucose 6-phosphate,6,13,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,28854259.753161833,42094109.8246902,1.4588525293939503,0.5448340533277574,0.1274673210604701,0.7829565408883704,Upregulated
Feature1015,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Phenol,317612.33609786164,359912.85062231036,1.1331828449869001,0.18038066634183045,0.3942125956477593,0.7873878775042317,Upregulated
Feature1014,1-linoleoyl-sn-glycerol,C21 H38 O4,354.27689,NA,NA,1-linoleoyl-sn-glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,129550385.2790322,175888756.205172,1.3576860912172037,0.44114995454990014,0.26133548264940876,0.7829565408883704,Upregulated
Feature1013,NA,C10 H17 N O9,295.09039,NA,NA,Feature1013,10,17,9,1,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,53635101.8124524,42132517.787906565,0.7855399983248416,-0.3482433579856639,0.15757634847273203,0.7829565408883704,Downregulated
Feature1012,(5S)-5-(Carboxymethyl)-L-proline,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,(5S)-5-(Carboxymethyl)-L-proline,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,41301714.10165947,32697034.382980034,0.7916628908548445,-0.33704186815081055,0.4885243608241777,0.7998439321266281,Downregulated
Feature1011,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak2,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,12466804.824313743,19066544.197195243,1.529384992055877,0.61295162201279485,0.5298002060559212,0.8098418097030804,Upregulated
Feature1010,N-Acetyl-α-D-glucosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-α-D-glucosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,70795182.12669523,126039606.98251903,1.7803415881741536,0.8321540728125639,0.22326365450749439,0.7829565408883704,Upregulated
Feature1009,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12119,NA,NA,Cyclo(phenylalanyl-prolyl)-peak2,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Phenol,158938650.248421,178890559.76957032,1.1255321439433674,0.17060725914257147,0.16854820720775596,0.7829565408883704,Upregulated
Feature1008,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13225,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak4,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,21039988.167529367,23999030.296239734,1.140638963536919,0.18984222025177297,0.13004467553852178,0.7829565408883704,Upregulated
Feature1007,NA,C7 H15 N O5,193.09509,NA,NA,Feature1007,7,15,5,1,0,0,2.142857142857143,0.7142857142857143,-0.2857142857142856,68.44285714285714,1,-4,-5,-0.7142857142857143,-5,Carbohydrate,49457536.88322437,38619383.385536864,0.7808594163660478,-0.35686526171592553,0.35320340997720134,0.7829565408883704,Downregulated
Feature1006,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09546,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,22340492.577219065,25503709.8341837,1.1415912046715664,0.19104612480228217,0.30273040159270387,0.7829565408883704,Upregulated
Feature1005,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",C7 H13 N O3,159.08956,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,12766958.602546323,15969094.2904226,1.2508142923904855,0.32286760937964526,0.38950378304451977,0.7873878775042317,Upregulated
Feature1004,Proacacipetalin,C11 H17 N O6,259.1056,NA,NA,Proacacipetalin-peak2,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,62158683.005098894,18017849.48957179,0.2898685850228484,-1.7865291074266267,0.11334496319294213,0.7829565408883704,Downregulated
Feature1003,NA,C6 H14 O4,150.08924,NA,NA,Feature1003,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,165880692.44635135,159971283.66408166,0.964375547900604,-0.052333023550577236,0.8021426036152908,0.9129441522826608,Downregulated
Feature1002,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,Other,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,1430342.437145562,1389341.65921732,0.9713349916331473,-0.04195916029312081,0.9077437694445978,0.9563272387951537,Downregulated
Feature1001,Buphedrine,C11 H17 N O,179.13104,NA,NA,Buphedrine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,225619.32448482135,280002.05001662,1.2410375337129302,0.3115467487339066,0.17409157115818025,0.7829565408883704,Upregulated
Feature1000,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05587,Metabolic pathways;Other,NA,Glycerylphosphorylethanolamine,5,14,6,1,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,45879230.394297704,27144764.5105926,0.5916569279236733,-0.7571672228393627,0.32092284452700043,0.7829565408883704,Downregulated
Feature0999,Linolenelaidic acid,C18 H30 O2,278.22466,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Linolenelaidic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,3928017.7613749234,6865725.718261413,1.7478856093202095,0.8056107704983644,0.05125823417586835,0.7829565408883704,Upregulated
Feature0998,Glutaric acid,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Glutaric acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,23319256.566259168,24612007.394952834,1.0554370515638203,0.07784053595189709,0.7456854931328378,0.8847091047453014,Upregulated
Feature0997,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,"DL-2,6-Diaminopimelic acid",7,14,4,2,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,42566295.606997564,39406737.704893135,0.9257732471889092,-0.11126922236941515,0.8071409448720636,0.9140326627977811,Downregulated
Feature0996,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,Methionine,5,11,2,1,1,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,85091807.6904823,133936293.09674335,1.5740210101533005,0.654454798178103,0.04962163139407257,0.7829565408883704,Upregulated
Feature0995,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Aspartic acid,4,7,4,1,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,100094845.5449857,157889869.22320434,1.577402596143113,0.6575509222285205,0.09979193402302486,0.7829565408883704,Upregulated
Feature0994,UQ1000000,C6 H6 O3,126.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,UQ1000000,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,7822195.08283682,6908547.394888536,0.8831980437367285,-0.17919111830394124,0.5463027969856015,0.8150953965662829,Downregulated
Feature0993,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,5218164.494113463,3995838.10853365,0.7657554898932946,-0.38504428998322093,0.19869523313003873,0.7829565408883704,Downregulated
Feature0992,Methylhippuric acid,C10 H11 N O3,193.07397,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak2,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,1098741.6929248758,1520734.6535912538,1.3840693070843821,0.46891618754358794,0.4897204351666181,0.7998439321266281,Upregulated
Feature0991,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.1028,NA,NA,L-alpha-Glycerylphosphorylcholine-peak1,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,65577507.2901124,46059875.12341593,0.7023730700779582,-0.5096905638093419,0.6377900703837535,0.8329695325287205,Downregulated
Feature0990,(Z)-dehydrobutyrine,C4 H7 N O2,101.04767,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak2,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,35619428.4426376,46302982.53778783,1.2999361461499948,0.3784407587189225,0.28924318766115054,0.7829565408883704,Upregulated
Feature0989,Î²-Glycerophosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,Î²-Glycerophosphate,3,9,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,56623128.693428405,94648859.98765287,1.6715582867224656,0.74119366216401394,0.11631400668195807,0.7829565408883704,Upregulated
Feature0988,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Phenol,689108.3984053027,555375.0570363447,0.8059327942041681,-0.31126855577535845,0.5757898872190681,0.820796478981062,Downregulated
Feature0987,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,5860682.968333676,6622283.735047467,1.1299508556987055,0.17626002770103394,0.6491836733121782,0.8359827589201833,Upregulated
Feature0986,NA,C18 H31 N O11,437.18971,NA,NA,Feature0986,18,31,11,1,0,0,1.7222222222222223,0.6111111111111112,-0.33333333333333304,69.79999999999998,4,-7,-1.3333333333333333,-0.21739130434782608,-8,Amino Sugar,9865182.81111112,7924940.917319126,0.8033242839041252,-0.31594560610016376,0.44778409799511193,0.7974180334973026,Downregulated
Feature0985,3-Hydroxy-5-methyl-L-tyrosine,C10 H13 N O4,211.08446,NA,NA,3-Hydroxy-5-methyl-L-tyrosine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Phenol,56115267.68724293,65710243.79092343,1.1709869078261885,0.22772494593321838,0.011608921163218534,0.7829565408883704,Upregulated
Feature0984,Mephedrone,C11 H15 N O,177.11538,NA,NA,Mephedrone,11,15,1,1,0,0,1.3636363636363635,0.09090909090909093,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,290491.1092005273,267503.0866115,0.9208649701800045,-0.1189384707462178,0.8273202201051919,0.9190731386471543,Downregulated
Feature0983,Anhydroecgonine,C9 H13 N O2,167.09466,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak3,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,9605813.224214258,10500171.270849034,1.0931059167775912,0.12843319808801454,0.3081660451259088,0.7829565408883704,Upregulated
Feature0982,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak2,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,110711949.39363533,99609817.4877222,0.8997205634376503,-0.15245109826777042,0.5242332361550415,0.8098418097030804,Downregulated
Feature0981,Linoleamide,C18 H33 N O,279.25629,NA,NA,Linoleamide,18,33,1,1,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909093,1,Lipid,31233925.53620833,86565257.29261,2.7715138525337815,1.4706742184969228,0.005050639988402559,0.7829565408883704,Upregulated
Feature0980,Acrylic acid,C3 H4 O2,72.02113,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid,3,4,2,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,16325294.0809205,29127783.972369567,1.7842119001342485,0.8352869656610297,0.08638732662539785,0.7829565408883704,Upregulated
Feature0979,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak3",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,1036789.503841758,1418645.8421626466,1.3683065240397825,0.45239145476760523,0.47208475996557464,0.7998439321266281,Upregulated
Feature0978,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak2,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Phenol,30153958.9137516,25361802.631368965,0.8410770441092168,-0.24969013499752243,0.5001171566986405,0.7998439321266281,Downregulated
Feature0977,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak2,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,5424589.8226044495,5733973.07614399,1.05703348338898,0.08002107733945306,0.760625180777859,0.8870802973555341,Upregulated
Feature0976,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,12215103.882184267,15602211.708677633,1.2772884994808325,0.3530844214866729,0.295733027621304,0.7829565408883704,Upregulated
Feature0975,Methylhippuric acid,C10 H11 N O3,193.07394,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak1,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,1417238.70691793,1776773.0666511366,1.2536865229394463,0.3261766556858417,0.4092733906872132,0.7873878775042317,Upregulated
Feature0974,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,8,1,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,39050477.95431773,33787795.9969816,0.8652338656778399,-0.208837960690911,0.3731620867314098,0.7829565408883704,Downregulated
Feature0973,Methylglutaric acid,C6 H10 O4,146.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Methylglutaric acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,103888310.2845349,94545507.5586585,0.9100687777066753,-0.13595251495315402,0.47572590072915855,0.7998439321266281,Downregulated
Feature0972,NA,C11 H20 N4 O3,256.15356,NA,NA,Feature0972,11,20,3,4,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,863840.0456787583,44905926.642516404,51.984076064952255,5.699997854671727,0.2247474648189079,0.7829565408883704,Upregulated
Feature0971,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,15890127.12292874,6763531.501369113,0.4256436370234975,-1.232282031242299,0.3776688503868925,0.7829565408883704,Downregulated
Feature0970,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10595,NA,NA,α-Aspartylphenylalanine-peak3,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Phenol,2606095.80467475,3713148.783414647,1.4247936613665901,0.5107530032932364,0.3733805884307268,0.7829565408883704,Upregulated
Feature0969,NA,C43 H79 N O9,753.57577,NA,NA,Feature0969,43,79,9,1,0,0,1.837209302325581,0.20930232558139536,-1.348837209302325,98.74186046511628,5,-4,-0.15151515151515152,-0.01333333333333333,-5,Lipid,35539041.43560482,3140586.11977916,0.08837002892916411,-3.5002990333571256,0.4245718947326739,0.7873878775042317,Downregulated
Feature0968,NA,C77 H123 N10 O14 P3,1504.84348,NA,NA,Feature0968,77,123,14,10,0,3,1.5974025974025974,0.18181818181818185,-1.0389610389610393,89.91038961038961,23,9,-0.08,0.05263157894736842,-4,Lipid,142699.49724191232,158720.64521283968,1.1122719300388801,0.153509543599282,0.506083535210991,0.7998439321266281,Upregulated
Feature0967,NA,C8 H16 N2 O2,172.12119,NA,NA,Feature0967,8,16,2,2,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,185168.66473197268,194919.00528519298,1.0526565365005667,0.07403478686959894,0.888735232799967,0.9487246486135,Upregulated
Feature0966,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak2,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,62419544.90779947,62973664.4229156,1.008877339877031,0.01275078107635521,0.9664945624830257,0.9833412914850813,Upregulated
Feature0965,DL-Mevalonic acid,C6 H12 O4,148.07354,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,DL-Mevalonic acid,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,67113430.15247643,82170579.64527717,1.224353746464636,0.29202044899213464,0.42367895974475356,0.7873878775042317,Upregulated
Feature0964,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,627397.239165007,678681.0026898157,1.0817404991980224,0.11335444979138282,0.652706349831798,0.8362522505118077,Upregulated
Feature0963,NA,C12 H18 N6,246.15928,NA,NA,Feature0963,12,18,0,6,0,0,1.5,0,0,60.3,7,7,0.16666666666666666,0.16666666666666666,1,Lipid,33963960.54111997,623477.6988471181,0.018357037545497005,-5.767522934033013,0.42125685384235134,0.7873878775042317,Downregulated
Feature0962,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak2,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,3180281.27090867,3114691.54412961,0.9793761239362581,-0.030065069658151717,0.8890161200341051,0.9487246486135,Downregulated
Feature0961,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,101347754.4887007,111679471.887851,1.1019432295394584,0.14004990034137368,0.22561210227044473,0.7829565408883704,Upregulated
Feature0960,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,L-Threonine,4,9,3,1,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,85853593.82450937,111097300.12645283,1.2940320279840973,0.37187332524541505,0.07757383759542458,0.7829565408883704,Upregulated
Feature0959,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.15227,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Phenol,287178.29392893,335986.03025549836,1.1699562166026627,0.22645454068719884,0.3925192668661996,0.7873878775042317,Upregulated
Feature0958,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,4-Phenylbutyric acid,10,12,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Phenol,92550578.20807888,107714532.04288536,1.163845046983,0.21889899224093012,0.3699349163956119,0.7829565408883704,Upregulated
Feature0957,Cantharidin,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,Cantharidin,10,12,4,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Phenol,22238106.219805416,37111198.79912624,1.668811113334585,0.7388206705322217,0.5113870716694818,0.8027811718493753,Upregulated
Feature0956,NA,C9 H15 N O7,249.08484,NA,NA,Feature0956,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,53455161.4903797,61090796.4940847,1.142841865795863,0.19262579269051916,0.1419470506488357,0.7829565408883704,Upregulated
Feature0955,NA,C23 H35 N O6,421.24649,NA,NA,Feature0955,23,35,6,1,0,0,1.5217391304347827,0.2608695652173913,-0.8695652173913047,85.08260869565218,7,1,0,0.15789473684210523,0,Lipid,2573940.3878546366,2974727.67289496,1.1557096220765146,0.20877895889868459,0.4239814769989415,0.7873878775042317,Upregulated
Feature0954,NA,C11 H19 N3 O2,225.14773,NA,NA,Feature0954,11,19,2,3,0,0,1.7272727272727273,0.18181818181818185,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,36788985.0480717,30977825.369875867,0.8420407719701302,-0.2480380040006676,0.4946827278780141,0.7998439321266281,Downregulated
Feature0953,N-Acetyltyramine,C10 H13 N O2,179.09456,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,79257037.65683393,92475437.80511443,1.1667788822175433,0.22253117993654692,0.07743275166513384,0.7829565408883704,Upregulated
Feature0952,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13229,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak3,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,11678227.963399107,12648704.9178897,1.0831013881157465,0.11516829861141067,0.6953356561614339,0.8562617001735352,Upregulated
Feature0951,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20371,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak1,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,1502991.1017723246,2131893.42253544,1.4184338283982618,0.5042988487663584,0.4550735160182426,0.7974180334973026,Upregulated
Feature0950,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",C19 H32 O2,292.24009,Other,NA,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",19,32,2,0,0,0,1.6842105263157894,0.10526315789473684,-1.473684210526316,102.3,4,2,0.1176470588235294,0.16666666666666666,2,Lipid,44443690.59052697,47207115.038681485,1.0621781047306529,0.08702569577282745,0.9554355267886852,0.976397314763342,Upregulated
Feature0949,NA,C18 H30 O15,486.1586,Metabolic pathways;ABC transporters;Other,NA,Feature0949,18,30,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,3525014.9014267568,4188810.044081203,1.1883098827144742,0.2489111054638332,0.46094066307710285,0.7995347728859721,Upregulated
Feature0948,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14735,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,12146036.9632766,12303268.14737376,1.0129450605635852,0.01855592833265972,0.9408684209662269,0.9711631723312848,Upregulated
Feature0947,L-Lysine,C6 H14 N2 O2,146.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,L-Lysine,6,14,2,2,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,55942293.3742723,67052031.322099835,1.1985928226699563,0.2613416400009044,0.1537118959146363,0.7829565408883704,Upregulated
Feature0946,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11624,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,34329693.02327937,25910483.63571077,0.754754306079596,-0.4059210121554745,0.6497120907115863,0.8359827589201833,Downregulated
Feature0945,NA,C75 H89 N10 O16 P3 S,1510.53964,NA,NA,Feature0945,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Phenol,386540.24978773866,400612.04607878363,1.0364044787024695,0.051587155084409225,0.8527760601037597,0.931902449955211,Upregulated
Feature0944,Misoprostol,C22 H38 O5,382.2719,NA,NA,Misoprostol,22,38,5,0,0,0,1.7272727272727273,0.2272727272727273,-1.2727272727272725,96.57272727272726,4,-1,-0.0588235294117647,0.07692307692307693,-1,Lipid,1487224.0856103434,1131403.2804417717,0.7607483575532964,-0.3945087809056537,0.40327844380298306,0.7873878775042317,Downregulated
Feature0943,NA,C15 H18 O11,374.08496,NA,NA,Feature0943,15,18,11,0,0,0,1.2,0.7333333333333333,0.2666666666666666,52.7,7,-4,-1,0.15789473684210523,-4,Tannin,116192.25048866487,128034.225794263,1.1019170835902983,0.1400156689239197,0.5021187039037307,0.7998439321266281,Upregulated
Feature0942,"Norspermidine-2,3-dihydroxybenzoate",C13 H21 N3 O3,267.15832,NA,Other,"Norspermidine-2,3-dihydroxybenzoate",13,21,3,3,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,19080492.286561865,17410872.209560033,0.9124959643636803,-0.13210991650639164,0.4487605266132176,0.7974180334973026,Downregulated
Feature0941,Mevalonolactone,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,17213242.357991133,3503274.4736139933,0.20352205591223907,-2.2967429454525217,0.26923905801466985,0.7829565408883704,Downregulated
Feature0940,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak2,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,71923176.0162513,92238774.95889,1.282462483832031,0.35891662296205196,0.10719751125193633,0.7829565408883704,Upregulated
Feature0939,NA,C10 H21 N O9,299.12162,NA,NA,Feature0939,10,21,9,1,0,0,2.1,0.9,0,60.3,1,-8,-Inf,-1,-9,Carbohydrate,21533055.23863473,22070036.127973735,1.0249375150617526,0.03553595903963404,0.8886247048924321,0.9487246486135,Upregulated
Feature0938,NA,C5 H14 N O4 P,183.06609,NA,NA,Feature0938,5,14,4,1,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,1140123.2071133696,899565.0006235423,0.7890068327800409,-0.3418903008904574,0.6195916374715944,0.8293364212030647,Downregulated
Feature0937,NA,C16 H27 N O14,457.14329,NA,NA,Feature0937,16,27,14,1,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,76090230.64353333,79931350.04360163,1.0504811112751535,0.07105022111171026,0.7204958804860883,0.87299824827796,Upregulated
Feature0936,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,47445844.93507697,43417140.70261054,0.9150883657361535,-0.12801703055753055,0.5406328696214207,0.8116192259717375,Downregulated
Feature0935,"9S,13R-12-Oxophytodienoic acid",C18 H28 O3,292.20376,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,"9S,13R-12-Oxophytodienoic acid",18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,4916287.628218616,15754517.310622713,3.2045556529676142,1.680124325111462,0.1475569757922459,0.7829565408883704,Upregulated
Feature0934,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.0954,Metabolic pathways;ABC transporters;Other,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,36058411.201271564,44958679.528480664,1.246829187163278,0.3182638326800711,0.07891415273647982,0.7829565408883704,Upregulated
Feature0933,NA,C23 H41 N,331.32396,NA,NA,Feature0933,23,41,0,1,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,60160278.48004016,37429459.529654354,0.6221623382623239,-0.684637028923252,0.6704317778888013,0.8383146233448654,Downregulated
Feature0932,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,6843183.45864353,7948197.182021337,1.1614765598578363,0.21596003893527774,0.5968041706928664,0.8210217305908382,Upregulated
Feature0931,Caffeic acid,C9 H8 O4,180.04227,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak2,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,74172493.91200203,70478615.1809813,0.9501988063741913,-0.07369870042982475,0.6975251283053576,0.8562617001735352,Downregulated
Feature0930,Isoamylamine,C5 H13 N,87.10481,NA,NA,Isoamylamine,5,13,0,1,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,252266.43535047094,376467.20456921036,1.4923396528998742,0.577575926871209,0.5177811327967926,0.8069818060683912,Upregulated
Feature0929,NA,C9 H15 N O7,249.08488,NA,NA,Feature0929,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,9158653.646232544,9618709.283422576,1.0502317977030695,0.0707077816910513,0.680716063317017,0.8450653356168011,Upregulated
Feature0928,2'-Deoxyguanosine,C10 H13 N5 O4,267.09677,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,2'-Deoxyguanosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Phenol,82950892.66528401,93890670.72185437,1.1318825838404607,0.1787243075541241,0.33342337233071817,0.7829565408883704,Upregulated
Feature0927,NP-007065,C8 H10 O3,154.063,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak3,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,1743215.0191785733,1646798.7342242799,0.9446905379465317,-0.08208628670450495,0.11844424644707033,0.7829565408883704,Downregulated
Feature0926,Isoprenaline,C11 H17 N O3,211.12084,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Isoprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,75519122.02441509,88801030.79032473,1.175874777273174,0.2337344310704534,0.16305702777565623,0.7829565408883704,Upregulated
Feature0925,NA,C20 H29 N5 O7,451.2068,NA,NA,Feature0925,20,29,7,5,0,0,1.45,0.35,0,60.3,9,2,-0.375,0.04347826086956521,-3,Phenol,3148973.4504759,2460396.244326543,0.7813328003621964,-0.35599091506732433,0.4689842707127453,0.7998439321266281,Downregulated
Feature0924,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Phenol,9835754.54118603,9502772.529660156,0.9661457583013534,-0.0496872361416885,0.6908801628341938,0.8533979271633765,Downregulated
Feature0923,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21537,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Phenol,450238.66141598095,380691.33292137436,0.8455323044096584,-0.24206821958823807,0.4618835332762761,0.7995347728859721,Downregulated
Feature0922,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,58435162.7961925,89504959.4801085,1.5316969303616015,0.6151308662455558,0.20660366768999452,0.7829565408883704,Upregulated
Feature0921,Methionine sulfoxide,C5 H11 N O3 S,165.04597,Metabolic pathways;Other,Other,Methionine sulfoxide,5,11,3,1,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,7952395.619784759,12698820.54252241,1.5968547277664384,0.6752330710058937,0.2108077305314919,0.7829565408883704,Upregulated
Feature0920,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.2507,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,1640573.58522466,2533939.491925773,1.5445448559863137,0.6271817696831352,0.27823651135030036,0.7829565408883704,Upregulated
Feature0919,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12596,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak1",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,250392.61683092936,292583.52190716536,1.168498998134295,0.2246564971611287,0.6539496167329051,0.8362522505118077,Upregulated
Feature0918,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak5,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,66276810.263200566,64209785.61584097,0.9688122491237741,-0.045710989105319136,0.9149472947569292,0.9603585751327469,Downregulated
Feature0917,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",C22 H31 N O4,373.22538,NA,NA,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",22,31,4,1,0,0,1.4090909090909092,0.18181818181818185,-0.9090909090909092,86.2090909090909,8,4,0.17647058823529413,0.2631578947368421,3,Phenol,1349396.78645837,1515278.9499617633,1.1229306051178378,0.16726877480372426,0.47598068112222647,0.7998439321266281,Upregulated
Feature0916,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak2,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,817988.4492995983,834125.263110077,1.0197274348119412,0.028183582594910574,0.871352802169606,0.9403497372086917,Upregulated
Feature0915,NA,C5 H13 O6 P,200.04503,NA,NA,Feature0915,5,13,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,23636782.608974252,2057880.9939590497,0.08706265264620776,-3.5218022125936823,0.23801211099521177,0.7829565408883704,Downregulated
Feature0914,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak2,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,14903004.521891333,15879557.540348934,1.0655272577434383,0.0915674998388608,0.65437905728149115,0.8362522505118077,Upregulated
Feature0913,"16?,17-isopropylidenedioxy-6?-methylprogesterone",C25 H36 O4,400.26153,NA,NA,"16?,17-isopropylidenedioxy-6?-methylprogesterone",25,36,4,0,0,0,1.44,0.16,-1.12,92.22,8,4,0.1904761904761905,0.2608695652173913,4,Phenol,1298301.1433129627,2240283.7299787933,1.7255501479896336,0.7870564020288046,0.222326905343962,0.7829565408883704,Upregulated
Feature0912,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,11417939.330439894,20396103.46198737,1.7863208825792192,0.836991259699864,0.28089133450795634,0.7829565408883704,Upregulated
Feature0911,NP-021733,C7 H13 N O2,143.09463,ABC transporters,NA,NP-021733,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,250804.85905767567,239809.81194817834,0.9561609485924318,-0.06467461037151373,0.9064901392207065,0.9563272387951537,Downregulated
Feature0910,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,15048562.600316932,16965833.72010983,1.1274055981767004,0.17300663636833818,0.6973835939089137,0.8562617001735352,Upregulated
Feature0909,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,72038442.40857577,74397625.0600022,1.0327489403233623,0.04648957988319861,0.7319604630042356,0.8779932381898025,Upregulated
Feature0908,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",C19 H34 O4,326.24576,NA,NA,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",19,34,4,0,0,0,1.7894736842105263,0.21052631578947367,-1.3684210526315788,99.29999999999998,3,-1,-0.06666666666666667,0.0588235294117647,-1,Lipid,8714266.46433791,9901104.656674653,1.1361948475174286,0.18421026568957538,0.7790211676141593,0.89831628989012,Upregulated
Feature0907,Glucosamine,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,15883201.2780117,18772104.257815666,1.181884176195846,0.24108865936031382,0.1837795687108784,0.7829565408883704,Upregulated
Feature0906,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Phenol,34695401.33494057,59991937.131286666,1.7291034207138802,0.7900241616863012,0.07161669500930916,0.7829565408883704,Upregulated
Feature0905,"5,6,7,4'-Tetramethoxyisoflavone",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,NA,"5,6,7,4'-Tetramethoxyisoflavone",19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,179635.444263619,201910.62802546567,1.1240021636774387,0.1686448127151615,0.39452903637758513,0.7873878775042317,Upregulated
Feature0904,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak2,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,60758845.36970357,54773467.0033963,0.9014895966194285,-0.14961725213951982,0.4675111471387645,0.7998439321266281,Downregulated
Feature0903,NA,C17 H30 N2 O8,390.20035,NA,NA,Feature0903,17,30,8,2,0,0,1.7647058823529411,0.4705882352941176,-0.47058823529411775,73.71176470588236,4,-4,-0.8571428571428571,-0.18181818181818185,-6,Protein,57573092.99556733,60107453.7494831,1.0440198818936286,0.06214918627199393,0.4218097951509864,0.7873878775042317,Upregulated
Feature0902,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Phenol,780034.5135752549,1046096.9037140834,1.3410905357499412,0.42340663550375945,0.031812051867676626,0.7829565408883704,Upregulated
Feature0901,Leu-Glu,C11 H20 N2 O5,260.13724,NA,NA,Leu-Glu-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,15589444.4676257,26189284.638513133,1.6799370043557305,0.7484071346661929,0.16716650525669413,0.7829565408883704,Upregulated
Feature0900,mycosporine,C11 H19 N O6,261.12123,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak3,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,574701.1288006577,1396631.581163451,2.4301876421890416,1.281067713009712,0.43553314781300095,0.7974180334973026,Upregulated
Feature0899,NA,C12 H18 O9,306.09516,NA,NA,Feature0899,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,4939370.635321846,7739093.7636668375,1.566817786121159,0.6478374106052475,0.0835983791303711,0.7829565408883704,Upregulated
Feature0898,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",C21 H32 N4 O6,436.23229,NA,NA,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",21,32,6,4,0,0,1.5238095238095235,0.2857142857142857,-0.3809523809523814,71.15714285714287,8,2,-0.18181818181818185,0.07142857142857142,-2,Lipid,453455.3417109457,501798.2481195357,1.1066100715148397,0.146146959255197,0.7168029632722668,0.8694626213961982,Upregulated
Feature0897,Veronal,C8 H12 N2 O3,184.0848,NA,NA,Veronal,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,10005859.326148566,12874966.388450367,1.2867426943334983,0.3637235914593469,0.12210748967672112,0.7829565408883704,Upregulated
Feature0896,Imidazoleacetic acid riboside,C10 H14 N2 O6,258.08518,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Imidazoleacetic acid riboside,10,14,6,2,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Phenol,13954298.202230666,11485214.673479,0.8230592830274353,-0.280931746561908,0.16720724872565065,0.7829565408883704,Downregulated
Feature0895,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09574,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak2,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,50221076.55492513,57404533.87299944,1.1430367051215637,0.19287173202711877,0.7085733928047164,0.8632131886285471,Upregulated
Feature0894,AC-LYS-OH,C8 H16 N2 O3,188.1161,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,55720830.29160963,56878701.5997116,1.0207798645864097,0.029671776586269308,0.8381434123743622,0.925587508547278,Upregulated
Feature0893,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Phenol,11902783.047762163,2540817.2637574966,0.21346413301510983,-2.22793441130945,0.2695191092391073,0.7829565408883704,Downregulated
Feature0892,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",C31 H42 O3,462.31357,NA,NA,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",31,42,3,0,0,0,1.3548387096774193,0.0967741935483871,-1.161290322580645,93.39677419354838,11,8,0.2857142857142857,0.3220338983050847,8,Unsaturated HC,620741.4993685813,815520.8094145803,1.313784901193377,0.3937290904365828,0.13213400482072207,0.7829565408883704,Upregulated
Feature0891,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak4,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,44689252.54036337,49813504.79273987,1.1146640850112288,0.15660900529888597,0.7312871779227487,0.8779932381898025,Upregulated
Feature0890,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15318,NA,NA,4-Hydroxyprolyllysine-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,11935382.3309547,12217862.444988266,1.02366745414606,0.033747121418921,0.8696989341803951,0.940079194749907,Upregulated
Feature0889,ALA-GLU,C8 H14 N2 O5,218.09029,NA,NA,ALA-GLU,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,9170047.621902866,43184459.59345526,4.709295019396432,2.2355111048179652,0.04598894884556402,0.7829565408883704,Upregulated
Feature0888,MFCD01318772,C8 H13 N3 O2,183.10077,NA,NA,MFCD01318772,8,13,2,3,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,51144548.8701103,49050994.0601723,0.9590659247918107,-0.06029810748409965,0.7519366726965027,0.8847091047453014,Downregulated
Feature0887,NP-008177,C28 H41 N O5,471.29851,NA,NA,NP-008177,28,41,5,1,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Phenol,1477592.3556667145,1832085.3494260435,1.2399125796772112,0.3102384066507423,0.33571192508715053,0.7829565408883704,Upregulated
Feature0886,Valylvaline,C10 H20 N2 O3,216.14739,NA,NA,Valylvaline,10,20,3,2,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,7169381.414333084,9658300.39414624,1.3471595157201832,0.42992068889452956,0.5305113459284885,0.8098418097030804,Upregulated
Feature0885,NA,C6 H15 N O6,197.08997,NA,NA,Feature0885,6,15,6,1,0,0,2.5,1,0,60.3,0,-6,7,-2,-7,Carbohydrate,21427814.778204698,23019714.317341633,1.0742912684104464,0.10338519865015669,0.7784871827392872,0.89831628989012,Upregulated
Feature0884,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak1,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,19592555.787089366,18333334.525060765,0.9357296069123165,-0.09583639320168126,0.7921472046220965,0.9061342006853577,Downregulated
Feature0883,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",C10 H16 N2 O3 S,244.08813,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;ABC transporters;Other,Other,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",10,16,3,2,1,0,1.6,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,57847806.0815107,67417481.8310875,1.165428499329648,0.22086049582089057,0.34059284029095194,0.7829565408883704,Upregulated
Feature0882,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,L-Cystathionine,7,14,4,2,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,31549969.719391633,31215870.479975767,0.9894104735317537,-0.015358923476184552,0.9445167040458611,0.9713544839041761,Downregulated
Feature0881,Pyrogallol,C6 H6 O3,126.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Phenol,12472035.691924367,14035913.736726766,1.1253907608534996,0.17042602442995528,0.4701051743485279,0.7998439321266281,Upregulated
Feature0880,afegostat,C6 H13 N O3,147.08955,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak2,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,8909701.791401394,12790002.761288226,1.4355141238993707,0.5215675251667169,0.6205947100023862,0.8293364212030647,Upregulated
Feature0879,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",C14 H19 N3 O2,261.14775,NA,NA,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",14,19,2,3,0,0,1.3571428571428572,0.14285714285714285,-0.4285714285714288,72.51428571428572,7,5,0.2222222222222222,0.3,2,Phenol,131402.07390875893,146992.3003398617,1.1186452083087217,0.16175254089372412,0.43985769205061537,0.7974180334973026,Upregulated
Feature0878,NA,C11 H21 N O8 S,327.09883,NA,NA,Feature0878,11,21,8,1,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,1882847.4831910732,1948359.5278084134,1.034794132399035,0.049343778633925146,0.8581362121563773,0.9347852718829663,Upregulated
Feature0877,Maraniol,C12 H12 O3,204.07864,NA,NA,Maraniol,12,12,3,0,0,0,1,0.25,-0.5,74.55,7,4,0.4444444444444444,0.5238095238095238,4,Phenol,695281.828640052,656738.9979468357,0.9445651689637786,-0.08227775809644311,0.5522994323633873,0.8185996870696441,Downregulated
Feature0876,NA,C30 H46 O11,582.30426,NA,NA,Feature0876,30,46,11,0,0,0,1.5333333333333334,0.36666666666666664,-0.7999999999999998,83.1,8,-3,-0.15789473684210523,0.1020408163265306,-3,Protein,634040.875443785,690325.315699621,1.0887709963753374,0.12270054070657155,0.6270544427962913,0.8293364212030647,Upregulated
Feature0875,4-O-(beta-L-Araf)-cis-L-Hyp,C10 H17 N O7,263.10053,NA,Other,4-O-(beta-L-Araf)-cis-L-Hyp,10,17,7,1,0,0,1.7,0.7,0,60.3,3,-4,-2.5,-0.2727272727272727,-5,Amino Sugar,23674173.939590998,19102005.362238068,0.8068710406107661,-0.30958998388532216,0.12708016520108997,0.7829565408883704,Downregulated
Feature0874,NA,C15 H21 N3 O5,323.14822,NA,NA,Feature0874,15,21,5,3,0,0,1.4,0.3333333333333333,-0.13333333333333375,64.10000000000001,7,2,-0.14285714285714285,0.15789473684210523,-1,Phenol,36532207.64331743,41408477.80954,1.1334786611811716,0.18075723122172246,0.07053433229080093,0.7829565408883704,Upregulated
Feature0873,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26144,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak2,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,36083691.602779865,51248776.8176822,1.4202753249818272,0.5061706279575661,0.2706697966324166,0.7829565408883704,Upregulated
Feature0872,RV0540000,C5 H12 O4,136.07356,NA,NA,RV0540000,5,12,4,0,0,0,2.4,0.8,-0.7999999999999998,83.1,0,-4,-4,-0.6666666666666666,-4,Carbohydrate,37007930.6624135,43522973.6904144,1.176044510227582,0.23394266346458917,0.36329933031876255,0.7829565408883704,Upregulated
Feature0871,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,110268.21933028306,123378.69121128866,1.1188961965708017,0.16207619928212602,0.6992807478821812,0.8574786875670025,Upregulated
Feature0870,"N-Acetyl-1,6-anhydro-Î²-muramic acid",C11 H17 N O7,275.10045,Metabolic pathways;Other,NA,"N-Acetyl-1,6-anhydro-Î²-muramic acid",11,17,7,1,0,0,1.5454545454545454,0.6363636363636364,0,60.3,4,-3,-1.3333333333333333,-0.07692307692307693,-4,Amino Sugar,2204730.0791906733,2853261.276400787,1.2941544651344261,0.3720098219547529,0.04505800769735934,0.7829565408883704,Upregulated
Feature0869,N-(3-Hydroxy-4-methoxybenzoyl)glycine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,N-(3-Hydroxy-4-methoxybenzoyl)glycine,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,118537.3009208262,114464.31288614737,0.9656396087726068,-0.05044324086584365,0.9444279557591959,0.9713544839041761,Downregulated
Feature0868,α-Linolenic acid,C18 H30 O2,278.22444,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Linolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,31973281.992252834,13728392.18111615,0.42937075350733644,-1.219704169193485,0.3658816426382727,0.7829565408883704,Downregulated
Feature0867,Propionylcarnitine,C10 H19 N O4,217.13141,NA,NA,Propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,236635.07863217534,276564.3469027487,1.1687377395666652,0.22495123074645806,0.363180345001826,0.7829565408883704,Upregulated
Feature0866,Glu-Gly,C7 H12 N2 O5,204.07472,NA,NA,Glu-Gly,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,16054184.503362333,18842326.364378966,1.1736707249398246,0.2310277149835266,0.18654746464121105,0.7829565408883704,Upregulated
Feature0865,arg-leu,C12 H25 N5 O3,287.19577,NA,NA,arg-leu,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,13957374.633444099,10585256.268860273,0.7583988068570079,-0.39897140035429135,0.31676269169377236,0.7829565408883704,Downregulated
Feature0864,Tridemorph,C19 H39 N O,297.30319,NA,NA,Tridemorph,19,39,1,1,0,0,2.0526315789473686,0.05263157894736842,-1.7894736842105263,111.3,1,0,-0.0588235294117647,-0.02857142857142857,-1,Lipid,11951044.234889913,21215794.871869866,1.775225198307978,0.8280020510251809,0.07601674304539856,0.7829565408883704,Upregulated
Feature0863,ornithinoalanine,C8 H17 N3 O4,219.12181,NA,NA,ornithinoalanine,8,17,4,3,0,0,2.125,0.5,0,60.3,2,-2,-5,-1,-5,Protein,395451.65654113237,940286.5282704156,2.3777534186978757,1.249599110345581,0.5744664240093925,0.820796478981062,Upregulated
Feature0862,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Superpathway of indole-3-acetate conjugate biosynthesis,Indole-3-acetic acid,10,9,2,1,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Phenol,25481322.165086,21018758.801065933,0.8248692381380985,-0.2777626597006443,0.6158894127160266,0.8293364212030647,Downregulated
Feature0861,NA,C11 H18 N3 O6 P S,351.06552,NA,NA,Feature0861,11,18,6,3,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,719874.5114559947,707776.6362734983,0.9831944665494162,-0.024451298688769735,0.912939656811551,0.9603585751327469,Downregulated
Feature0860,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,372666.6195937167,459389.3570142483,1.232708627123828,0.3018318330905683,0.46618559117854685,0.7998439321266281,Upregulated
Feature0859,NA,C22 H33 N6 O10 P S,604.17155,NA,NA,Feature0859,22,33,10,6,1,1,1.5,0.4545454545454546,0.09090909090909084,57.70909090909091,10,0,-2,-0.3333333333333333,-8,Protein,190364.38120247368,213889.475250277,1.1235792846287864,0.16810193093079262,0.4972761689476921,0.7998439321266281,Upregulated
Feature0858,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14749,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,2270045.2567781466,1471152.8502284007,0.6480720354960648,-0.6257739122143493,0.31990002060577777,0.7829565408883704,Downregulated
Feature0857,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,C19 H32 O3,308.23512,NA,NA,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,19,32,3,0,0,0,1.6842105263157894,0.15789473684210523,-1.3684210526315788,99.29999999999998,4,1,0.0625,0.14285714285714285,1,Lipid,8740050.26226658,13119282.8881996,1.5010534830491171,0.5859753815922475,0.02452436554524565,0.7829565408883704,Upregulated
Feature0856,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",C6 H6 O4,142.02662,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",6,6,4,0,0,0,1,0.6666666666666666,0.3333333333333335,50.8,4,0,0,0.5,0,Tannin,46854972.643469565,53694459.1372936,1.1459714115269533,0.19657105372592767,0.2756658303626565,0.7829565408883704,Upregulated
Feature0855,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,209926.53000402398,173497.535453563,0.8264678859324608,-0.27496933309041227,0.44517249537094544,0.7974180334973026,Downregulated
Feature0854,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Eleostearic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,4851848.11400986,5603971.910182556,1.155018001078994,0.20791533637295298,0.5745490634734867,0.820796478981062,Upregulated
Feature0853,imazamethabenz-methyl,C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,imazamethabenz-methyl,16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Phenol,3021196.0338315233,3940566.9611385902,1.304306942353922,0.3832834187276386,0.2805504872629403,0.7829565408883704,Upregulated
Feature0852,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,3585310.399330277,7891024.881268803,2.200932137631045,1.138114662624968,0.22040148501191129,0.7829565408883704,Upregulated
Feature0851,Isobutyraldehyde,C4 H8 O,72.05754,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Isobutyraldehyde,4,8,1,0,0,0,2,0.25,-1.5,103.05,1,0,0,0.14285714285714285,0,Lipid,2676162.29547632,1202015.6724255066,0.4491564934074988,-1.1547099039810682,0.39227061962099574,0.7873878775042317,Downregulated
Feature0850,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,C12 H16 O5,240.09978,NA,NA,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Phenol,9137520.46373254,9105191.994709374,0.9964620085775479,-0.005113293417215753,0.9460692470328473,0.9714677168020872,Downregulated
Feature0849,"3,4,5-Trimethoxyphenyl acetate",C11 H14 O5,226.08413,NA,NA,"3,4,5-Trimethoxyphenyl acetate",11,14,5,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Phenol,379449.6960157727,510377.68863151566,1.345047035194622,0.42765662352952394,0.4631885939178983,0.7995347728859721,Upregulated
Feature0848,NA,C18 H33 N O15,503.18514,NA,NA,Feature0848,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,2774357.0117483465,3210310.8857858065,1.1571369049445912,0.2105595648775539,0.5808229243887058,0.820796478981062,Upregulated
Feature0847,pentobarbital,C11 H18 N2 O3,226.13174,NA,NA,pentobarbital,11,18,3,2,0,0,1.6363636363636365,0.2727272727272727,-0.5454545454545459,75.84545454545456,4,1,-0.16666666666666666,0.06666666666666667,-1,Lipid,12435767.74014322,15777006.231506633,1.2686797117139574,0.34332789530613095,0.33270344664364254,0.7829565408883704,Upregulated
Feature0846,5-Hydroxy-2-furoic acid,C5 H4 O4,128.01093,NA,NA,5-Hydroxy-2-furoic acid,5,4,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,14216150.937672967,12707912.80883386,0.8939067167018987,-0.1618038075205064,0.655138795187058,0.8362522505118077,Downregulated
Feature0845,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak3,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,293618.59999279934,368470.82809154567,1.2549301307906993,0.3276070432455493,0.4427484517118804,0.7974180334973026,Upregulated
Feature0844,DL-2-(acetylamino)-3-phenylpropanoic acid,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,DL-2-(acetylamino)-3-phenylpropanoic acid,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Phenol,1052772.962359587,992781.8057139977,0.9430160549420544,-0.08464576175145325,0.8073140542180044,0.9140326627977811,Downregulated
Feature0843,NA,C16 H21 N8 O2 P,388.15237,NA,NA,Feature0843,16,21,2,8,0,1,1.3125,0.125,0.125,56.7375,11,9,0,0.16666666666666666,0,Unsaturated HC,544509.638434968,452367.09637151234,0.8307788594371036,-0.26746359003520975,0.34879364123937506,0.7829565408883704,Downregulated
Feature0842,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11068,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak2,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Phenol,20629457.513230734,23033148.935763035,1.1165174324623268,0.1590057764900899,0.42175229464997166,0.7873878775042317,Upregulated
Feature0841,NA,C14 H31 N O,229.24056,NA,NA,Feature0841,14,31,1,1,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.2285714285714,0,-1,-0.16666666666666666,-0.12,-2,Lipid,33084879.8868149,10708784.003672129,0.32367607318833974,-1.6273773724306588,0.14857153175009438,0.7829565408883704,Downregulated
Feature0840,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Phenol,2063436.5024424433,2339439.2971182168,1.1337588020513716,0.18111375130645008,0.34530782932196863,0.7829565408883704,Upregulated
Feature0839,NA,C12 H19 N O7,289.11624,NA,NA,Feature0839,12,19,7,1,0,0,1.5833333333333333,0.5833333333333334,-0.16666666666666696,65.05000000000001,4,-3,-1,-0.06666666666666667,-4,Amino Sugar,1287638.72386649,2239555.8576346072,1.7392734593362678,0.7984847799201633,0.303515305905379,0.7829565408883704,Upregulated
Feature0838,"1D-myo-Inositol 1,2-cyclic phosphate",C6 H11 O8 P,242.01913,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis",Other,"1D-myo-Inositol 1,2-cyclic phosphate",6,11,8,0,0,1,1.8333333333333333,1.3333333333333333,0,60.3,2,-6,2.3333333333333335,-3,-7,Carbohydrate,12811483.093814684,17170027.6232526,1.3402060867989747,0.42245486452025327,0.3664538140085691,0.7829565408883704,Upregulated
Feature0837,APM,C7 H13 N O4,175.08447,NA,NA,APM-peak3,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,3294905.8421347835,3171392.0215847134,0.962513702525094,-0.05512101556982651,0.8895473375912398,0.9487246486135,Downregulated
Feature0836,NA,C16 H23 N5 O9,429.1496,NA,NA,Feature0836,16,23,9,5,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Phenol,1576068.33382196,2146778.388266307,1.3621099683288331,0.4458431823207989,0.07361086708115445,0.7829565408883704,Upregulated
Feature0835,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,321266.2143279758,191566.21549798932,0.596284971635462,-0.7459261183805372,0.5059953094624184,0.7998439321266281,Downregulated
Feature0834,NA,C11 H20 N2 O8,308.12197,NA,NA,Feature0834,11,20,8,2,0,0,1.818181818181818,0.7272727272727273,0.18181818181818168,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,4743821.75227725,6024334.917431287,1.269932816202323,0.3447521755048874,0.2527704509507942,0.7829565408883704,Upregulated
Feature0833,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,32335702.876394067,47753889.774767764,1.476816197789515,0.5624902817301634,0.0668931560723899,0.7829565408883704,Upregulated
Feature0832,cis-4-Decenedioic acid,C10 H16 O4,200.10487,NA,NA,cis-4-Decenedioic acid,10,16,4,0,0,0,1.6,0.4,-0.7999999999999998,83.1,3,-1,-0.16666666666666666,0.125,-1,Protein,2866914.9952669637,3034055.063500967,1.058299624687142,0.08174813960032568,0.9306085623351985,0.9668782304488788,Upregulated
Feature0831,EDDA,C6 H12 N2 O4,176.07974,Other,NA,EDDA,6,12,4,2,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,11894381.996793913,14456594.36600044,1.2154136608272008,0.2814474124776728,0.6189771687809813,0.8293364212030647,Upregulated
Feature0830,Neolinustatin,C17 H29 N O11,423.17418,NA,NA,Neolinustatin,17,29,11,1,0,0,1.7058823529411764,0.6470588235294118,-0.23529411764705888,67.00588235294117,4,-7,-1.6,-0.23809523809523808,-8,Amino Sugar,1854242.2382242733,1853213.8448671903,0.9994453834909576,-8.003644553824263e-4,0.9987717813813538,0.9991408892032351,Downregulated
Feature0829,NA,C12 H19 N3 O4 S,301.10964,NA,NA,Feature0829,12,19,4,3,1,0,1.5833333333333333,0.3333333333333333,0,60.3,5,1,-0.75,-0.16666666666666666,-3,Protein,276676.7262548457,325281.0193064817,1.175671780238092,0.23348535004280394,0.6634079204199839,0.8383146233448654,Upregulated
Feature0828,Gly-Phe,C11 H14 N2 O3,222.10044,NA,NA,Gly-Phe,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Phenol,10705556.7630738,18163968.834824268,1.696686051628481,0.7627196387400393,0.20846597540576345,0.7829565408883704,Upregulated
Feature0827,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",C9 H16 N2 O4,216.11101,Metabolic pathways;Other,Other,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,11672789.1636994,18403948.4578005,1.5766538913453507,0.6568659930121957,0.19060114253781707,0.7829565408883704,Upregulated
Feature0826,N-Acetyl-6-oxo-L-norleucine,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetyl-6-oxo-L-norleucine,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,955507.8760638126,1343567.4541063001,1.4061291254249917,0.4917290837821025,0.2104600937316608,0.7829565408883704,Upregulated
Feature0825,Hymexazol N-glucoside,C10 H15 N O7,261.08485,NA,NA,Hymexazol N-glucoside,10,15,7,1,0,0,1.5,0.7,0.20000000000000015,54.599999999999994,4,-3,-2,-0.09090909090909093,-4,Amino Sugar,372097.6800791257,500345.791520396,1.3446624859741094,0.42724409775094085,0.7356068275047684,0.8792678186094197,Upregulated
Feature0824,"(2Z,4E)-2,4-Pentadecadienal",C15 H26 O,222.19833,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2Z,4E)-2,4-Pentadecadienal",15,26,1,0,0,0,1.7333333333333334,0.06666666666666667,-1.5999999999999996,105.89999999999998,3,2,0.14285714285714285,0.1724137931034483,2,Lipid,26826173.0728536,43322534.68128413,1.6149353306425884,0.6914763940032549,0.1622628775960346,0.7829565408883704,Upregulated
Feature0823,pro-his,C11 H16 N4 O3,252.12227,NA,NA,pro-his,11,16,3,4,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818168,55.11818181818182,6,3,-0.25,0.09090909090909093,-1,Phenol,12126502.34338849,11069174.392955799,0.9128084982386402,-0.13161587172081335,0.7332260821602896,0.8779932381898025,Downregulated
Feature0822,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,C11 H23 N3 O2,229.17901,NA,NA,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,11,23,2,3,0,0,2.090909090909091,0.18181818181818185,-0.9090909090909092,86.2090909090909,2,0,-0.5,-0.2857142857142857,-3,Lipid,13015484.20381825,5548779.9279884035,0.42632143692054125,-1.2299864940509435,0.36353808065560317,0.7829565408883704,Downregulated
Feature0821,NA,C12 H19 N O8,305.11113,NA,NA,Feature0821,12,19,8,1,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,16466209.827336933,16264020.502851266,0.9877209554229052,-0.017824576446672177,0.9555118107042331,0.976397314763342,Downregulated
Feature0820,NA,C18 H33 N O15,503.18519,NA,NA,Feature0820,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,11565165.890241833,13608313.994070001,1.1766639686121652,0.23470237472347616,0.23550663106306383,0.7829565408883704,Upregulated
Feature0819,2762577,C15 H23 N3 O4,309.16894,NA,NA,2762577,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,7611059.2013070695,22201499.40109937,2.9170052175243413,1.5444879667262383,0.07122764391114028,0.7829565408883704,Upregulated
Feature0818,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10012,NA,NA,N-(Carboxymethyl)norleucine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,25214202.383601833,32979506.526952133,1.307973420107094,0.3873332235047188,0.15509981688224045,0.7829565408883704,Upregulated
Feature0817,2'-Deoxycytidine,C9 H13 N3 O4,227.0906,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxycytidine,9,13,4,3,0,0,1.4444444444444444,0.4444444444444444,0.44444444444444464,47.633333333333326,5,1,-1,0,-2,Phenol,5122669.962106023,3626501.439165193,0.7079318921561506,-0.49831752493925774,0.47377140649884303,0.7998439321266281,Downregulated
Feature0816,NA,C7 H17 N O6,211.10558,NA,NA,Feature0816,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,6337937.273637567,6311687.43522515,0.9958582994310148,-0.005987618910961868,0.9786145899755428,0.9900664202164838,Downregulated
Feature0815,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Phenol,28478719.232754666,27878892.702626765,0.9789377280198046,-0.030711004552139293,0.9175618471856548,0.9603585751327469,Downregulated
Feature0814,Tiglic acid,C5 H8 O2,100.05241,NA,NA,Tiglic acid-peak2,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,17068127.552935068,22879211.050797034,1.3404640303887747,0.4227325069922576,0.030323654163250696,0.7829565408883704,Upregulated
Feature0813,"(2E,4E,7E)-2,4,7-Decatrienoic acid",C10 H14 O2,166.0994,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2E,4E,7E)-2,4,7-Decatrienoic acid",10,14,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Phenol,1481424.8751327521,1744377.2192595734,1.1774996144190286,0.23572658741695757,0.5952063178546599,0.820796478981062,Upregulated
Feature0812,NA,C32 H36 O10,580.23105,NA,NA,Feature0812,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Phenol,236666.370179821,261376.46923808433,1.1044090000598243,0.14327454991001617,0.5864887428243003,0.820796478981062,Upregulated
Feature0811,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08922,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak2",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,1292215.0674037763,1092048.936899427,0.8450984394521043,-0.2428086945129873,0.5844787798153963,0.820796478981062,Downregulated
Feature0810,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,C14 H18 N2 O8,342.10633,Biosynthesis of secondary metabolites;Other,NA,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,14,18,8,2,0,0,1.2857142857142858,0.5714285714285714,0.2857142857142856,52.15714285714286,7,-1,-0.75,0.125,-3,Phenol,251662.93935451,293835.46392580634,1.1675754271942647,0.2235157532960658,0.3962446283266085,0.7873878775042317,Upregulated
Feature0809,10-Deoxymethymycin,C25 H43 N O6,453.30918,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,10-Deoxymethymycin,25,43,6,1,0,0,1.72,0.24,-1.12,92.22,5,-1,-0.1111111111111111,0.04761904761904761,-2,Lipid,1019691.7528754696,795902.7760986914,0.7805327186910096,-0.35746898593349175,0.06573382731668273,0.7829565408883704,Downregulated
Feature0808,NA,C46 H84 N10 O13 P2 S,1078.54184,NA,NA,Feature0808,46,84,13,10,1,2,1.826086956521739,0.2826086956521739,-0.7826086956521738,82.60434782608695,11,-2,-0.75,-0.32075471698113206,-15,Lipid,330004.43827884266,365962.10648694803,1.108961165479,0.14920884489381622,0.5941959412475718,0.820796478981062,Upregulated
Feature0807,Diethyl tartrate,C8 H14 O6,206.07905,NA,NA,Diethyl tartrate,8,14,6,0,0,0,1.75,0.75,-0.25,67.425,2,-4,-2,-0.2,-4,Carbohydrate,1831382.0467527534,2166243.04832395,1.1828460654427309,0.24226233481679163,0.05309269296322052,0.7829565408883704,Upregulated
Feature0806,NA,C9 H19 N O3,189.13649,NA,NA,Feature0806,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,1312925.75995004,1337634.3223617866,1.0188194665421806,0.026898430503664455,0.9040949256036175,0.955173734959754,Upregulated
Feature0805,5-guanidino-2-oxopentanoic acid,C6 H11 N3 O3,173.08005,Metabolic pathways;Other,NA,5-guanidino-2-oxopentanoic acid,6,11,3,3,0,0,1.8333333333333333,0.5,0.6666666666666665,41.3,3,0,-Inf,-1,-3,Protein,218190.857686151,325919.865341485,1.493737495685053,0.5789266361135228,0.1844523111238219,0.7829565408883704,Upregulated
Feature0804,"(E,E)-alpha-Farnesene",C15 H24,204.18778,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,"(E,E)-alpha-Farnesene",15,24,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,24967616.7253616,40058732.86552826,1.6044275793787484,0.6820586707483398,0.17094982198456077,0.7829565408883704,Upregulated
Feature0803,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,4266210.768788647,5169979.831337267,1.2118435097394957,0.27720340978503905,0.569574019001814,0.820796478981062,Upregulated
Feature0802,NA,C11 H17 N O5,243.11065,NA,NA,Feature0802,11,17,5,1,0,0,1.5454545454545454,0.4545454545454546,-0.3636363636363633,70.66363636363636,4,-1,-0.4,0.06666666666666667,-2,Protein,1797049.6162449638,1211458.3238286066,0.6741373821163696,-0.5688854674252855,0.2942192065443891,0.7829565408883704,Downregulated
Feature0801,8722455,C11 H17 N O8,291.09546,NA,NA,8722455,11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,6598305.85649967,6927382.892247947,1.0498729587419957,0.07021476324226364,0.7275551541656231,0.8768172749450367,Upregulated
Feature0800,2-methylbutyrylcarnitine,C12 H23 N O4,245.1627,NA,NA,2-methylbutyrylcarnitine,12,23,4,1,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,1072683.08535976,1115642.1449726333,1.0400482306463008,0.05665043269408865,0.9420668121287806,0.9713544839041761,Upregulated
Feature0799,dihydropyranone,C5 H6 O2,98.03675,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak1,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Phenol,36138508.10698517,37068950.194369264,1.025746555021851,0.03667430893555396,0.7322813336099896,0.8779932381898025,Upregulated
Feature0798,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Phenol,13821811.837702902,25303629.222299464,1.8307027703326606,0.8723975767301423,0.18236587525935938,0.7829565408883704,Upregulated
Feature0797,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04732,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak1,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Phenol,2024721.1986163668,3969709.9097989164,1.960620510375303,0.9713103204454407,0.4822887302049439,0.7998439321266281,Upregulated
Feature0796,UNII:74D1OHC38H,C19 H32 O4,324.23008,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak2,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1303957.775935771,1779672.109555188,1.3648234186709198,0.4487143068322462,0.5851617931680984,0.820796478981062,Upregulated
Feature0795,NA,C7 H17 N O6,211.10569,NA,NA,Feature0795,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,5632350.034322296,4170827.0225529866,0.7405127517176469,-0.43340351577916353,0.6570189860606875,0.8363589828247083,Downregulated
Feature0794,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",C11 H19 N O7,277.11616,NA,NA,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",11,19,7,1,0,0,1.7272727272727273,0.6363636363636364,-0.18181818181818168,65.48181818181817,3,-4,-1.6666666666666667,-0.2307692307692308,-5,Amino Sugar,4805893.76977429,2518977.6635202635,0.5241434339150131,-0.9319664299156567,0.2617784249423099,0.7829565408883704,Downregulated
Feature0793,NP-019722,C8 H13 N O4,187.08445,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,13317533.9336793,14893566.859205134,1.1183427001856654,0.16136234927045687,0.550128735310477,0.8164609008179302,Upregulated
Feature0792,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,2576210.94529568,2960318.61838363,1.149097912105899,0.20050173209311264,0.62294222146911,0.8293364212030647,Upregulated
Feature0791,NA,C15 H27 N O5,301.18898,NA,NA,Feature0791,15,27,5,1,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,929788.2121723803,1119230.7318666778,1.2037480333845911,0.2675334410771538,0.5397587370904139,0.8116192259717375,Upregulated
Feature0790,Bis(4-ethylbenzylidene)sorbitol,C24 H30 O6,414.20433,NA,NA,Bis(4-ethylbenzylidene)sorbitol,24,30,6,0,0,0,1.25,0.25,-0.75,81.675,10,4,0.2222222222222222,0.3333333333333333,4,Phenol,14760556.075276956,8560101.07902725,0.5799307990411625,-0.7860473357444329,0.40894738575442874,0.7873878775042317,Downregulated
Feature0789,NA,C31 H40 O6,508.28264,NA,NA,Feature0789,31,40,6,0,0,0,1.2903225806451613,0.1935483870967742,-0.903225806451613,86.04193548387097,12,6,0.24,0.32142857142857145,6,Phenol,124518.67941910363,143018.86753923568,1.1485735972019453,0.1998433033126158,0.45347607771000326,0.7974180334973026,Upregulated
Feature0788,Apocynin,C9 H10 O3,166.06303,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak2,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Phenol,1563170.4545707565,1286969.7016117433,0.8233073353252077,-0.2804970149309382,0.5082608338454999,0.7998439321266281,Downregulated
Feature0787,NA,C6 H9 O7 P,224.00856,NA,NA,Feature0787,6,9,7,0,0,1,1.5,1.1666666666666667,0,60.3,3,-4,2.5,-1,-5,Carbohydrate,7797635.931120917,11246072.7746336,1.44224132467505,0.5283125853709367,0.34336658453634084,0.7829565408883704,Upregulated
Feature0786,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.2981,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak2,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,14703527.806579923,26903831.224316966,1.8297534835332054,0.8716492922029271,0.30786413835889925,0.7829565408883704,Upregulated
Feature0785,Glycylproline,C7 H12 N2 O3,172.08476,NA,NA,Glycylproline,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,3373647.2195300334,11400960.515744243,3.379416925914517,1.7567743498635913,0.17548279148448212,0.7829565408883704,Upregulated
Feature0784,Phosphoric acid,H3 O4 P,97.97687,ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of purine nucleotide salvage;Other,Phosphoric acid,0,3,4,0,0,1,Inf,Inf,NA,NA,0,-4,1,1,-5,Other,14928513.786525933,20955362.612044133,1.4037139203339766,0.4892489415044595,0.13000311073668055,0.7829565408883704,Upregulated
Feature0783,NA,C52 H85 N10 O8 P3,1070.57651,NA,NA,Feature0783,52,85,8,10,0,3,1.6346153846153846,0.15384615384615383,-1.0384615384615383,89.89615384615384,17,9,-0.12903225806451613,0,-4,Lipid,141454.04071053577,157523.88869819767,1.1136047291893654,0.155237243062531,0.5833532392668914,0.820796478981062,Upregulated
Feature0782,Glycylglutamic acid,C7 H12 N2 O5,204.07457,NA,NA,Glycylglutamic acid,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,5744537.754030527,12815993.843730396,2.2309878344412204,1.1576826465990082,0.05397174580957432,0.7829565408883704,Upregulated
Feature0781,NA,C12 H22 N4 O6,318.15394,NA,NA,Feature0781,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,32442671.63011433,33526350.793606933,1.0334028952932068,0.04740283089137765,0.7841240703806424,0.901638149577507,Upregulated
Feature0780,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",C12 H14 N2 O5,266.0903,NA,NA,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",12,14,5,2,0,0,1.1666666666666667,0.4166666666666667,0.16666666666666652,55.55,7,2,0,0.3333333333333333,0,Phenol,107819.1226927442,121859.77190947667,1.130224109286667,0.1766088693653167,0.4775092144819872,0.7998439321266281,Upregulated
Feature0779,Pipecolic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,6682971.596449307,6037645.34703075,0.9034372299649721,-0.1465037275153896,0.6356849388221063,0.8327137707002961,Downregulated
Feature0778,NA,C11 H14 N O P S,239.05347,NA,NA,Feature0778,11,14,1,1,1,1,1.2727272727272727,0.09090909090909093,-1.0909090909090908,91.39090909090908,6,5,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,194092.30749008767,220394.71963655434,1.1355149644341775,0.1833467187904815,0.28358945227740695,0.7829565408883704,Upregulated
Feature0777,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",C13 H21 N O2,223.15721,NA,NA,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",13,21,2,1,0,0,1.6153846153846154,0.15384615384615383,-1.0769230769230766,90.99230769230768,4,2,0.1,0.18181818181818185,1,Lipid,29136705.151380602,28537651.708406735,0.9794399044139869,-0.029971119253799652,0.7843126862634999,0.901638149577507,Downregulated
Feature0776,NA,C16 H21 N5 O9,427.13398,NA,NA,Feature0776,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,28262747.3261123,25066443.4449088,0.8869075308099863,-0.1731443982483246,0.6337231067749807,0.8316226032766414,Downregulated
Feature0775,NA,C4 H11 O6 P,186.02935,NA,NA,Feature0775,4,11,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,17776676.7961467,16255308.387212267,0.9144177268687135,-0.1290747230304119,0.7930693271595555,0.9061342006853577,Downregulated
Feature0774,NA,C13 H19 N O6,285.1213,NA,NA,Feature0774,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Phenol,408357.8557775607,367766.478512462,0.900598515025974,-0.15104399602886776,0.7482965391641918,0.8847091047453014,Downregulated
Feature0773,Kanosamine,C6 H13 N O5,179.07944,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,11197864.309641046,8929753.91658925,0.7974515201886295,-0.3265312797207,0.5954797984764568,0.820796478981062,Downregulated
Feature0772,Ser-Glu,C8 H14 N2 O6,234.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,Ser-Glu,8,14,6,2,0,0,1.75,0.75,0.5,46.05,3,-3,-Inf,-0.6666666666666666,-5,Carbohydrate,6092711.411056063,16702873.176068284,2.741451555666763,1.454939979920747,0.13251230310847847,0.7829565408883704,Upregulated
Feature0771,Apocynin,C9 H10 O3,166.06304,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak1,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Phenol,861902.5394135483,771583.817653088,0.8952100526099916,-0.15970185798195402,0.8352202132814113,0.9237754086702655,Downregulated
Feature0770,Ethyl lactate,C5 H10 O3,118.06297000000001,Metabolic pathways;Other,NA,Ethyl lactate,5,10,3,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,16660753.662814101,19778677.2018482,1.1871418065554342,0.2474922781936655,0.14584641374194635,0.7829565408883704,Upregulated
Feature0769,Furan,C4 H4 O,68.02622,Other,NA,Furan,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Phenol,17518109.857934933,18552933.813088432,1.059071667180165,0.082800219535176,0.5556543451081971,0.820796478981062,Upregulated
Feature0768,Acetylcholine,C7 H15 N O2,145.11029,NA,NA,Acetylcholine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,3339707.04269075,2709288.18200576,0.8112352812308137,-0.3018076972923188,0.3776151744422653,0.7829565408883704,Downregulated
Feature0767,3-Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,3-Methylhippuric acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Phenol,2634344.0597624667,4599855.75026097,1.7461104722500558,0.8041448377333777,0.1650328447434946,0.7829565408883704,Upregulated
Feature0766,glycidyl oleate,C21 H38 O3,338.28215,NA,NA,glycidyl oleate,21,38,3,0,0,0,1.8095238095238095,0.14285714285714285,-1.5238095238095235,103.72857142857144,3,0,0,0.07692307692307693,0,Lipid,1328506.0702837142,1534914.5224842615,1.1553688438596799,0.20835349602126169,0.7569703570013274,0.8847091047453014,Upregulated
Feature0765,Muramic acid,C9 H17 N O7,251.10052,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak1,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,1591202.1506800633,1300421.0428661634,0.8172569665710777,-0.291138324828491,0.29486753853376374,0.7829565408883704,Downregulated
Feature0764,NP-001346,C11 H15 N5 O3 S,297.08963,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,NP-001346,11,15,3,5,1,0,1.3636363636363635,0.2727272727272727,0.7272727272727271,39.57272727272728,7,4,-1,-0.14285714285714285,-2,Phenol,2444567.2781775966,2106400.11402154,0.8616658387049355,-0.21479960644422377,0.6308327330447281,0.8293364212030647,Downregulated
Feature0763,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",C8 H15 N O5,205.09502,NA,NA,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,6285503.032914303,6664800.657942883,1.0603448320750737,0.08453351631917701,0.6582587670579785,0.8363589828247083,Upregulated
Feature0762,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,3784513.43723092,4530740.0583566865,1.197179012177526,0.25963889219053893,0.7491787009044346,0.8847091047453014,Upregulated
Feature0761,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10594,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,5,2,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Phenol,236296.111644129,316990.59524652665,1.341497297780027,0.42384414853560826,0.33264933109470074,0.7829565408883704,Upregulated
Feature0760,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08948,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak2",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,916860.9060775621,982799.4525797183,1.0719177206325101,0.10019417016962938,0.9254822699318455,0.9659452156870052,Upregulated
Feature0759,Fluoranthene,C16 H10,202.07831,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak2,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,3897084.6737683634,2370662.986921739,0.6083170332117468,-0.7171046938566736,0.630727226891239,0.8293364212030647,Downregulated
Feature0758,Icacine,C22 H31 N O6,405.21526,NA,NA,Icacine-peak2,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Phenol,515795.7749504643,540365.7953612953,1.0476351719111903,0.06713640074049894,0.7532837206649188,0.8847091047453014,Upregulated
Feature0757,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,2382628.6344733573,2356223.5468663974,0.9889176654620385,-0.01607768368484804,0.9885931318844806,0.9956925439626456,Downregulated
Feature0756,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,4440859.277566744,3052452.72009127,0.6873563266260001,-0.5408699064907001,0.39928803885576997,0.7873878775042317,Downregulated
Feature0755,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature0755,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,1493870.2451069765,2004311.4097783368,1.341690428832932,0.42405183375269945,0.28158791817055057,0.7829565408883704,Upregulated
Feature0754,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,NA,Cytidine 5'-diphosphocholine,14,26,11,4,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,1475491.3273642699,516213.463511253,0.34985869041560963,-1.515155766551012,0.4208225293279146,0.7873878775042317,Downregulated
Feature0753,NA,C18 H28 O,260.21405,NA,NA,Feature0753,18,28,1,0,0,0,1.5555555555555556,0.05555555555555555,-1.4444444444444446,101.46666666666668,5,4,0.2352941176470588,0.2571428571428571,4,Lipid,1240029.0918568387,1350951.0492747333,1.0894510928383128,0.12360143307305933,0.6442425947119346,0.8329695325287205,Upregulated
Feature0752,Pogostone,C12 H16 O4,224.10484,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,Pogostone,12,16,4,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,5,1,0.125,0.3,1,Phenol,113898.21335687733,146243.75536535567,1.283986386223022,0.36062990601733824,0.24119493208087991,0.7829565408883704,Upregulated
Feature0751,NA,C13 H18 O9,318.09513,NA,NA,Feature0751,13,18,9,0,0,0,1.3846153846153846,0.6923076923076923,0,60.3,5,-4,-1,0.0588235294117647,-4,Tannin,129324.37045032273,1951958.046371996,15.093505111024685,3.9158559715992447,0.23017649115844807,0.7829565408883704,Upregulated
Feature0750,Acetylarginine,C8 H16 N4 O3,216.12223,NA,NA,Acetylarginine,8,16,3,4,0,0,2,0.375,0.25,53.175,3,0,-4,-1,-4,Protein,1547521.5076384866,2182806.8914716835,1.4105179674062434,0.49622504332354694,0.2820271448133106,0.7829565408883704,Upregulated
Feature0749,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11096,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,4221423.178315717,6068695.251371357,1.43759462035092,0.5236569152351369,0.3414569867107894,0.7829565408883704,Upregulated
Feature0748,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",C11 H17 N O8,291.09544,NA,NA,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,24838710.78778953,28119307.153379068,1.132075951671463,0.1789707527139244,0.18158005172533598,0.7829565408883704,Upregulated
Feature0747,NA,C6 H15 N O4 S,197.07221,NA,NA,Feature0747,6,15,4,1,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,14902379.955123367,20814052.291012466,1.3966931693924967,0.48201511909012346,0.1313079020079603,0.7829565408883704,Upregulated
Feature0746,NA,C10 H25 N10 O4 P,380.1797,NA,NA,Feature0746,10,25,4,10,0,1,2.5,0.4,0.7999999999999998,37.5,4,0,2.2,3,-11,Other,4308041.204835377,6580611.837261913,1.5275183138628727,0.6111896770395917,0.034801890195818065,0.7829565408883704,Upregulated
Feature0745,4149853,C21 H41 N O4,371.30356,NA,NA,4149853,21,41,4,1,0,0,1.9523809523809523,0.1904761904761905,-1.4285714285714288,101.01428571428572,2,-2,-0.1875,-0.05555555555555555,-3,Lipid,12078440.377236757,25211993.003597133,2.0873550074488176,1.0616759881019209,0.019504648154123325,0.7829565408883704,Upregulated
Feature0744,Terpendole I,C27 H35 N O5,453.2516,Biosynthesis of secondary metabolites;Other,NA,Terpendole I,27,35,5,1,0,0,1.2962962962962965,0.18518518518518515,-0.8148148148148149,83.52222222222223,11,6,0.23809523809523808,0.3191489361702128,5,Phenol,608647.0139041137,938632.841022208,1.542162895043925,0.6249551617898825,0.3828855239794354,0.7829565408883704,Upregulated
Feature0743,mycosporine,C11 H19 N O6,261.12118,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak2,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,315270.571792814,250428.30785668068,0.794328206507185,-0.33219286073791016,0.36499557393314,0.7829565408883704,Downregulated
Feature0742,N-Benzylformamide,C8 H9 N O,135.06844,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,N-Benzylformamide,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,220462.283964317,455235.4689174177,2.0649131485506156,1.046081102327344,0.010914073603126165,0.7829565408883704,Upregulated
Feature0741,Arg-Glu,C11 H21 N5 O5,303.15426,NA,NA,Arg-Glu,11,21,5,5,0,0,1.9090909090909092,0.4545454545454546,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,7351443.086696863,13460005.12310531,1.830933731563871,0.8725795754747878,0.1183067028289846,0.7829565408883704,Upregulated
Feature0740,Mesalazine,C7 H7 N O3,153.04261,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,Mesalazine,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Phenol,4370130.769517093,5816268.615082613,1.3309140897230682,0.4124174485370828,0.03319211841996996,0.7829565408883704,Upregulated
Feature0739,Fluoranthene,C16 H10,202.07828,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak1,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,228413.328176365,235754.59957944267,1.0321402934832649,0.04563908215294206,0.930684927704803,0.9668782304488788,Upregulated
Feature0738,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak2,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,1014774.285664735,1055834.4658322623,1.040462377444488,0.057224798945828124,0.8245058885904912,0.9177535783715587,Upregulated
Feature0737,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,2333354.562866962,884746.973492278,0.3791738244894942,-1.399068720795246,0.3383741517443424,0.7829565408883704,Downregulated
Feature0736,1726033,C6 H13 N O6,195.07432,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak2,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,10446262.820064576,7333074.140146007,0.7019806285230602,-0.5104968756386078,0.012864060481286356,0.7829565408883704,Downregulated
Feature0735,Norharman,C11 H8 N2,168.06878,NA,NA,Norharman,11,8,0,2,0,0,0.7272727272727273,0,-0.18181818181818168,65.48181818181817,9,9,0.7777777777777778,0.7777777777777778,7,Condensed HC,7631480.8622159995,7551763.30981374,0.9895541174980931,-0.015149486238959876,0.9352851942127154,0.9691719887335095,Downregulated
Feature0734,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11607,NA,Other,N1-Acetyl-5-methoxykynuramine,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Phenol,2426433.2839538935,1993745.3103880766,0.8216773663520028,-0.28335606756729753,0.35495785254710877,0.7829565408883704,Downregulated
Feature0733,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature0733,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,21809632.7863606,22026717.2340038,1.0099536039771821,0.014289018868678376,0.7505023008995435,0.8847091047453014,Upregulated
Feature0732,4-Acetamidobutanoic acid,C6 H11 N O3,145.07388,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak1,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,747892.8203202327,686515.38137752,0.9179328410768377,-0.12353948960306976,0.8181415588262442,0.9142978308596724,Downregulated
Feature0731,N-Acetylglucosaminitol,C8 H17 N O6,223.10552,NA,NA,N-Acetylglucosaminitol-peak1,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,17722084.145549603,12010733.199251834,0.6777269028071954,-0.5612240535869397,0.13333122475832687,0.7829565408883704,Downregulated
Feature0730,D-Alanyl-D-alanine,C6 H12 N2 O3,160.08481,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,D-Alanyl-D-alanine,6,12,3,2,0,0,2,0.5,0,60.3,2,-1,-3,-0.6,-3,Protein,7337734.422690333,7335620.1407053,0.9997118617459777,-4.15755530581589e-4,0.9983747725831436,0.9991408892032351,Downregulated
Feature0729,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08924,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak1",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Phenol,871435.9750904327,1264740.6935579167,1.4513294489898343,0.5373750455757932,0.1099109543842842,0.7829565408883704,Upregulated
Feature0728,cys-val,C8 H16 N2 O3 S,220.08814,NA,NA,cys-val-peak2,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,3941691.88111353,2125920.594425733,0.5393421552333917,-0.8907272949173399,0.3698992559395416,0.7829565408883704,Downregulated
Feature0727,NA,C29 H30 O10,538.18408,NA,NA,Feature0727,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Phenol,350238.05621094664,396768.009776318,1.132852363528841,0.17995985737801887,0.5292145500996949,0.8098418097030804,Upregulated
Feature0726,2'-O-Methyladenosine,C11 H15 N5 O4,281.11245,NA,NA,2'-O-Methyladenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Phenol,10139235.926685331,16465249.175329566,1.6239141977153206,0.6994754072763018,0.017662636846855064,0.7829565408883704,Upregulated
Feature0725,Imidazoleacetic acid,C5 H6 N2 O2,126.04288,Metabolic pathways;Other,Other,Imidazoleacetic acid,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Phenol,29180957.838676333,31904046.15596037,1.0933173041247763,0.1287121628149946,0.5682273569411436,0.820796478981062,Upregulated
Feature0724,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10594,NA,NA,α-Aspartylphenylalanine-peak2,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Phenol,2487793.50721406,3976676.6279427134,1.5984753623687884,0.6766965077328875,0.24235469250881989,0.7829565408883704,Upregulated
Feature0723,Indole-3-lactic acid,C11 H11 N O3,205.07389,Metabolic pathways;Other,Other,Indole-3-lactic acid,11,11,3,1,0,0,1,0.2727272727272727,-0.18181818181818168,65.48181818181817,7,4,0.42857142857142855,0.5294117647058824,3,Phenol,5270894.486921307,4393275.799343104,0.8334972005689277,-0.2627507411850975,0.50636717320199,0.7998439321266281,Downregulated
Feature0722,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10622,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak3,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,7811031.380019766,8675297.197791796,1.1106468244363707,0.15140012578396317,0.6699930538295047,0.8383146233448654,Upregulated
Feature0721,N-Acetylvaline,C7 H13 N O3,159.08955,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,3734909.36480916,3545240.6577510033,0.9492173200117674,-0.07518966980101882,0.8730396754209023,0.9403497372086917,Downregulated
Feature0720,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06372,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Phenol,24118215.4354955,26951795.495827567,1.1174871361403382,0.16025822404093457,0.12971944030707563,0.7829565408883704,Upregulated
Feature0719,Prolylglycine,C7 H12 N2 O3,172.08478,NA,NA,Prolylglycine,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,5413932.1547114635,9337995.83469392,1.7248084327335997,0.786436136677781,0.020012493906102526,0.7829565408883704,Upregulated
Feature0718,NA,C10 H22 N2 O6,266.14776,NA,NA,Feature0718,10,22,6,2,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-5,-3.5,-0.8,-7,Amino Sugar,22886068.3715825,19627408.999066498,0.8576138408918562,-0.22159990548054134,0.1065932358997376,0.7829565408883704,Downregulated
Feature0717,Acetyl-L-methionine,C7 H13 N O3 S,191.06162,NA,NA,Acetyl-L-methionine-peak2,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,8378278.696594346,2318470.25879428,0.2767239361155061,-1.8534806550537124,0.2116300995409722,0.7829565408883704,Downregulated
Feature0716,NP-007735,C18 H24 O12,432.1269,NA,NA,NP-007735,18,24,12,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,7,-5,-0.8333333333333334,0.08333333333333333,-5,Tannin,125112.40155444543,145293.27532291468,1.1613019454325404,0.21574313029302639,0.3834406849214782,0.7829565408883704,Upregulated
Feature0715,NA,C16 H28 N2 O8,376.18453,NA,NA,Feature0715,16,28,8,2,0,0,1.75,0.5,-0.375,70.9875,4,-4,-1,-0.2,-6,Protein,10723948.2145859,12905254.128749367,1.2034051144704914,0.26712239334586485,0.13624460526343257,0.7829565408883704,Upregulated
Feature0714,HC blue 2,C12 H19 N3 O5,285.1325,NA,NA,HC blue 2-peak2,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,6239692.193596397,7652517.15187324,1.2264254252360047,0.29445951117788344,0.35699847775505916,0.7829565408883704,Upregulated
Feature0713,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Stavudine,10,12,4,2,0,0,1.2,0.4,0.20000000000000015,54.599999999999994,6,2,0,0.3333333333333333,0,Phenol,195682.74058957933,182672.68352120635,0.9335145397638314,-0.09925560186082645,0.8975788282090689,0.952451823989676,Downregulated
Feature0712,val-his,C11 H18 N4 O3,254.1379,NA,NA,val-his,11,18,3,4,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909093,-2,Lipid,10078426.742309617,12205919.2171937,1.2110937083019901,0.27631049779209355,0.17964473711642068,0.7829565408883704,Upregulated
Feature0711,lamifiban,C24 H28 N4 O6,468.20096,NA,NA,lamifiban-peak3,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Phenol,23624802.308456134,26616246.646119032,1.12662304211503,0.17200488352938217,0.2911904356027457,0.7829565408883704,Upregulated
Feature0710,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,26413015.1336038,29542640.645668633,1.1184880066222802,0.16154978667926057,0.2564276368162086,0.7829565408883704,Upregulated
Feature0709,NA,C6 H19 N4 O P,194.12956,NA,NA,Feature0709,6,19,1,4,0,1,3.1666666666666665,0.16666666666666666,-1.666666666666667,107.8,0,-1,-Inf,-11,-6,Other,1103364.169572668,1889756.6758966832,1.7127225335118363,0.7762914491746072,0.33218660710435033,0.7829565408883704,Upregulated
Feature0708,indospicine,C7 H15 N3 O2,173.11643,NA,NA,indospicine,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,1435147.563337297,1121438.4368792907,0.7814098462958708,-0.3558486603118654,0.41613227016913584,0.7873878775042317,Downregulated
Feature0707,ser-gln,C8 H15 N3 O5,233.10121,NA,NA,ser-gln,8,15,5,3,0,0,1.875,0.625,0.5,46.05,3,-2,-Inf,-1,-5,Amino Sugar,3939991.98210936,3769289.22111433,0.9566743379757742,-0.06390019519799794,0.7919847814084695,0.9061342006853577,Downregulated
Feature0706,Isovalerylglutamic acid,C10 H17 N O5,231.11068,NA,NA,Isovalerylglutamic acid-peak6,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,6942308.60078755,8102195.795885273,1.16707514197311,0.22289745175820894,0.3175670061069037,0.7829565408883704,Upregulated
Feature0705,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",C9 H12 O4,184.07358,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",9,12,4,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Phenol,583837.9129803313,708638.7866792476,1.2137594543352663,0.2794825332712289,0.4782374515607836,0.7998439321266281,Upregulated
Feature0704,NA,C26 H40 O3 S2,464.24195,Other,NA,Feature0704,26,40,3,0,2,0,1.5384615384615383,0.1153846153846154,-1.1538461538461542,93.1846153846154,7,4,0.09523809523809525,0.15555555555555556,2,Lipid,13801411.456524476,8820627.734684294,0.6391105549218614,-0.6458625811773396,0.6808726055236971,0.8450653356168011,Downregulated
Feature0703,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",C21 H22 O7,386.13664,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",21,22,7,0,0,0,1.0476190476190477,0.3333333333333333,-0.3809523809523814,71.15714285714287,11,4,0.2857142857142857,0.42857142857142855,4,Phenol,168770.16621850934,202202.20355089067,1.198092104081336,0.2607388204753751,0.45507770420166915,0.7974180334973026,Upregulated
Feature0702,nicotianamine,C12 H21 N3 O6,303.14313,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,nicotianamine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,559810.9722604023,1129209.9668872994,2.0171272498068062,1.0123020987622209,0.18151646077949785,0.7829565408883704,Upregulated
Feature0701,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,6844491.322364833,7638934.043724247,1.1160703818505138,0.15842800955507907,0.6661273066628319,0.8383146233448654,Upregulated
Feature0700,N-(2-morpholinophenyl)-2-furamide,C15 H16 N2 O3,272.11607,NA,NA,N-(2-morpholinophenyl)-2-furamide,15,16,3,2,0,0,1.0666666666666669,0.2,-0.2666666666666666,67.89999999999999,9,6,0.4,0.4782608695652174,4,Phenol,2162376.111941113,3143602.7248198967,1.4537724068723457,0.5398014280076888,0.2203273677387172,0.7829565408883704,Upregulated
Feature0699,17-Methyl-6Z-octadecenoic acid,C19 H36 O2,296.27159,NA,NA,17-Methyl-6Z-octadecenoic acid,19,36,2,0,0,0,1.894736842105263,0.10526315789473684,-1.6842105263157894,108.3,2,0,0,0.05555555555555555,0,Lipid,3580392.5155365635,5197310.798529923,1.4516036373042873,0.5376475769163019,0.5274636992290502,0.8098418097030804,Upregulated
Feature0698,NA,C23 H33 N3 O5,431.24203,NA,NA,Feature0698,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Phenol,1266239.8441197986,1712423.3435651534,1.3523688671757998,0.4354887095071388,0.1592065751797377,0.7829565408883704,Upregulated
Feature0697,threonylphenylalanine,C13 H18 N2 O4,266.12655,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak4,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,136229.435832708,156218.80799619434,1.146733134739203,0.19752968953712843,0.6677130211690928,0.8383146233448654,Upregulated
Feature0696,NA,C27 H33 N8 O7 P,612.22109,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Feature0696,27,33,7,8,0,1,1.2222222222222223,0.25925925925925924,0,60.3,16,9,0,0.2413793103448276,0,Phenol,532053.1025504853,590484.1316324064,1.1098217993689394,0.1503280461198738,0.5913146639615253,0.820796478981062,Upregulated
Feature0695,Phenacetin,C10 H13 N O2,179.09465,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,2850178.88748823,1347954.4553434318,0.4729367904803127,-1.0802807192600579,0.19842716477038175,0.7829565408883704,Downregulated
Feature0694,2181,C11 H15 N O2,193.11028,NA,NA,2181,11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Phenol,21642212.711967766,26074773.483397633,1.2048108865032428,0.26880671117268007,0.10530326435159867,0.7829565408883704,Upregulated
Feature0693,N-Acetyl-L-leucine,C8 H15 N O3,173.10517,Other,NA,N-Acetyl-L-leucine-peak4,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,4988757.33030108,5820999.599337326,1.1668235622489216,0.22258642470187265,0.43815639867260275,0.7974180334973026,Upregulated
Feature0692,NA,C20 H30 N4 O6,422.21665,NA,NA,Feature0692,20,30,6,4,0,0,1.5,0.3,-0.2999999999999998,68.85,8,2,-0.2,0.07692307692307693,-2,Lipid,790433.719977719,486721.794455509,0.6157654742629513,-0.6995471166017646,0.14300626806790476,0.7829565408883704,Downregulated
Feature0691,1â€²-Acetoxyeugenol acetate,C14 H16 O5,264.09978,NA,NA,1â€²-Acetoxyeugenol acetate,14,16,5,0,0,0,1.1428571428571428,0.35714285714285715,-0.4285714285714288,72.51428571428572,7,2,0.2222222222222222,0.391304347826087,2,Phenol,249819.42975307832,285333.81902168033,1.1421602367105892,0.19176506444073707,0.6709505630692416,0.8383146233448654,Upregulated
Feature0690,Val-lys,C11 H23 N3 O3,245.17392,NA,NA,Val-lys,11,23,3,3,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,3900834.4300859496,4241423.793557974,1.0873119250704828,0.12076587614896397,0.7253261355268212,0.876012835372544,Upregulated
Feature0689,Crotanecine,C8 H13 N O3,171.08958,Other,NA,Crotanecine-peak2,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,7307706.353234463,8723284.544390101,1.193710327526925,0.25545278656723436,0.30475659837329533,0.7829565408883704,Upregulated
Feature0688,thiodiglycol,C4 H10 O2 S,122.04011,NA,NA,thiodiglycol,4,10,2,0,1,0,2.5,0.5,-1,88.8,0,-2,-3,-1,-3,Other,17648733.963040866,18713809.1196489,1.0603485303160252,0.08453854810168299,0.6906565101935469,0.8533979271633765,Upregulated
Feature0687,NA,C17 H29 N3 O7,387.20043,NA,NA,Feature0687,17,29,7,3,0,0,1.7058823529411764,0.4117647058823529,-0.35294117647058787,70.35882352941175,5,-2,-0.7142857142857143,-0.14285714285714285,-5,Protein,474686.30055668805,564478.7235689033,1.189161606111049,0.24994478950908094,0.409576027985682,0.7873878775042317,Upregulated
Feature0686,NA,C16 H22 N2 O8,370.13769,NA,NA,Feature0686,16,22,8,2,0,0,1.375,0.5,0,60.3,7,-1,-0.5,0.1,-3,Phenol,20422361.007440433,23050669.690641366,1.1286975919308921,0.17465900155621067,0.24753474962340424,0.7829565408883704,Upregulated
Feature0685,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10596,NA,NA,α-Aspartylphenylalanine-peak1,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Phenol,4287062.905616663,5184746.01834072,1.2093935014454684,0.27428373194600486,0.07030542743241198,0.7829565408883704,Upregulated
Feature0684,N-Acetyl-L-leucine,C8 H15 N O3,173.10514,Other,NA,N-Acetyl-L-leucine-peak3,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,3590723.407071347,4421532.320983057,1.2313764720155183,0.30027190826786815,0.35363771139443634,0.7829565408883704,Upregulated
Feature0683,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",C23 H28 O7,416.18357,NA,NA,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",23,28,7,0,0,0,1.2173913043478262,0.30434782608695654,-0.6086956521739131,77.64782608695651,10,3,0.1875,0.3333333333333333,3,Phenol,235851.05119322732,256896.49625981066,1.0892319324425708,0.12331118284987971,0.6522727469738808,0.8362522505118077,Upregulated
Feature0682,MFCD00672375,C5 H9 N O5,163.04806,Metabolic pathways;Other,NA,MFCD00672375,5,9,5,1,0,0,1.8,1,0.7999999999999998,37.5,2,-3,4,-1,-4,Carbohydrate,8648866.601740938,12372301.4793335,1.4305113084809364,0.5165309025019776,0.5047286999060886,0.7998439321266281,Upregulated
Feature0681,Phe-his,C15 H18 N4 O3,302.13799,NA,NA,Phe-his,15,18,3,4,0,0,1.2,0.2,0,60.3,9,6,0.25,0.3684210526315789,2,Phenol,2759233.0086197634,3452712.19116035,1.2513304169579655,0.3234627870780119,0.02082014778519802,0.7829565408883704,Upregulated
Feature0680,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",C10 H14 O4,198.08925,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",10,14,4,0,0,0,1.4,0.4,-0.5999999999999996,77.39999999999999,4,0,0,0.25,0,Phenol,1978590.4267642633,1787264.7606631033,0.9033020358771021,-0.1467196345299534,0.8175909409113197,0.9142978308596724,Downregulated
Feature0679,lamifiban,C24 H28 N4 O6,468.20102,NA,NA,lamifiban-peak2,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Phenol,9954772.373984937,6490091.49105068,0.651957799458218,-0.6171495115395059,0.5644098342302099,0.820796478981062,Downregulated
Feature0678,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10008,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak3",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Phenol,9902845.924888054,11058394.260384807,1.116688509975966,0.15922681537981112,0.445857797501456,0.7974180334973026,Upregulated
Feature0677,NA,C14 H27 N O9,353.16869,Biosynthesis of secondary metabolites;Other,NA,Feature0677,14,27,9,1,0,0,1.9285714285714288,0.6428571428571429,-0.4285714285714288,72.51428571428572,2,-7,-2,-0.4117647058823529,-8,Amino Sugar,133108.22366005316,151786.93806140867,1.1403272757140785,0.18944793955495406,0.591604434667025,0.820796478981062,Upregulated
Feature0676,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07865,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak1",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,18918793.890794165,16716802.883858733,0.8836082775865054,-0.17852116105489715,0.24720789187927827,0.7829565408883704,Downregulated
Feature0675,met-pro,C10 H18 N2 O3 S,246.10387,NA,NA,met-pro,10,18,3,2,1,0,1.8,0.3,-0.4000000000000003,71.7,3,0,-0.75,-0.2727272727272727,-3,Lipid,6387627.131099683,4877489.050409457,0.7635838708653234,-0.38914146578140657,0.2969448172613297,0.7829565408883704,Downregulated
Feature0674,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,408881.6069422947,409012.51936304034,1.0003201719483659,4.618365525293775e-4,0.9991408892032351,0.9991408892032351,Upregulated
Feature0673,NA,C18 H35 N5 O8,449.24869,NA,NA,Feature0673,18,35,8,5,0,0,1.9444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,-4,-1.8,-0.5555555555555556,-9,Protein,12823097.24551199,10786167.739975696,0.8411515200628142,-0.2495623924406796,0.36432786722948757,0.7829565408883704,Downregulated
Feature0672,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07395,NA,NA,Phenyl D-glucopyranosiduronic acid-peak3,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,6553007.200203817,21298869.40858067,3.250243553512075,1.700547828996119,0.08000014776247034,0.7829565408883704,Upregulated
Feature0671,Borrelidin,C28 H43 N O6,489.30914,NA,NA,Borrelidin,28,43,6,1,0,0,1.5357142857142858,0.21428571428571427,-1,88.8,8,2,0.04761904761904761,0.16666666666666666,1,Lipid,645189.9556541783,516135.19991676335,0.7999740160143034,-0.3219749543574976,0.34220898212988765,0.7829565408883704,Downregulated
Feature0670,L-Ergothioneine,C9 H15 N3 O2 S,229.08852,NA,NA,L-Ergothioneine,9,15,2,3,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,9122457.698245954,14174422.241524266,1.553794241682227,0.6357954701816083,0.2738672118376727,0.7829565408883704,Upregulated
Feature0669,Propoxur,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Propoxur,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,10515573.760662444,12747745.578534367,1.2122729456971926,0.27771456108029974,0.22160762397359257,0.7829565408883704,Upregulated
Feature0668,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0668,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Phenol,8121275.46531626,7577463.88471762,0.9330386485569773,-0.09999125290286832,0.7783856312522414,0.89831628989012,Downregulated
Feature0667,NA,C5 H10 N9 O2 P,259.06957,NA,NA,Feature0667,5,10,2,9,0,1,2,0.4,3.2,-30.90000000000001,6,4,0.8571428571428571,0.8333333333333334,-6,Protein,2184497.9282775465,2323726.6878797133,1.0637349011870874,0.08913865422653092,0.5789945706119664,0.820796478981062,Upregulated
Feature0666,NA,C11 H19 N5 O2,253.15395,NA,NA,Feature0666,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,2916871.1529228534,2302726.8250601334,0.7894509919482332,-0.34107838658246625,0.40660861023348915,0.7873878775042317,Downregulated
Feature0665,NA,C16 H30 N2 O9,394.19526,NA,NA,Feature0665,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,4744707.14027695,6528548.2223691065,1.3759644229565733,0.46044316808676183,0.38424759244234674,0.7829565408883704,Upregulated
Feature0664,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak1,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,17644129.076620165,21962779.850156866,1.244764179335961,0.31587244950009546,0.26510088114677793,0.7829565408883704,Upregulated
Feature0663,NA,C9 H19 N O9,285.106,NA,NA,Feature0663,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,12113336.061901763,5172563.591326383,0.4270139592341421,-1.227644862070417,0.18380859698000326,0.7829565408883704,Downregulated
Feature0662,NA,C13 H25 N3 O4,287.18454,NA,NA,Feature0662,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,8503210.892765714,8428830.915457854,0.9912527187381487,-0.012675177142962488,0.9770628617385675,0.989408421363423,Downregulated
Feature0661,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak1,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,587051.396003852,298045.157926851,0.5076985762331708,-0.9779558806426042,0.22395284274179367,0.7829565408883704,Downregulated
Feature0660,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,NA,N8-Acetylspermidine,9,21,1,3,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666664,1,0,-0.6,-0.4545454545454546,-3,Lipid,1277346.0278490388,264269.15920487134,0.20688924805276301,-2.273069423995975,0.20294559368621387,0.7829565408883704,Downregulated
Feature0659,NA,C19 H41 N O2,315.3138,NA,NA,Feature0659,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,10468141.230016967,16198917.629052466,1.547449281884231,0.6298921254504044,0.5586442147370263,0.820796478981062,Upregulated
Feature0658,Guanine,C5 H5 N5 O,151.0494,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak1,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Phenol,17762838.367039565,19606497.1652409,1.1037930290252709,0.14246967936988814,0.01851833956645177,0.7829565408883704,Upregulated
Feature0657,NA,C18 H34 N2 O8,406.23161,NA,NA,Feature0657,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,91068.72825440357,102124.1934820586,1.1213969431611168,0.1652970422502799,0.5936981538930437,0.820796478981062,Upregulated
Feature0656,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,C9 H15 N3 O3 S,245.08343,NA,NA,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,9,15,3,3,1,0,1.6666666666666667,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,4688827.501723477,9065761.645914543,1.9334815884316991,0.951201026430158,0.33472968891266836,0.7829565408883704,Upregulated
Feature0655,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Phenol,19044403.423702918,18773982.5305755,0.9858005059485954,-0.020632373434576946,0.9644409345619672,0.9833412914850813,Downregulated
Feature0654,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07396,NA,NA,Phenyl D-glucopyranosiduronic acid-peak2,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,12492891.547885787,11425702.51170653,0.9145762986824406,-0.1288245628148331,0.7753397628709751,0.8968363030322001,Downregulated
Feature0653,Glu-Glu,C10 H16 N2 O7,276.09576,Other,NA,Glu-Glu,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,8574328.52546854,9811654.327723414,1.144305854222825,0.19447271242680503,0.3786910145262644,0.7829565408883704,Upregulated
Feature0652,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",C25 H34 O3,382.25081,NA,NA,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",25,34,3,0,0,0,1.36,0.12,-1.12,92.22,9,6,0.2727272727272727,0.3191489361702128,6,Unsaturated HC,468135.9463201237,498695.47841234534,1.0652791829647796,0.0912315742027073,0.7926794401068676,0.9061342006853577,Upregulated
Feature0651,387122,C12 H18 O,178.13575,NA,NA,387122,12,18,1,0,0,0,1.5,0.08333333333333333,-1.333333333333333,98.29999999999998,4,3,0.2727272727272727,0.30434782608695654,3,Lipid,1389875.340454139,2289931.4464304466,1.6475804554401374,0.7203489173306834,0.2535660998961418,0.7829565408883704,Upregulated
Feature0650,NA,C19 H41 N O2,315.31381,NA,NA,Feature0650,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,613553.4000021043,566713.1558475067,0.9236574287512106,-0.11457021887490121,0.9277081065057884,0.9668497879551831,Downregulated
Feature0649,NA,C12 H21 N O8,307.12685,NA,NA,Feature0649,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,1924661.2072642033,3221917.18452395,1.674017833561327,0.7433148972152837,0.10725911415462831,0.7829565408883704,Upregulated
Feature0648,NA,C62 H106 N2 O14 P2 S2,1228.65592,NA,NA,Feature0648,62,106,14,2,2,2,1.7096774193548387,0.2258064516129032,-1.258064516129032,96.1548387096774,12,-2,-0.1904761904761905,-0.02040816326530612,-8,Lipid,846638.741824212,943390.8494207653,1.1142779119557962,0.15610910000002204,0.7229448345051952,0.8740776986151175,Upregulated
Feature0647,gamma glutamyl ornithine,C10 H19 N3 O5,261.13251,NA,NA,gamma glutamyl ornithine,10,19,5,3,0,0,1.9,0.5,0,60.3,3,-2,-2.5,-0.5555555555555556,-5,Protein,693819.6620670717,389075.332799179,0.5607729991969687,-0.8345112085602591,0.18203971244381081,0.7829565408883704,Downregulated
Feature0646,NA,C20 H28 N2 O9,440.17967,NA,NA,Feature0646,20,28,9,2,0,0,1.4,0.45,-0.20000000000000015,66,8,-1,-0.3333333333333333,0.1111111111111111,-3,Phenol,13494698.382192133,14845062.743515166,1.1000662870023832,0.1375904592483856,0.06752809131445063,0.7829565408883704,Upregulated
Feature0645,Anhalamine,C11 H15 N O3,209.10518,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak2,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,470695.82868840767,263057.07226717763,0.558868501129881,-0.839419230576088,0.49312244950012984,0.7998439321266281,Downregulated
Feature0644,NA,C24 H40 N8 O7,552.30201,NA,NA,Feature0644,24,40,7,8,0,0,1.6666666666666667,0.2916666666666667,-0.08333333333333304,62.67499999999999,9,2,-0.6666666666666666,-0.2,-6,Lipid,64807.40285344517,85670.39811138103,1.3219230263727004,0.4026381732877794,0.17752770311912877,0.7829565408883704,Upregulated
Feature0643,MFCD02728197,C14 H20 N2 O4,280.14234,NA,NA,MFCD02728197,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Phenol,3715751.6916134236,5269784.071061334,1.4182282640025201,0.5040897531989778,0.2471081811215653,0.7829565408883704,Upregulated
Feature0642,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,11436717.947954936,13071555.871499734,1.1429464231770385,0.19275777728081844,0.1949070952274629,0.7829565408883704,Upregulated
Feature0641,DiisopropylSulfate,C6 H14 O4 S,182.0613,NA,NA,DiisopropylSulfate,6,14,4,0,1,0,2.3333333333333335,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,16654300.723371867,20972024.868364,1.2592558052547256,0.3325713819334814,0.3766912348618849,0.7829565408883704,Upregulated
Feature0640,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C24 H32 O8,448.20981,Other,NA,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",24,32,8,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,9,1,0.0625,0.25,1,Phenol,412281.687027684,348597.4849184863,0.8455323044583317,-0.24206821950518895,0.46188353339847915,0.7995347728859721,Downregulated
Feature0639,NA,C17 H25 N3 O4,335.18462,NA,NA,Feature0639,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Phenol,8962343.969523087,5621844.011509287,0.6272738505268999,-0.672832673321924,0.11204586221619817,0.7829565408883704,Downregulated
Feature0638,NA,C7 H9 O7 P,236.00858,NA,NA,Feature0638,7,9,7,0,0,1,1.2857142857142858,1,0,60.3,4,-3,4,-0.2,-4,Tannin,4671421.372515197,4411869.40646725,0.9444383314305472,-0.08247149821437125,0.7217323061242416,0.8735530177684995,Downregulated
Feature0637,MFCD00020424,C18 H20 N2 O3,312.14738,NA,NA,MFCD00020424,18,20,3,2,0,0,1.1111111111111112,0.16666666666666666,-0.44444444444444464,72.96666666666667,10,7,0.38461538461538464,0.4482758620689655,5,Phenol,717814.9429298594,585625.2990830127,0.8158443967364393,-0.29363407683673254,0.4203341618144051,0.7873878775042317,Downregulated
Feature0636,NA,C16 H22 N2 O4,306.15784,NA,NA,Feature0636,16,22,4,2,0,0,1.375,0.25,-0.5,74.55,7,3,0.1,0.25,1,Phenol,1948355.5959330467,2225006.1436466165,1.1419918151958728,0.1915523107544858,0.28157231482804057,0.7829565408883704,Upregulated
Feature0635,Panthenol,C9 H19 N O4,205.13142,Other,NA,Panthenol,9,19,4,1,0,0,2.111111111111111,0.4444444444444444,-0.8888888888888893,85.63333333333334,1,-3,-1,-0.3333333333333333,-4,Protein,271981.0981380763,370957.77764096,1.3639101400077307,0.44774859682854184,0.4689084116817439,0.7998439321266281,Upregulated
Feature0634,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,609039.27083733,426731.006173986,0.7006625460905013,-0.5132083158439189,0.3895464969632121,0.7873878775042317,Downregulated
Feature0633,Erythritol,C4 H10 O4,122.05787,ABC transporters,NA,Erythritol,4,10,4,0,0,0,2.5,1,-0.5,74.55,0,-4,-Inf,-1,-4,Carbohydrate,18981113.537466798,20409496.3600414,1.0752528464547202,0.10467595045082419,0.6440145330117181,0.8329695325287205,Upregulated
Feature0632,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.0794,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak2",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,3821712.802969597,3288968.2137536434,0.860600569252092,-0.21658430031703704,0.34530572173558416,0.7829565408883704,Downregulated
Feature0631,NA,C76 H121 N10 O14 P3,1490.82761,NA,NA,Feature0631,76,121,14,10,0,3,1.5921052631578947,0.18421052631578944,-1.026315789473684,89.55,23,9,-0.08163265306122448,0.05357142857142857,-4,Lipid,167289.71586401068,185708.40745978066,1.1101005611770092,0.15069037255736814,0.5349810864930955,0.811395486596221,Upregulated
Feature0630,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,3215192.1220878633,2579207.785991208,0.8021939865653617,-0.3179769434754644,0.6294113544944484,0.8293364212030647,Downregulated
Feature0629,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08007,NA,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Phenol,5044453.85960488,5129558.832016657,1.0168709982845285,0.02413666843850328,0.8775457906274107,0.942207059410483,Upregulated
Feature0628,pro-asn,C9 H15 N3 O4,229.10627,NA,NA,pro-asn,9,15,4,3,0,0,1.6666666666666667,0.4444444444444444,0.22222222222222232,53.96666666666666,4,0,-1.5,-0.25,-3,Protein,3816791.5781159066,4380631.060576327,1.1477260340054383,0.19877830703830485,0.505184873759986,0.7998439321266281,Upregulated
Feature0627,NA,C15 H27 N O13,429.14831,NA,NA,Feature0627,15,27,13,1,0,0,1.8,0.8666666666666667,0.1333333333333333,56.5,3,-10,-11,-0.6,-11,Carbohydrate,4093391.1886706734,2404960.8990453472,0.5875228601902466,-0.7672831076497728,0.5572923911062583,0.820796478981062,Downregulated
Feature0626,NA,C6 H2 O4,137.99529,NA,NA,Feature0626,6,2,4,0,0,0,0.3333333333333333,0.6666666666666666,1,31.799999999999997,6,2,1,1,2,Condensed HC,5556089.69188205,4852945.84110701,0.8734462743100788,-0.1952091292040369,0.5622037017789365,0.820796478981062,Downregulated
Feature0625,NA,C12 H12 N6 O3,288.09707,NA,NA,Feature0625,12,12,3,6,0,0,1,0.25,1,31.799999999999997,10,7,0.3333333333333333,0.5555555555555556,1,Phenol,498002.491486697,698014.5534951853,1.4016286372612077,0.4871041566589342,0.02162958573326705,0.7829565408883704,Upregulated
Feature0624,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Phenol,498980.94933312165,470363.15275087435,0.9426475166627214,-0.08520968880901292,0.8740516955245614,0.9403497372086917,Downregulated
Feature0623,N-Acetylglucosamine 1-phosphate,C8 H16 N O9 P,301.05635,Metabolic pathways;Other,Other,N-Acetylglucosamine 1-phosphate,8,16,9,1,0,1,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,6222915.88098755,7302400.433703916,1.1734692503259512,0.23078003787003767,0.5349185703242275,0.811395486596221,Upregulated
Feature0622,NA,C14 H27 N3 O4,301.20023,NA,NA,Feature0622,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4775383.665316587,2361117.681176878,0.4944351798004373,-1.0161466980892782,0.08329744030443757,0.7829565408883704,Downregulated
Feature0621,NA,C21 H33 N3 O2,359.25734,NA,NA,Feature0621,21,33,2,3,0,0,1.5714285714285714,0.09523809523809525,-0.9523809523809526,87.44285714285715,7,5,0.125,0.17647058823529413,2,Lipid,111402.37201327336,117890.65270448333,1.0582418540463117,0.08166938336720396,0.748040268172072,0.8847091047453014,Upregulated
Feature0620,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",C18 H18 N2 O2,294.13684,Biosynthesis of secondary metabolites;Other,NA,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",18,18,2,2,0,0,1,0.1111111111111111,-0.44444444444444464,72.96666666666667,11,9,0.5,0.5333333333333333,7,Unsaturated HC,231558.07300432265,257522.94597197167,1.112131149783598,0.1533269301347852,0.5792314769139351,0.820796478981062,Upregulated
Feature0619,NA,C10 H24 N2 O6 S,300.13557,NA,NA,Feature0619,10,24,6,2,1,0,2.4,0.6,-0.4000000000000003,71.7,0,-6,-9,-1.5,-9,Other,1843371.64344536,1892422.39404379,1.0266092574293655,0.037887175194745375,0.8973956728149962,0.952451823989676,Upregulated
Feature0618,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26122,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak1,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,1008547.9255682023,1398860.8078304266,1.387004794087824,0.47197277424751155,0.3471966047870225,0.7829565408883704,Upregulated
Feature0617,NA,C15 H28 N2 O9,380.17959,NA,NA,Feature0617,15,28,9,2,0,0,1.8666666666666667,0.6,-0.2666666666666666,67.89999999999999,3,-6,-2,-0.4117647058823529,-8,Amino Sugar,9294466.23298083,10398470.198236642,1.1187807817665014,0.16192737675986846,0.1728168544653642,0.7829565408883704,Upregulated
Feature0616,4-Methyleneglutamic acid,C6 H9 N O4,159.05318,Other,NA,4-Methyleneglutamic acid-peak2,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,16741144.1519005,19054609.1055785,1.138190372933105,0.18674188199980063,0.21956481167358707,0.7829565408883704,Upregulated
Feature0615,threonylphenylalanine,C13 H18 N2 O4,266.12654,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak3,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,106112.41850963523,120385.562124876,1.1345096437882503,0.18206887255044482,0.4428380697818909,0.7974180334973026,Upregulated
Feature0614,CI-976,C23 H39 N O4,393.28787,NA,NA,CI-976,23,39,4,1,0,0,1.6956521739130437,0.17391304347826086,-1.2173913043478262,94.99565217391304,5,1,0,0.1,0,Lipid,928338.424214224,754995.5311733073,0.813276184073023,-0.29818272815992125,0.19402292555255832,0.7829565408883704,Downregulated
Feature0613,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak2,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,1853611.8149563132,1513794.17953711,0.8166727074799034,-0.29217008004139094,0.29120311625038325,0.7829565408883704,Downregulated
Feature0612,NA,C13 H27 N O11,373.15852,NA,NA,Feature0612,13,27,11,1,0,0,2.076923076923077,0.8461538461538461,-0.1538461538461542,64.6846153846154,1,-10,-11,-0.8461538461538461,-11,Carbohydrate,85755.15095546117,101037.04480485916,1.1782038009277715,0.23658911230669222,0.12336099349359295,0.7829565408883704,Upregulated
Feature0611,Methionylleucine,C11 H22 N2 O3 S,262.13517,NA,NA,Methionylleucine-peak2,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,262987.049350979,99084.40180461691,0.3767653276050875,-1.4082618900051005,0.22698330907935044,0.7829565408883704,Downregulated
Feature0610,2-ethyl-1H-perimidine,C13 H12 N2,196.10009,NA,NA,2-ethyl-1H-perimidine,13,12,0,2,0,0,0.9230769230769232,0,-0.4615384615384617,73.45384615384616,9,9,0.6363636363636364,0.6363636363636364,7,Unsaturated HC,98783.5715934067,111557.46174062234,1.1293118880110247,0.17544397782684332,0.40788070152940836,0.7873878775042317,Upregulated
Feature0609,NA,C12 H21 N O8,307.12682,NA,NA,Feature0609,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,15453838.867875699,17210450.273726135,1.1136682879165998,0.15531958219195693,0.6062821815084521,0.8265475184112798,Upregulated
Feature0608,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak2,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,231841.898763846,213319.433495693,0.9201073431208395,-0.12012591376739659,0.8130236810915252,0.9142978308596724,Downregulated
Feature0607,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Phenol,3288055.93712647,3218739.4041894735,0.978918688044713,-0.030739064707540602,0.9147791339309851,0.9603585751327469,Downregulated
Feature0606,uridine 5′-diphosphate,C9 H14 N2 O12 P2,404.00229,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,uridine 5′-diphosphate,9,14,12,2,0,2,1.5555555555555556,1.3333333333333333,0.6666666666666665,41.3,5,-7,1.5714285714285714,5,-11,Carbohydrate,5596992.295959284,6713056.782837457,1.1994043278715802,0.2623180836755486,0.5954519689140303,0.820796478981062,Upregulated
Feature0605,DH2090000,C9 H10 O5,198.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak2,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Phenol,299197.900972618,387351.343694543,1.2946325573654094,0.37254269027692377,0.2649949230412294,0.7829565408883704,Upregulated
Feature0604,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",C6 H11 N O5,177.06376,Other,NA,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",6,11,5,1,0,0,1.8333333333333333,0.8333333333333334,0.3333333333333335,50.8,2,-3,-Inf,-0.6,-4,Carbohydrate,15751045.132732535,18250725.7427868,1.1586993490901523,0.21250627484770784,0.4882581705713031,0.7998439321266281,Upregulated
Feature0603,3-Hydroxyhexadecadienoylcarnitine,C23 H41 N O5,411.2985,NA,NA,3-Hydroxyhexadecadienoylcarnitine,23,41,5,1,0,0,1.7826086956521738,0.21739130434782608,-1.2173913043478262,94.99565217391304,4,-1,-0.1176470588235294,0.02564102564102564,-2,Lipid,198158.52062203933,213772.94230354068,1.0787976294558828,0.10942425651930238,0.7467690394969334,0.8847091047453014,Upregulated
Feature0602,NA,C12 H21 N O8,307.12679,NA,NA,Feature0602,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,740611.0280929847,460020.70316403965,0.6211367178106393,-0.6870172412589461,0.2991229840100648,0.7829565408883704,Downregulated
Feature0601,NA,C17 H32 N2 O8,392.21597,NA,NA,Feature0601,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,10300685.30250945,11681259.552728234,1.134027417562446,0.1814555209707982,0.15158458517372778,0.7829565408883704,Upregulated
Feature0600,Maleic acid,C4 H4 O4,116.01093,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Tyrosine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of purine nucleotide salvage;Other,Maleic acid,4,4,4,0,0,0,1,1,1,31.799999999999997,3,-1,-Inf,0.5,-1,Tannin,319020.31972508965,305060.0404848433,0.9562401565759937,-0.06455510305179922,0.7606871484838168,0.8870802973555341,Downregulated
Feature0599,NA,C12 H21 N3 O4,271.15326,NA,NA,Feature0599,12,21,4,3,0,0,1.75,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,0,-0.6,-0.14285714285714285,-3,Protein,12505588.2440842,10777262.048307143,0.8617956898913055,-0.21458221178832262,0.34065913177665524,0.7829565408883704,Downregulated
Feature0598,(Ac)2-L-Lys-D-Ala,C13 H23 N3 O5,301.16384,NA,NA,(Ac)2-L-Lys-D-Ala,13,23,5,3,0,0,1.7692307692307692,0.38461538461538464,-0.3076923076923075,69.06923076923076,4,-1,-0.8,-0.2,-4,Protein,1419090.7726021968,1146102.5706526863,0.8076316136923856,-0.3082307106858238,0.560768488061601,0.820796478981062,Downregulated
Feature0597,1-Naphthol,C10 H8 O,144.05749,Other,NA,1-Naphthol,10,8,1,0,0,0,0.8,0.1,-0.5999999999999996,77.39999999999999,7,6,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,153181.63200415613,139733.06371258467,0.9122050854556337,-0.1325698817831522,0.7952882021575188,0.9077450283018679,Downregulated
Feature0596,thr-pro,C9 H16 N2 O4,216.11107,Metabolic pathways;Other,Other,thr-pro-peak2,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,8125495.4503702605,12000616.640461532,1.476908911433172,0.5625808504249638,0.026362132215738052,0.7829565408883704,Upregulated
Feature0595,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13227,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak1,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,14006114.5046046,15879937.106516633,1.1337860404679685,0.18114841146206073,0.24693433295973538,0.7829565408883704,Upregulated
Feature0594,Nonivamide,C17 H27 N O3,293.199,NA,NA,Nonivamide,17,27,3,1,0,0,1.588235294117647,0.17647058823529413,-1.0588235294117645,90.47647058823529,5,2,0.07692307692307693,0.1724137931034483,1,Lipid,470851.240851896,553709.5184951624,1.1759754896118646,0.2338579909702651,0.6423784900394454,0.8329695325287205,Upregulated
Feature0593,NA,C18 H34 N2 O8,406.23163,NA,NA,Feature0593,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,6536083.813634723,7313614.74046704,1.1189597546485455,0.16215814818821533,0.10337285968247414,0.7829565408883704,Upregulated
Feature0592,butalbital,C11 H16 N2 O3,224.11607,NA,NA,butalbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,14683395.109169256,18853670.957007565,1.284013051261838,0.36065986670868777,0.4480715903269555,0.7974180334973026,Upregulated
Feature0591,Arg-pro,C11 H21 N5 O3,271.16445,NA,NA,Arg-pro,11,21,3,5,0,0,1.9090909090909092,0.2727272727272727,0,60.3,4,1,-1.3333333333333333,-0.5555555555555556,-4,Lipid,2902666.7578373533,1810016.3066874966,0.6235701365995104,-0.6813762573125958,0.11292351798223185,0.7829565408883704,Downregulated
Feature0590,NA,C10 H18 N2 O7,278.11141,NA,NA,Feature0590,10,18,7,2,0,0,1.8,0.7,0.20000000000000015,54.599999999999994,3,-4,-6,-0.5555555555555556,-6,Amino Sugar,3776729.3046521298,7340975.385212664,1.9437388261240058,0.958834381716902,0.14855196247602134,0.7829565408883704,Upregulated
Feature0589,Paracetamol,C8 H9 N O2,151.06336,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak2,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Phenol,103762.68748050806,136806.8621333882,1.3184591249054487,0.3988528452181735,0.5811841697175801,0.820796478981062,Upregulated
Feature0588,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.0957,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak1,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,3450519.9977902067,4263033.710029467,1.2354757290957923,0.30506666922025805,0.2556744855033914,0.7829565408883704,Upregulated
Feature0587,1-linoleoyl-sn-glycero-3-phosphoethanolamine,C23 H44 N O7 P,477.28563,NA,NA,1-linoleoyl-sn-glycero-3-phosphoethanolamine,23,44,7,1,0,1,1.9130434782608696,0.30434782608695654,-1.391304347826087,99.95217391304348,3,-4,-0.42857142857142855,-0.14285714285714285,-6,Protein,503510.02759201033,548083.0791876563,1.0885246552264558,0.12237408512842045,0.7326177021726978,0.8779932381898025,Upregulated
Feature0586,NA,C17 H29 N O14,471.15895,NA,NA,Feature0586,17,29,14,1,0,0,1.7058823529411764,0.8235294117647058,0.11764705882352944,56.94705882352941,4,-10,-5.5,-0.4444444444444444,-11,Carbohydrate,5153068.019323247,4733576.313492514,0.9185937961118114,-0.12250105479568119,0.8774783763793212,0.942207059410483,Downregulated
Feature0585,lys-leu,C12 H25 N3 O3,259.1896,NA,NA,lys-leu-peak2,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,1200765.5727047396,1536471.3080760166,1.2795764160818632,0.3556663074479912,0.278058814446549,0.7829565408883704,Upregulated
Feature0584,(+)-sesamin monocatechol,C19 H18 O6,342.11045,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak2,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,873931.8498751316,728893.224040171,0.8340389747144655,-0.2618132923763267,0.37442948350776983,0.7829565408883704,Downregulated
Feature0583,(2S)-2-Amino-4-hexynoic acid,C6 H9 N O2,127.06329,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,(2S)-2-Amino-4-hexynoic acid,6,9,2,1,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,1,0,0.25,0,Protein,8560353.60426367,15229167.6770959,1.7790348835018543,0.831094799397501,0.12448433769015588,0.7829565408883704,Upregulated
Feature0582,DL-Lactic Acid,C3 H6 O3,90.03171,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,DL-Lactic Acid,3,6,3,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,6356431.29656091,4854802.15726369,0.7637622324165348,-0.3888045135660118,0.18654048535547535,0.7829565408883704,Downregulated
Feature0581,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",C7 H15 N O4,177.10012,NA,NA,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",7,15,4,1,0,0,2.142857142857143,0.5714285714285714,-0.5714285714285712,76.58571428571427,1,-3,-2,-0.5,-4,Amino Sugar,11123276.667460684,12200053.765794434,1.0968039482002352,0.13330566955458284,0.32398389382860554,0.7829565408883704,Upregulated
Feature0580,thr-pro,C9 H16 N2 O4,216.111,Metabolic pathways;Other,Other,thr-pro-peak1,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,3141759.98650875,2928689.477981353,0.9321811629652305,-0.10131773495110323,0.35271292596821463,0.7829565408883704,Downregulated
Feature0579,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,2505546.53306775,1126520.3840182084,0.4496106414910265,-1.1532519128769048,0.05085334546652219,0.7829565408883704,Downregulated
Feature0578,N-acetyldopamine,C10 H13 N O3,195.08954,Other,NA,N-acetyldopamine,10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,13165100.2116255,16465503.3114157,1.2506933518725338,0.32272810927775475,0.22394321821534974,0.7829565408883704,Upregulated
Feature0577,NA,C16 H30 N2 O9,394.19522,NA,NA,Feature0577,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,9518777.265962703,9909494.996382393,1.0410470504249343,0.05803527313376264,0.47268094089670737,0.7998439321266281,Upregulated
Feature0576,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",C25 H36 O3,384.26647,NA,NA,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",25,36,3,0,0,0,1.44,0.12,-1.2000000000000002,94.5,8,5,0.2272727272727273,0.2765957446808511,5,Unsaturated HC,326913.927583951,381596.4387962913,1.1672688331649557,0.22313686576536215,0.25124931717787313,0.7829565408883704,Upregulated
Feature0575,NA,C6 H11 N O7,209.05351,NA,NA,Feature0575,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,12361538.238522634,9439283.92046979,0.7636010776598875,-0.38910895608804924,0.048514728731685275,0.7829565408883704,Downregulated
Feature0574,NA,C15 H5 N10 O18 P3 S2,769.84371,NA,NA,Feature0574,15,5,18,10,2,3,0.3333333333333333,1.2,3.3333333333333335,-34.7,20,2,0.7222222222222222,0.4444444444444444,-13,Other,11698433.863089656,12096173.7151892,1.0339994102419532,0.0482353627889674,0.8660341763850834,0.9379434753860953,Upregulated
Feature0573,NA,C18 H34 N2 O8,406.23164,NA,NA,Feature0573,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,13005959.940908534,14710318.426340833,1.1310444206483725,0.17765559085793448,0.01575875412282133,0.7829565408883704,Upregulated
Feature0572,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13666,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Phenol,329575.4710136077,356522.274697866,1.0817621639176713,0.11338334329277171,0.738004024741197,0.8799580401271232,Upregulated
Feature0571,4-Methyleneglutamic acid,C6 H9 N O4,159.05324,Other,NA,4-Methyleneglutamic acid-peak1,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,9177017.585242087,9813819.618525244,1.069390957069454,0.09678938225480377,0.6003715275966885,0.8224870011764158,Upregulated
Feature0570,9-Nitrooleate,C18 H33 N O4,327.24099,NA,NA,9-Nitrooleate,18,33,4,1,0,0,1.8333333333333333,0.2222222222222222,-1.2222222222222223,95.13333333333333,3,-1,-0.15384615384615383,0,-2,Lipid,1396814.6582985525,1588928.58888844,1.1375371667590457,0.18591368326560506,0.5553114823172676,0.820796478981062,Upregulated
Feature0569,4-Nitrosodiphenylamine,C12 H10 N2 O,198.07934,NA,NA,4-Nitrosodiphenylamine,12,10,1,2,0,0,0.8333333333333334,0.08333333333333333,-0.16666666666666696,65.05000000000001,9,8,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,3409825.7365343566,3926234.6428586897,1.1514473014826838,0.20344838453122796,0.48657296344912004,0.7998439321266281,Upregulated
Feature0568,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",C17 H18 N2 O5,330.12166,NA,NA,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",17,18,5,2,0,0,1.0588235294117647,0.29411764705882354,-0.117647058823529,63.65294117647058,10,5,0.3,0.44,3,Phenol,6071963.725215826,8071672.031840913,1.3293346925510507,0.4107043841420775,0.1434122132546341,0.7829565408883704,Upregulated
Feature0567,3-(6-Amino-1H-purin-1-yl)-1-propanol,C8 H11 N5 O,193.09636,NA,NA,3-(6-Amino-1H-purin-1-yl)-1-propanol,8,11,1,5,0,0,1.375,0.125,0.75,38.925,6,5,0,0.2,0,Unsaturated HC,85967.6933367814,80413.22327220313,0.9353888670384763,-0.0963618369279873,0.7725663527469042,0.8954746361384572,Downregulated
Feature0566,NA,C20 H28 N2 O8,424.18475,NA,NA,Feature0566,20,28,8,2,0,0,1.4,0.4,-0.2999999999999998,68.85,8,0,-0.2,0.14285714285714285,-2,Phenol,12638724.701915566,13201637.369616168,1.0445387237222823,0.062865977791839,0.4891467186195245,0.7998439321266281,Upregulated
Feature0565,NA,C17 H30 N2 O12,454.18001,NA,NA,Feature0565,17,30,12,2,0,0,1.7647058823529411,0.7058823529411765,0,60.3,4,-8,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,60104.25716381443,69390.88303551164,1.154508620685328,0.20727894571795114,0.14282049298277655,0.7829565408883704,Upregulated
Feature0564,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak1,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Phenol,74664.1303626766,76261.64358494431,1.021395993156391,0.030542304612601462,0.9350963229165756,0.9691719887335095,Upregulated
Feature0563,Aspartyl-L-proline,C9 H14 N2 O5,230.09027,Biosynthesis of secondary metabolites;Other,NA,Aspartyl-L-proline,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,6299208.390535846,8667661.0930174,1.3759921176825964,0.4604722056411736,0.48214408149365096,0.7998439321266281,Upregulated
Feature0562,Tyrosylalanine,C12 H16 N2 O4,252.11103,NA,NA,Tyrosylalanine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Phenol,1642713.2628817733,1449004.7012738667,0.8820801134410468,-0.18101840280603837,0.6398746703222982,0.8329695325287205,Downregulated
Feature0561,NA,C11 H23 N O11,345.1272,NA,NA,Feature0561,11,23,11,1,0,0,2.090909090909091,1,0.18181818181818168,55.11818181818182,1,-10,11,-1.2222222222222223,-11,Carbohydrate,12875932.517771,14217046.290501734,1.1041566326073677,0.14294484336352256,0.48620725643039686,0.7998439321266281,Upregulated
Feature0560,NA,C10 H15 N O5,229.09493,NA,NA,Feature0560,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,2287781.829205407,3451257.3397241468,1.5085605172949723,0.5931725726862066,0.07096650385410058,0.7829565408883704,Upregulated
Feature0559,NA,C9 H17 N3 O2,199.13214,NA,NA,Feature0559,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,6551432.641093473,6483077.321460667,0.9895663554252163,-0.015131644377372137,0.8794703018261021,0.943370629683448,Downregulated
Feature0558,Myristicin,C11 H12 O3,192.07871,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,Myristicin,11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Phenol,1350247.6732824459,1116997.4146530204,0.8272537229689164,-0.273598215636696,0.48228913941081825,0.7998439321266281,Downregulated
Feature0557,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",C14 H14 O6,278.07905,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",14,14,6,0,0,0,1,0.42857142857142855,-0.14285714285714324,64.37142857142858,8,2,0.25,0.4545454545454546,2,Phenol,204858.878200138,230300.46859227002,1.124190811819621,0.16888692871036703,0.4537323422618004,0.7974180334973026,Upregulated
Feature0556,6-Methoxyquinoline,C10 H9 N O,159.06843,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,6-Methoxyquinoline,10,9,1,1,0,0,0.9,0.1,-0.4000000000000003,71.7,7,6,0.625,0.6470588235294118,5,Unsaturated HC,3321441.81111139,4227544.876007213,1.2728041364038323,0.3480104293105103,0.1593674933437683,0.7829565408883704,Upregulated
Feature0555,D-PANTOTHENIC ACID,C9 H17 N O5,219.11064,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak2,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,8608319.112382207,9200803.919518244,1.0688270032048193,0.09602836211767958,0.7694418873106669,0.8927753852766993,Upregulated
Feature0554,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.12123,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak2,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,10399558.715550587,12077863.261536634,1.1613822847575694,0.21584293305084207,0.2347404921249635,0.7829565408883704,Upregulated
Feature0553,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak1,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Phenol,11936949.591030186,13924156.4050285,1.1664752622807057,0.22215571206846588,0.4058512031045413,0.7873878775042317,Upregulated
Feature0552,mebutamate,C10 H20 N2 O4,232.14227,Other,NA,mebutamate,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,1121523.938771032,1281837.6804231687,1.1429427728736747,0.19275316964316935,0.755920726292973,0.8847091047453014,Upregulated
Feature0551,Methyl alpha-aspartylphenylalaninate,C14 H18 N2 O5,294.12162,Other,NA,Methyl alpha-aspartylphenylalaninate,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Phenol,2400472.907975043,3611418.6451928033,1.5044613222647334,0.589247017343147,0.20477425790158868,0.7829565408883704,Upregulated
Feature0550,Cynometrine,C16 H19 N3 O2,285.14778,NA,NA,Cynometrine,16,19,2,3,0,0,1.1875,0.125,-0.375,70.9875,9,7,0.3636363636363637,0.4166666666666667,4,Unsaturated HC,692644.1305706113,659452.3027164697,0.9520795363893467,-0.07084599408377008,0.5840840057604816,0.820796478981062,Downregulated
Feature0549,2-Amino-3-methoxybenzoic acid,C8 H9 N O3,167.05827,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,2-Amino-3-methoxybenzoic acid,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Phenol,4940632.233523197,6967299.404752287,1.4102040134616256,0.4959038916440053,0.054055587816965574,0.7829565408883704,Upregulated
Feature0548,NA,C7 H11 O3 P S,206.01667,NA,NA,Feature0548,7,11,3,0,1,1,1.5714285714285714,0.42857142857142855,-1.1428571428571432,92.87142857142858,3,0,-1,-0.14285714285714285,-2,Protein,6421170.601666204,4929874.34565403,0.7677532106645473,-0.3812854544720998,0.1738568387564417,0.7829565408883704,Downregulated
Feature0547,NA,C15 H27 N3 O6,345.19012,NA,NA,Feature0547,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,6557086.26726705,6541997.591950623,0.9976988749726003,-0.003323647197667428,0.9880854348582738,0.9956925439626456,Downregulated
Feature0546,Pro-Pro,C10 H16 N2 O3,212.11603,NA,NA,Pro-Pro,10,16,3,2,0,0,1.6,0.3,-0.4000000000000003,71.7,4,1,-0.2,0.07692307692307693,-1,Lipid,10855419.90333594,11574937.1039782,1.0662818395832987,0.0925888216121298,0.5978384615799597,0.8210217305908382,Upregulated
Feature0545,NA,C79 H121 N6 O18 P3,1534.79514,NA,NA,Feature0545,79,121,18,6,0,3,1.5316455696202531,0.2278481012658228,-1.037974683544304,89.88227848101266,24,6,-0.05769230769230769,0.09836065573770492,-3,Lipid,298609.0422806,342627.37609556364,1.147411255462251,0.19838257520285796,0.4877084563641576,0.7998439321266281,Upregulated
Feature0544,Pyroquilon,C11 H11 N O,173.08408,NA,NA,Pyroquilon,11,11,1,1,0,0,1,0.09090909090909093,-0.5454545454545459,75.84545454545456,7,6,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,270219.7573410037,457462.8708392083,1.692929026880567,0.759521492008671,0.234220267144775,0.7829565408883704,Upregulated
Feature0543,NA,C11 H19 N O5,245.12631,NA,NA,Feature0543,11,19,5,1,0,0,1.7272727272727273,0.4545454545454546,-0.5454545454545459,75.84545454545456,3,-2,-0.6,-0.06666666666666667,-3,Protein,224059.26639596434,371692.40594851336,1.6589021821201861,0.7302288196688955,0.0536118262717467,0.7829565408883704,Upregulated
Feature0542,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16888,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak4,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,2435858.590103703,921595.185238071,0.37834510959802287,-1.402225297581374,0.05080479867532622,0.7829565408883704,Downregulated
Feature0541,NA,C22 H40 N2 O7,444.2837,NA,NA,Feature0541,22,40,7,2,0,0,1.818181818181818,0.3181818181818182,-0.9090909090909092,86.2090909090909,4,-3,-0.38461538461538464,-0.09090909090909093,-5,Protein,272754.69049202633,338952.19252512034,1.2426997750751025,0.31347779652991586,0.17630370594522557,0.7829565408883704,Upregulated
Feature0540,NA,C20 H30 N2 O8,426.2003,NA,NA,Feature0540,20,30,8,2,0,0,1.5,0.4,-0.4000000000000003,71.7,7,-1,-0.3,0.07142857142857142,-3,Protein,5094754.515995524,5482789.68862405,1.0761636642963361,0.10589750141986373,0.2639898805648629,0.7829565408883704,Upregulated
Feature0539,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,C18 H20 N2 O4,328.14237,NA,NA,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Phenol,1391211.2736032533,765709.6277409983,0.550390614473531,-0.8614722261699196,0.004894100586908151,0.7829565408883704,Downregulated
Feature0538,N-Methylhexanamide,C7 H15 N O,129.11533,NA,NA,N-Methylhexanamide,7,15,1,1,0,0,2.142857142857143,0.14285714285714285,-1.4285714285714288,101.01428571428572,1,0,-0.2,-0.09090909090909093,-1,Lipid,213899.92014167886,200051.012643002,0.9352552002380184,-0.09656801236654743,0.9037495613782668,0.955173734959754,Downregulated
Feature0537,"β,β-dimethylacrylshikonin",C21 H22 O6,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"β,β-dimethylacrylshikonin",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Phenol,1244050.0402509067,1057114.7166956454,0.8497364916948523,-0.2349125725361261,0.34895706760474365,0.7829565408883704,Downregulated
Feature0536,NA,C13 H24 N2 O9,352.14823,NA,NA,Feature0536,13,24,9,2,0,0,1.8461538461538465,0.6923076923076923,0,60.3,3,-6,-4,-0.5384615384615384,-8,Amino Sugar,5252073.050894183,4333860.56571947,0.8251714177855192,-0.2772342447405644,0.33275779827724133,0.7829565408883704,Downregulated
Feature0535,threonylphenylalanine,C13 H18 N2 O4,266.12671,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak2,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,3553721.9928248003,4521571.447567154,1.2723481062099133,0.34749343665656407,0.3366440913214687,0.7829565408883704,Upregulated
Feature0534,NA,C17 H26 N2 O8,386.16898,NA,NA,Feature0534,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,11782817.919997633,12562424.953056667,1.066164735664454,0.0924303695832566,0.4710349553725736,0.7998439321266281,Upregulated
Feature0533,Proacacipetalin,C11 H17 N O6,259.10561,NA,NA,Proacacipetalin-peak1,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,159844.72874109924,231075.22013784037,1.4456230240292332,0.5316913888942028,0.5834263698434689,0.820796478981062,Upregulated
Feature0532,NA,C17 H34 N6 O4,386.26429,NA,NA,Feature0532,17,34,4,6,0,0,2,0.2352941176470588,-0.47058823529411775,73.71176470588236,4,0,-0.8571428571428571,-0.4444444444444444,-6,Lipid,545815.3889943734,256016.412883843,0.46905312317326797,-1.0921767687384842,0.2237550582048282,0.7829565408883704,Downregulated
Feature0531,Ectoine,C6 H10 N2 O2,142.07423,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,6366127.266636596,5888724.814941877,0.9250089682943231,-0.11246074174379288,0.6847396988010158,0.8489259028229168,Downregulated
Feature0530,Malonyl-L-carnitine,C10 H17 N O6,247.10558,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Malonyl-L-carnitine,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,263259.091321997,318539.9315855914,1.2099864433398784,0.27499088366855373,0.7565230113027396,0.8847091047453014,Upregulated
Feature0529,NA,C12 H19 N O9,321.10608,NA,NA,Feature0529,12,19,9,1,0,0,1.5833333333333333,0.75,0.16666666666666652,55.55,4,-5,-3,-0.2307692307692308,-6,Carbohydrate,525756.540125486,975936.7308378234,1.856252193467512,0.892392730696074,0.1276054778467626,0.7829565408883704,Upregulated
Feature0528,NA,C6 H15 N O4,165.10013,NA,NA,Feature0528,6,15,4,1,0,0,2.5,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,7912218.18631192,10051536.503612064,1.270381613211975,0.3452619369890801,0.15049761181604077,0.7829565408883704,Upregulated
Feature0527,Isovalerylglutamic acid,C10 H17 N O5,231.11065,NA,NA,Isovalerylglutamic acid-peak5,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1774399.88387588,1778440.6110250899,1.0022772359184242,0.0032816218693904244,0.995175443535863,0.9991408892032351,Upregulated
Feature0526,NA,C11 H20 N4 O5,288.1433,NA,NA,Feature0526,11,20,5,4,0,0,1.818181818181818,0.4545454545454546,0.18181818181818168,55.11818181818182,4,-1,-2.5,-0.5555555555555556,-5,Protein,5608325.273773484,6636589.932362666,1.1833461164240442,0.24287210868655656,0.39833365269776055,0.7873878775042317,Upregulated
Feature0525,Imazapyr,C13 H15 N3 O3,261.1114,NA,NA,Imazapyr,13,15,3,3,0,0,1.1538461538461535,0.2307692307692308,0,60.3,8,5,0.2857142857142857,0.4117647058823529,2,Phenol,4143905.338695553,6510203.652617606,1.57103097694479,0.6517116273819726,0.31119388207254944,0.7829565408883704,Upregulated
Feature0524,NA,C17 H26 N2 O8,386.16902,NA,NA,Feature0524,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,9651708.019158121,6485534.91726466,0.6719572229486451,-0.5735587014728919,0.5366867781719534,0.8115398451602854,Downregulated
Feature0523,NA,C14 H24 N2 O11,396.13811,NA,NA,Feature0523,14,24,11,2,0,0,1.7142857142857142,0.7857142857142857,0.2857142857142856,52.15714285714286,4,-7,-9,-0.5384615384615384,-9,Carbohydrate,9083533.39245301,9963750.31190709,1.096902480722469,0.1334352697412025,0.2753953576115865,0.7829565408883704,Upregulated
Feature0522,NA,C22 H32 N4 O5,432.23734,NA,NA,Feature0522,22,32,5,4,0,0,1.4545454545454546,0.2272727272727273,-0.45454545454545414,73.25454545454544,9,4,0,0.16129032258064516,0,Phenol,74845.23976891796,82119.12140961197,1.0971856281461834,0.1338076297978928,0.49786391029524757,0.7998439321266281,Upregulated
Feature0521,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak2,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,260028.60555370332,525422.636753244,2.020633982305186,1.0148080155642751,0.1726134117629398,0.7829565408883704,Upregulated
Feature0520,Adipic acid,C6 H10 O4,146.05793,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,8493476.626694597,10784185.35033077,1.2697021283883425,0.3444900810122539,0.4881749366169865,0.7998439321266281,Upregulated
Feature0519,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",C14 H24 N2 O9,364.14823,NA,NA,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",14,24,9,2,0,0,1.7142857142857142,0.6428571428571429,0,60.3,4,-5,-2.3333333333333335,-0.3333333333333333,-7,Amino Sugar,10910470.869058633,11783853.247140666,1.080049925302389,0.11109800250117187,0.08668711034489113,0.7829565408883704,Upregulated
Feature0518,Stearidonic acid,C18 H28 O2,276.20889,Biosynthesis of secondary metabolites;Other,NA,Stearidonic acid,18,28,2,0,0,0,1.5555555555555556,0.1111111111111111,-1.333333333333333,98.29999999999998,5,3,0.1875,0.2352941176470588,3,Lipid,2920989.41032695,4416211.15272889,1.5118887925836673,0.596352025611595,0.5069044204248633,0.7998439321266281,Upregulated
Feature0517,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,C26 H50 N O7 P,519.33266,NA,NA,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,26,50,7,1,0,1,1.9230769230769231,0.2692307692307692,-1.4615384615384617,101.95384615384616,3,-4,-0.35294117647058826,-0.12195121951219512,-6,Lipid,494556.287955654,514198.6539103143,1.0397171493579747,0.05619110267405231,0.8058130178982076,0.9140326627977811,Upregulated
Feature0516,NA,C12 H22 N2 O9,338.1325,NA,NA,Feature0516,12,22,9,2,0,0,1.8333333333333333,0.75,0.16666666666666652,55.55,3,-6,-8,-0.6363636363636364,-8,Carbohydrate,5507846.8048586035,4533329.399863826,0.8230674454970076,-0.2809174390919308,0.33221970085045127,0.7829565408883704,Downregulated
Feature0515,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0515,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,2396837.5299947034,734964.0102428127,0.30663906128190377,-1.7053866081703897,0.16041696462588412,0.7829565408883704,Downregulated
Feature0514,NA,C12 H17 N3 O7,315.10673,NA,NA,Feature0514,12,17,7,3,0,0,1.4166666666666667,0.5833333333333334,0.5,46.05,6,-1,-2,-0.09090909090909093,-4,Phenol,1599886.56334768,1588419.51928488,0.9928325893063282,-0.01037762279241048,0.956861679271112,0.9768869919401161,Downregulated
Feature0513,NS1800000,C8 H9 N O4,183.05316,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,NS1800000,8,9,4,1,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Phenol,1890101.3522957268,1968801.19562654,1.0416378958912569,0.05885384134646428,0.7663890504771049,0.8901537418585008,Upregulated
Feature0512,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,4909553.463811837,6305503.092708809,1.284333318536293,0.3610196686547521,0.5231168772310949,0.8095684637976394,Upregulated
Feature0511,methoxyresorcinol,C7 H8 O3,140.04734,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak1,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Phenol,491404.36878685537,320547.3896807997,0.6523087909701425,-0.6163730234663043,0.2470157972635893,0.7829565408883704,Downregulated
Feature0510,fructosylglycine,C8 H15 N O7,237.08491,NA,NA,fructosylglycine,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,5645693.43595835,8957297.555904284,1.586571721881635,0.6659127405837255,0.12335691855924953,0.7829565408883704,Upregulated
Feature0509,Xamoterol [USAN:BAN:INN],C16 H25 N3 O5,339.17949,NA,NA,Xamoterol [USAN:BAN:INN],16,25,5,3,0,0,1.5625,0.3125,-0.375,70.9875,6,1,-0.25,0.04761904761904761,-2,Protein,175890.51113953366,187635.831566446,1.066776316418768,0.09325770097590844,0.5755917251300464,0.820796478981062,Upregulated
Feature0508,UNII:74D1OHC38H,C19 H32 O4,324.23009,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak1,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1166934.8641069406,1561264.2765008633,1.3379189571953567,0.41999072913824403,0.4334373584544207,0.7974180334973026,Upregulated
Feature0507,NA,C33 H47 N O8,585.33043,NA,NA,Feature0507,33,47,8,1,0,0,1.4242424242424243,0.24242424242424243,-0.8484848484848486,84.48181818181818,11,3,0.08333333333333333,0.21428571428571427,2,Phenol,134558.62041443755,154550.478668283,1.1485735970855748,0.19984330316644572,0.4534760778333878,0.7974180334973026,Upregulated
Feature0506,N-acetyl-L-2-aminoadipic acid 6-phosphate,C8 H14 N O8 P,283.04574,NA,NA,N-acetyl-L-2-aminoadipic acid 6-phosphate,8,14,8,1,0,1,1.75,1,0,60.3,3,-5,3.5,-1.5,-7,Carbohydrate,4301509.4173783995,5024970.5501561,1.1681877365779711,0.22427214482179886,0.6025747817547757,0.8234944033238226,Upregulated
Feature0505,NA,C29 H28 O9,520.17351,NA,NA,Feature0505,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Phenol,685363.4884107823,516044.614218197,0.7529502562425654,-0.4093735386790013,0.5840304253649276,0.820796478981062,Downregulated
Feature0504,asn-phe,C13 H17 N3 O4,279.12195,NA,NA,asn-phe-peak2,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Phenol,2698067.7333210767,2436361.3476676866,0.9030022921881011,-0.1471984450281733,0.36173314818441055,0.7829565408883704,Downregulated
Feature0503,N-Acetylvanilalanine,C12 H15 N O5,253.09509,NA,NA,N-Acetylvanilalanine-peak2,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Phenol,7861724.54903757,8905151.154619746,1.1327223561540212,0.17979428261810657,0.5846147291212693,0.820796478981062,Upregulated
Feature0502,gepefrine,C9 H13 N O,151.09965,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,gepefrine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,201254.47446364065,232424.96269871134,1.1548809700660945,0.20774416528239034,0.4086591546642733,0.7873878775042317,Upregulated
Feature0501,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13662,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Phenol,176842.277689002,201132.52691293033,1.137355442043365,0.18568319032219063,0.4507145479965723,0.7974180334973026,Upregulated
Feature0500,Isovalerylglutamic acid,C10 H17 N O5,231.11063,NA,NA,Isovalerylglutamic acid-peak4,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,8463904.266064154,8678546.985940717,1.0253597764257765,0.03613020884621452,0.8130257537664832,0.9142978308596724,Upregulated
Feature0499,NA,C20 H42 N9 O17 P,711.2437,NA,NA,Feature0499,20,42,17,9,0,1,2.1,0.85,0.7000000000000002,40.349999999999994,5,-12,3.142857142857143,-9,-22,Carbohydrate,39517.87566819543,61948.32332599243,1.567602566649334,0.6485598401918483,0.1320449638824147,0.7829565408883704,Upregulated
Feature0498,NA,C77 H114 N8 O16 P2,1468.7833,NA,NA,Feature0498,77,114,16,8,0,2,1.4805194805194806,0.2077922077922078,-0.883116883116883,85.46883116883116,26,10,0,0.13559322033898305,0,Phenol,162987.59735728067,185374.830849761,1.1373554421040142,0.1856831903991221,0.4507145477671361,0.7974180334973026,Upregulated
Feature0497,MFCD00056023,C12 H14 N2 O3,234.10044,NA,NA,MFCD00056023,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Phenol,1918994.4846711643,1292473.3940585083,0.673515950349375,-0.570215982581432,0.4510557884996236,0.7974180334973026,Downregulated
Feature0496,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Phenol,303966.6820198697,516252.25196808466,1.6983843378411398,0.7641629721736959,0.40495883801980953,0.7873878775042317,Upregulated
Feature0495,Linamarin,C10 H17 N O6,247.10559,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,10481416.981842566,10142819.215995094,0.9676954207208777,-0.04737505995007857,0.7532361250802956,0.8847091047453014,Downregulated
Feature0494,Otonecine,C9 H15 N O3,185.10524,Other,NA,Otonecine,9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,299601.74457640667,202426.64227531868,0.6756524150469169,-0.5656468425398983,0.06644538604885739,0.7829565408883704,Downregulated
Feature0493,N-(Carboxyacetyl)phenylalanine,C12 H13 N O5,251.07938,NA,NA,N-(Carboxyacetyl)phenylalanine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Phenol,103927.76155816687,736890.2020838206,7.090407712393515,2.825868587653289,0.2918340286819063,0.7829565408883704,Upregulated
Feature0492,NA,C10 H23 N O6,253.1525,NA,NA,Feature0492,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,1961608.9376341186,136301.2878454731,0.06948443455292624,-3.847166358821447,0.1947798304755998,0.7829565408883704,Downregulated
Feature0491,Meconin,C10 H10 O4,194.05794,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak1,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Phenol,576611.8322363817,1248666.7646625899,2.1655240056723284,1.1147161653274213,0.2768026897290593,0.7829565408883704,Upregulated
Feature0490,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,4760617.04014335,6348478.508837894,1.3335411051351298,0.41526229527551395,0.16839080655741703,0.7829565408883704,Upregulated
Feature0489,NA,C9 H23 N10 O5 P,382.15886,NA,NA,Feature0489,9,23,5,10,0,1,2.5555555555555554,0.5555555555555556,1.3333333333333337,22.29999999999999,4,-1,1.7142857142857142,2.111111111111111,-12,Other,8025297.662252317,7097068.255373714,0.8843370743437204,-0.17733172211001183,0.21189617318712328,0.7829565408883704,Downregulated
Feature0488,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0488,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,1587830.1192735333,1020970.2082810616,0.6429971291564728,-0.6371157986420183,0.09726445727295421,0.7829565408883704,Downregulated
Feature0487,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",C8 H17 N O7,239.10053,Metabolic pathways;Biosynthesis of cofactors;Other,NA,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",8,17,7,1,0,0,2.125,0.875,0,60.3,1,-6,-Inf,-1,-7,Carbohydrate,176853.39313272532,177153.41968747132,1.0016964704461215,0.0024454157978171976,0.9924468231760284,0.9986774310345325,Upregulated
Feature0486,ser-asn,C7 H13 N3 O5,219.08553,Biosynthesis of secondary metabolites;Other,NA,ser-asn,7,13,5,3,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,3,-2,5,-1.6666666666666667,-5,Carbohydrate,1883606.5964518567,2544331.75714779,1.3507766228577343,0.43378911675070225,0.1908051244566916,0.7829565408883704,Upregulated
Feature0485,D-Glucono-delta-lactone,C6 H10 O6,178.04778,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Glucono-delta-lactone,6,10,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,145965.43419812666,184099.23017751033,1.2612522354273452,0.3348568263481536,0.06684416339251145,0.7829565408883704,Upregulated
Feature0484,NA,C18 H29 N O12,451.16881,NA,NA,Feature0484,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,146066.14499468467,126942.57200404133,0.869075938224157,-0.20244585235530474,0.381199843026141,0.7829565408883704,Downregulated
Feature0483,lys-leu,C12 H25 N3 O3,259.18958,NA,NA,lys-leu-peak1,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,419744.71935261664,384247.3471929163,0.9154310452923652,-0.12747687556200596,0.8394879794357555,0.9258913540116168,Downregulated
Feature0482,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0482,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,5084467.2575374795,2674235.932125902,0.525961874995158,-0.926969867135646,0.2296926926541435,0.7829565408883704,Downregulated
Feature0481,Zalcitabine,C9 H13 N3 O3,211.09565,Other,NA,Zalcitabine,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Phenol,3277426.1950552133,2836889.6028739866,0.8655845880386621,-0.20825328305874694,0.7650698246193599,0.8895423245833387,Downregulated
Feature0480,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11578,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak1,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,556837.9830681073,830746.608037134,1.4919000378886238,0.5771508736134718,0.22911865708467885,0.7829565408883704,Upregulated
Feature0479,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12117,NA,NA,Cyclo(phenylalanyl-prolyl)-peak1,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Phenol,10775765.884365793,11802537.706191767,1.0952852755752316,0.1313066799225948,0.3277027555521331,0.7829565408883704,Upregulated
Feature0478,NA,C14 H20 N2 O10,376.1119,NA,NA,Feature0478,14,20,10,2,0,0,1.4285714285714286,0.7142857142857143,0.4285714285714284,48.08571428571429,6,-4,-3,-0.14285714285714285,-6,Tannin,186637.47337132934,834014.8502595033,4.468635559591871,2.1598343902668637,0.41330483354710573,0.7873878775042317,Upregulated
Feature0477,N(6)-[(indol-3-yl)acetyl]-L-lysine,C16 H21 N3 O3,303.15835,NA,NA,N(6)-[(indol-3-yl)acetyl]-L-lysine,16,21,3,3,0,0,1.3125,0.1875,-0.375,70.9875,8,5,0.2,0.30434782608695654,2,Phenol,4855506.10469708,6518912.089338287,1.3425813805551752,0.42500953980471573,0.282289693087147,0.7829565408883704,Upregulated
Feature0476,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak2,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,1673299.7019721137,1602490.06170396,0.9576826313990858,-0.062380457678446445,0.9171831301251737,0.9603585751327469,Downregulated
Feature0475,Leu-Gly-Pro,C13 H23 N3 O4,285.16888,NA,NA,Leu-Gly-Pro-peak3,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,2958369.28985073,2076794.5790458233,0.7020065365641394,-0.5104436309889162,0.25396872431946615,0.7829565408883704,Downregulated
Feature0474,NA,C21 H32 N2 O8,440.21604,NA,NA,Feature0474,21,32,8,2,0,0,1.5238095238095235,0.380952380952381,-0.4761904761904763,73.87142857142857,7,-1,-0.2727272727272727,0.06666666666666667,-3,Protein,6650038.839824236,6845882.0318883,1.0294499320652448,0.041873665309950625,0.3580316295791778,0.7829565408883704,Upregulated
Feature0473,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10731,NA,NA,N(6)-OH-Me-Adenosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Phenol,8026357.25866399,8360037.965861123,1.041573119217556,0.05876412121224262,0.8658324301214457,0.9379434753860953,Upregulated
Feature0472,NA,C19 H35 P S,326.21985,NA,NA,Feature0472,19,35,0,0,1,1,1.8421052631578947,0,-2,117.3,3,3,0.0588235294117647,0.0588235294117647,1,Lipid,3204041.16929384,1650817.00138856,0.5152296472371467,-0.9567124837884864,0.36476069321161947,0.7829565408883704,Downregulated
Feature0471,xylometazoline,C16 H24 N2,244.19396,NA,NA,xylometazoline,16,24,0,2,0,0,1.5,0,-1.125,92.3625,6,6,0.2857142857142857,0.2857142857142857,4,Lipid,5077344.46968108,11556673.8155198,2.276125617343765,1.1865801808948968,0.18208220459747354,0.7829565408883704,Upregulated
Feature0470,Threonylglutamine,C9 H17 N3 O5,247.11681,NA,NA,Threonylglutamine,9,17,5,3,0,0,1.8888888888888888,0.5555555555555556,0.22222222222222232,53.96666666666666,3,-2,-5,-0.7142857142857143,-5,Amino Sugar,5643104.736007187,9425598.538015744,1.6702859470024445,0.7400951080934386,0.12742666310607104,0.7829565408883704,Upregulated
Feature0469,(S)-(+)-2-Aminobutyric Acid,C4 H9 N O2,103.06328,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,(S)-(+)-2-Aminobutyric Acid,4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,353214.8129669259,319731.3666076713,0.9052037311855607,-0.1436855635836937,0.8473491299924094,0.9297987128514287,Downregulated
Feature0468,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14231,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak2",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Phenol,563677.1994604319,651592.2210107703,1.1559669641321189,0.20910016828513686,0.5708053650370936,0.820796478981062,Upregulated
Feature0467,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak1",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,9721686.267426167,10202549.627519166,1.04946295805741,0.0696512460297966,0.6961011941111261,0.8562617001735352,Upregulated
Feature0466,2'-deamino-2'-hydroxy-6'-dehydroparomamine,C12 H22 N2 O8,322.13771,Biosynthesis of secondary metabolites;Other,Kanamycin biosynthesis,2'-deamino-2'-hydroxy-6'-dehydroparomamine,12,22,8,2,0,0,1.8333333333333333,0.6666666666666666,0,60.3,3,-5,-3.5,-0.5,-7,Amino Sugar,1253384.5784716664,887054.092952724,0.7077269883393387,-0.49873515905509036,0.29688204541979785,0.7829565408883704,Downregulated
Feature0465,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak2,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,1673348.19833275,1358602.19108269,0.8119064474664275,-0.30061459352596376,0.1473743696193036,0.7829565408883704,Downregulated
Feature0464,NA,C16 H29 N3 O9,407.19049,NA,NA,Feature0464,16,29,9,3,0,0,1.8125,0.5625,-0.125,63.8625,4,-5,-2,-0.4117647058823529,-8,Amino Sugar,7479280.28526706,1367016.4535806803,0.18277379660092105,-2.4518688419072987,0.20467500629562566,0.7829565408883704,Downregulated
Feature0463,butoctamide,C16 H29 N O5,315.20464,NA,NA,butoctamide,16,29,5,1,0,0,1.8125,0.3125,-1,88.8,3,-2,-0.3,-0.04,-3,Protein,3122737.8249198734,3437055.4083239567,1.1006544900746345,0.13836165901567896,0.6312418036607997,0.8293364212030647,Upregulated
Feature0462,NA,C23 H33 N3 O5,431.24202,NA,NA,Feature0462,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Phenol,542839.7636084047,695215.1225778736,1.2807004371908723,0.3569330609101674,0.6544239347494382,0.8362522505118077,Upregulated
Feature0461,NA,C29 H28 O9,520.17353,NA,NA,Feature0461,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Phenol,146689.72480960272,165516.84460273734,1.128346547909688,0.17421022923167423,0.5356468313982274,0.811395486596221,Upregulated
Feature0460,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23298,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak2,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,108768.4869734146,97722.48436405227,0.8984448261005762,-0.15449818498090842,0.44940154378717595,0.7974180334973026,Downregulated
Feature0459,NA,C14 H29 N O2,243.2198,NA,NA,Feature0459,14,29,2,1,0,0,2.0714285714285716,0.14285714285714285,-1.5714285714285712,105.08571428571427,1,-1,-0.18181818181818185,-0.08333333333333333,-2,Lipid,1650489.6858632895,4163827.05701407,2.52278283995224,1.3350160250982896,0.16224499555945732,0.7829565408883704,Upregulated
Feature0458,NA,C32 H37 N4 O2 P3,602.213,NA,NA,Feature0458,32,37,2,4,0,3,1.15625,0.0625,-1.125,92.3625,18,16,0.391304347826087,0.4166666666666667,9,Unsaturated HC,278476.916701044,313446.4960671377,1.1255744274260078,0.17066145663948235,0.43628350680145567,0.7974180334973026,Upregulated
Feature0457,Homo-L-arginine,C7 H16 N4 O2,188.12733,NA,NA,Homo-L-arginine,7,16,2,4,0,0,2.2857142857142856,0.2857142857142857,0,60.3,2,0,-4,-1.5,-4,Lipid,5231804.973110854,4705935.575149337,0.8994860472314524,-0.15282719222785207,0.6609375467765968,0.8369886314710402,Downregulated
Feature0456,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak1,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,9708852.2645758,10874289.6113508,1.1200386322724545,0.16354849444955896,0.1497714186193431,0.7829565408883704,Upregulated
Feature0455,NA,C16 H23 N5 O10,445.14463,NA,NA,Feature0455,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Phenol,9818673.753141271,10678435.685804266,1.0875639576463099,0.12110024571166435,0.29445563622662235,0.7829565408883704,Upregulated
Feature0454,Isovalerylglutamic acid,C10 H17 N O5,231.11073,NA,NA,Isovalerylglutamic acid-peak3,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,3285217.60382081,2786683.1352181467,0.848249178981979,-0.23743996633095188,0.5583166648245947,0.820796478981062,Downregulated
Feature0453,propionylcarnitine,C10 H19 N O4,217.13149,NA,NA,propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,8470480.94020404,7898359.128827836,0.9324569861599357,-0.1008909188868149,0.6189475569862246,0.8293364212030647,Downregulated
Feature0452,Tetrahydrothiophene,C4 H8 S,88.03465,NA,NA,Tetrahydrothiophene,4,8,0,0,1,0,2,0,-1.5,103.05,1,1,0,0,0,Lipid,115893.39039873297,124392.59333126,1.073336390481678,0.10210229680489279,0.6197967952955694,0.8293364212030647,Upregulated
Feature0451,glu-asp,C9 H14 N2 O7,262.08011,NA,NA,glu-asp,9,14,7,2,0,0,1.5555555555555556,0.7777777777777778,0.6666666666666665,41.3,4,-3,-Inf,-0.42857142857142855,-5,Carbohydrate,3768027.0972151533,4132272.8889802266,1.0966675085840751,0.13312619080434887,0.703614112798252,0.8608429447534801,Upregulated
Feature0450,Succinic anhydride,C4 H4 O3,100.01602,NA,NA,Succinic anhydride,4,4,3,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,377961.23666151334,289698.974202569,0.7664780038330004,-0.38368370445978417,0.2062394426407772,0.7829565408883704,Downregulated
Feature0449,dapdiamide A,C12 H20 N4 O5,300.14339,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,dapdiamide A,12,20,5,4,0,0,1.6666666666666667,0.4166666666666667,0.16666666666666652,55.55,5,0,-1.3333333333333333,-0.2727272727272727,-4,Protein,6928330.7856964795,7723826.069925593,1.1148177402082782,0.15680786549019438,0.6360389496347181,0.8327137707002961,Upregulated
Feature0448,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",C10 H11 N O2,177.07899,NA,NA,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",10,11,2,1,0,0,1.1,0.2,-0.4000000000000003,71.7,6,4,0.42857142857142855,0.5,3,Phenol,3433886.742378313,3989124.1057228833,1.1616935574759266,0.21622955117295528,0.2891019304569187,0.7829565408883704,Upregulated
Feature0447,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak3,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1518090.7244955266,761743.3473095819,0.5017772225455861,-0.9948811117177037,0.037413052636016346,0.7829565408883704,Downregulated
Feature0446,NA,C61 H95 N10 O14 P3,1284.62434,NA,NA,Feature0446,61,95,14,10,0,3,1.5573770491803278,0.22950819672131148,-0.8524590163934427,84.5950819672131,21,7,-0.17647058823529413,0.02439024390243902,-6,Lipid,5652638.399947284,8255381.037089543,1.460447396947686,0.5464103954629387,0.5791541823853511,0.820796478981062,Upregulated
Feature0445,NA,C16 H23 N5 O10,445.14459,NA,NA,Feature0445,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Phenol,6321186.46198739,5514437.39453551,0.8723737905370637,-0.1969816683637766,0.7152624841538662,0.8694626213961982,Downregulated
Feature0444,MFCD00142316,C12 H14 N2 O3,234.1004,NA,NA,MFCD00142316,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Phenol,102201.06187416603,115150.84125113767,1.126708853504046,0.17211476495935307,0.4615719814654289,0.7995347728859721,Upregulated
Feature0443,NA,C13 H25 N3 O5,303.17945,NA,NA,Feature0443,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,2012029.1801506067,1004606.688435701,0.499300257842435,-1.002020443200518,0.12606121350757277,0.7829565408883704,Downregulated
Feature0442,2-Hexenoylcarnitine,C13 H23 N O4,257.16273,NA,NA,2-Hexenoylcarnitine,13,23,4,1,0,0,1.7692307692307692,0.3076923076923077,-0.9230769230769234,86.6076923076923,3,-1,-0.25,0,-2,Protein,153157.48429534296,388182.00432045,2.53452846987154,1.3417173695347282,0.20322457256477244,0.7829565408883704,Upregulated
Feature0441,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak2,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,2166961.8628233066,2728812.28585859,1.2592802543849368,0.3325993923634103,0.5973517672658193,0.8210217305908382,Upregulated
Feature0440,Leonurine,C14 H21 N3 O5,311.14823,NA,NA,Leonurine-peak2,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,318839.25969845965,182013.00809568865,0.570861343323361,-0.808787723365108,0.22892062658179008,0.7829565408883704,Downregulated
Feature0439,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak3,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1824762.04941803,2365049.7790614567,1.2960866759672802,0.37416220186975935,0.31219862405840093,0.7829565408883704,Upregulated
Feature0438,ile-his,C12 H20 N4 O3,268.15359,NA,NA,ile-his-peak1,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,3490583.17412986,7163206.278501267,2.0521517239843243,1.0371373992431145,0.0874072049461705,0.7829565408883704,Upregulated
Feature0437,Apaxifylline,C16 H22 N4 O3,318.1693,NA,NA,Apaxifylline,16,22,3,4,0,0,1.375,0.1875,-0.25,67.425,8,5,0.1111111111111111,0.23809523809523808,1,Phenol,442874.555185057,1004351.5388428436,2.267801405802533,1.1812943072075996,0.09541380675028927,0.7829565408883704,Upregulated
Feature0436,Levetiracetam,C8 H14 N2 O2,170.10558,NA,NA,Levetiracetam,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,5748634.18869586,6851802.666244737,1.1919009700979326,0.2532643734815583,0.15676961342854442,0.7829565408883704,Upregulated
Feature0435,Butenylcarnitine,C11 H19 N O4,229.13142,NA,NA,Butenylcarnitine,11,19,4,1,0,0,1.7272727272727273,0.3636363636363637,-0.7272727272727275,81.02727272727273,3,-1,-0.3333333333333333,0,-2,Protein,561369.1894856766,613092.820232518,1.0921383497983392,0.127155625420037,0.7078653233739443,0.8632131886285471,Upregulated
Feature0434,NA,C12 H24 N O13 P,421.09864,NA,NA,Feature0434,12,24,13,1,0,1,2,1.0833333333333333,0,60.3,2,-11,4.333333333333333,-1.8571428571428572,-13,Carbohydrate,285437.2866776957,339164.48590376467,1.188227683395602,0.24881130603171836,0.155291659347398,0.7829565408883704,Upregulated
Feature0433,NA,C10 H20 N2 O6,264.13219,NA,NA,Feature0433,10,20,6,2,0,0,2,0.6,-0.20000000000000015,66,2,-4,-3,-0.6,-6,Amino Sugar,270951.36733339867,268253.26746148337,0.99004212490799,-0.014438183732564277,0.9796232258155898,0.9900664202164838,Downregulated
Feature0432,NA,C16 H14 O3 S,286.0665,NA,NA,Feature0432,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Phenol,5025577.483352207,10295795.625947576,2.04867911400303,1.0346940317430204,0.043349866557664846,0.7829565408883704,Upregulated
Feature0431,NA,C10 H22 N2 O4,234.15795,NA,NA,Feature0431,10,22,4,2,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-3,-1.25,-0.5,-5,Protein,127609.83589699194,141848.66980142033,1.1115810063099065,0.15261308839471105,0.45301855350144293,0.7974180334973026,Upregulated
Feature0430,NP-021030,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,NP-021030,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,145270.3541977877,230805.60319638066,1.588800443634463,0.66793793081701,0.12281403143467466,0.7829565408883704,Upregulated
Feature0429,NA,C7 H15 N O6,209.08992,NA,NA,Feature0429,7,15,6,1,0,0,2.142857142857143,0.8571428571428571,0,60.3,1,-5,-Inf,-1,-6,Carbohydrate,2144145.924749793,1762382.7756021167,0.8219509480483586,-0.28287579479905983,0.642214241417304,0.8329695325287205,Downregulated
Feature0428,NA,C13 H25 N3 O4,287.18456,NA,NA,Feature0428,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,63121.0101593427,59498.994678611336,0.9426179100811608,-0.0852550015461933,0.6092618648747568,0.8271412231626079,Downregulated
Feature0427,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",C10 H13 N O3,195.08955,Other,NA,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Phenol,6459122.87642545,10128716.32994117,1.568125660979299,0.6490411737437223,0.13003739663344163,0.7829565408883704,Upregulated
Feature0426,5-Pentylresorcinol,C11 H16 O2,180.11499,NA,NA,5-Pentylresorcinol,11,16,2,0,0,0,1.4545454545454546,0.18181818181818185,-1.0909090909090908,91.39090909090908,4,2,0.2222222222222222,0.3,2,Phenol,1088685.1367457933,1572579.2024554666,1.4444756793098958,0.5305459133975883,0.31325955699707236,0.7829565408883704,Upregulated
Feature0425,NA,C16 H28 N2 O5,328.19992,NA,NA,Feature0425,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,91858.44420093454,99778.2972245387,1.0862180183052088,0.1193137001589214,0.6242108284502413,0.8293364212030647,Upregulated
Feature0424,NA,C16 H25 N O9,375.15307,NA,NA,Feature0424,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,255665.52351066965,325804.0293045943,1.2743369728965337,0.3497468198586369,0.11702971628417105,0.7829565408883704,Upregulated
Feature0423,asn-phe,C13 H17 N3 O4,279.12194,NA,NA,asn-phe-peak1,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Phenol,819473.6828158466,955178.4708974886,1.1655999343570596,0.22107270126699582,0.6051624392443484,0.8260246433481252,Upregulated
Feature0422,4'-Methoxyacetophenone,C9 H10 O2,150.06812,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Other,Other,4'-Methoxyacetophenone,9,10,2,0,0,0,1.1111111111111112,0.2222222222222222,-0.666666666666667,79.30000000000001,5,3,0.42857142857142855,0.5,3,Phenol,723229.609393311,745853.332457539,1.031281522175518,0.04443821748331846,0.8943590069206243,0.9511571618625029,Upregulated
Feature0421,NA,C20 H38 N4 O6,430.27924,NA,NA,Feature0421,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,127278.45703487027,86115.52082564482,0.6765914894934019,-0.5636430645820708,0.35084551020885557,0.7829565408883704,Downregulated
Feature0420,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0420,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,2477718.843356143,1418867.494929699,0.5726507261848165,-0.8042726229890014,0.19498548116444325,0.7829565408883704,Downregulated
Feature0419,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16772,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,3,1,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,817420.4554110516,570882.7213396137,0.698395443324864,-0.5178839487408387,0.6587245761298222,0.8363589828247083,Downregulated
Feature0418,NA,C22 H37 N2 O8 P3 S,582.1482,NA,NA,Feature0418,22,37,8,2,1,3,1.681818181818182,0.3636363636363637,-1.2727272727272725,96.57272727272726,7,-1,-0.875,-0.25,-7,Protein,170497.970211232,187329.595115701,1.0987203829090522,0.1358242766259041,0.541993697599836,0.8119051117583658,Upregulated
Feature0417,NA,C16 H29 N3 O6,359.20575,NA,NA,Feature0417,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,5996040.11259655,7321315.47312855,1.2210250991730103,0.28809285641070687,0.3513003344386598,0.7829565408883704,Upregulated
Feature0416,VLK,C17 H34 N4 O4,358.25811,NA,NA,VLK,17,34,4,4,0,0,2,0.2352941176470588,-0.8235294117647056,83.7705882352941,3,-1,-0.5555555555555556,-0.2727272727272727,-5,Lipid,110860.1679948662,89931.41434789944,0.811214848168587,-0.30184403576215774,0.2436995698234738,0.7829565408883704,Downregulated
Feature0415,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16891,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak2,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1724936.0307892533,912939.8736567086,0.5292601333389669,-0.9179511082115654,0.09347968068566036,0.7829565408883704,Downregulated
Feature0414,Methionylleucine,C11 H22 N2 O3 S,262.13515,NA,NA,Methionylleucine-peak1,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,999870.8205950904,873073.6135657303,0.8731864112667128,-0.19563841594513193,0.6225857192760961,0.8293364212030647,Downregulated
Feature0413,NA,C11 H19 N3 O4,257.13761,NA,NA,Feature0413,11,19,4,3,0,0,1.7272727272727273,0.3636363636363637,-0.18181818181818168,65.48181818181817,4,0,-0.75,-0.16666666666666666,-3,Protein,104909.29108748354,98158.19717725147,0.935648274425929,-0.09596179596081233,0.755194685791156,0.8847091047453014,Downregulated
Feature0412,NA,C11 H22 N4 O3,258.16921,NA,NA,Feature0412,11,22,3,4,0,0,2,0.2727272727272727,-0.3636363636363633,70.66363636363636,3,0,-1,-0.4545454545454546,-4,Lipid,104766.02819529513,1509124.5472980165,14.404712799504495,3.8484689912851002,0.3166556174081287,0.7829565408883704,Upregulated
Feature0411,glu-leu,C11 H20 N2 O5,260.13722,NA,NA,glu-leu,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,787988.3219784843,1799410.9928569933,2.2835503302117788,1.1912785875471177,0.06589995369801904,0.7829565408883704,Upregulated
Feature0410,NA,C13 H24 N2 O10,368.14308,NA,NA,Feature0410,13,24,10,2,0,0,1.8461538461538465,0.7692307692307693,0.15384615384615374,55.91538461538462,3,-7,-9,-0.6666666666666666,-9,Carbohydrate,4099839.73693005,2138794.6438981397,0.521677621842766,-0.9387695467985124,0.3620506600237833,0.7829565408883704,Downregulated
Feature0409,6-methyltetrahydropterin,C7 H11 N5 O,181.09637,NA,NA,6-methyltetrahydropterin,7,11,1,5,0,0,1.5714285714285714,0.14285714285714285,0.8571428571428572,35.87142857142857,5,4,-1,-0.3333333333333333,-1,Lipid,589143.1331430944,2827389.0726741035,4.799154761577051,2.262780337363268,0.006907818229313375,0.7829565408883704,Upregulated
Feature0408,NA,C39 H72 N2 O5,648.54423,NA,NA,Feature0408,39,72,5,2,0,0,1.8461538461538465,0.1282051282051282,-1.435897435897436,101.22307692307692,5,0,-0.0625,0.0144927536231884,-2,Lipid,2941129.3677087394,297333.310825178,0.10109494471398,-3.306217238283612,0.42796695984361216,0.7913025583045388,Downregulated
Feature0407,NA,C13 H24 N2 O3,256.17864,NA,NA,Feature0407,13,24,3,2,0,0,1.8461538461538465,0.2307692307692308,-0.9230769230769234,86.6076923076923,3,0,-0.25,-0.05263157894736842,-2,Lipid,785469.737303838,814912.9660756066,1.0374848671736658,0.05309029336295703,0.9195119739529873,0.9614849472688375,Upregulated
Feature0406,NP-004713,C15 H24 O2,236.17762,Other,Other,NP-004713,15,24,2,0,0,0,1.6,0.13333333333333333,-1.333333333333333,98.29999999999998,4,2,0.15384615384615383,0.21428571428571427,2,Lipid,4705980.250155074,7135980.388156603,1.5163642873174945,0.6006163843614616,0.3975106209203723,0.7873878775042317,Upregulated
Feature0405,NA,C16 H31 N3 O4,329.23156,NA,NA,Feature0405,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,1099504.32948552,482076.246108921,0.43844870200237784,-1.1895200360166627,0.04231749981607297,0.7829565408883704,Downregulated
Feature0404,1-Methyl-4-(1-methyl-2-propenyl)-benzene,C13 H18,174.14087,NA,NA,1-Methyl-4-(1-methyl-2-propenyl)-benzene,13,18,0,0,0,0,1.3846153846153846,0,-1.384615384615385,99.76153846153846,5,5,0.38461538461538464,0.38461538461538464,5,Unsaturated HC,1013431.1569293056,690895.1172125797,0.6817385793683218,-0.5527094678827885,0.5600295190491751,0.820796478981062,Downregulated
Feature0403,anthramycin,C16 H17 N3 O4,315.12196,NA,NA,anthramycin,16,17,4,3,0,0,1.0625,0.25,0,60.3,10,6,0.3333333333333333,0.4545454545454546,3,Phenol,144410.36833003056,162246.310923604,1.1235087397105157,0.16801134720404923,0.5743323377904244,0.820796478981062,Upregulated
Feature0402,"(8Z,11Z,14Z)-Heptadecatrienal",C17 H28 O,248.21402,Other,NA,"(8Z,11Z,14Z)-Heptadecatrienal",17,28,1,0,0,0,1.6470588235294117,0.0588235294117647,-1.5294117647058822,103.88823529411764,4,3,0.1875,0.21212121212121213,3,Lipid,1506497.2563150222,1050964.713570389,0.6976213923821596,-0.5194838142185502,0.563968889063603,0.820796478981062,Downregulated
Feature0401,NA,C30 H51 N4 O17 P3,832.24652,NA,NA,Feature0401,30,51,17,4,0,3,1.7,0.5666666666666667,-0.666666666666667,79.30000000000001,9,-8,-2.5,-0.4482758620689655,-15,Amino Sugar,4794005.392953407,3483875.85110451,0.7267150463004016,-0.46053831791943634,0.5638896489714949,0.820796478981062,Downregulated
Feature0400,NA,C17 H31 N3 O9,421.20619,NA,NA,Feature0400,17,31,9,3,0,0,1.8235294117647056,0.5294117647058824,-0.23529411764705888,67.00588235294117,4,-5,-1.6,-0.3684210526315789,-8,Protein,4531041.54984468,655011.8289965354,0.14456098488414623,-2.7902498545556558,0.20872508949273963,0.7829565408883704,Downregulated
Feature0399,Hopantenic acid,C10 H19 N O5,233.12632,NA,NA,Hopantenic acid,10,19,5,1,0,0,1.9,0.5,-0.5999999999999996,77.39999999999999,2,-3,-1,-0.2307692307692308,-4,Protein,6507683.52688069,7738852.729126107,1.189187012115746,0.24997561183403832,0.3604968313304596,0.7829565408883704,Upregulated
Feature0398,1726033,C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak1,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,5884337.157569326,7719425.829742746,1.311859878697272,0.39161363222410056,0.23938448118248495,0.7829565408883704,Upregulated
Feature0397,NA,C13 H24 N2 O8,336.15337,NA,NA,Feature0397,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,6878915.081698104,7491013.090421161,1.0889817655042133,0.12297979699615036,0.3811210689618978,0.7829565408883704,Upregulated
Feature0396,valienone,C7 H10 O5,174.05284,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,valienone,7,10,5,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,4391870.857388597,2306716.2032110803,0.5252240510056009,-0.9289951134013322,0.38130454167736516,0.7829565408883704,Downregulated
Feature0395,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0395,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,1804279.41989807,843897.0017388437,0.4677196848958785,-1.0962839462159566,0.012070645999229466,0.7829565408883704,Downregulated
Feature0394,NA,C37 H51 N3 O12,729.34763,NA,NA,Feature0394,37,51,12,3,0,0,1.3783783783783785,0.32432432432432434,-0.4864864864864869,74.16486486486487,14,2,-0.04545454545454545,0.17857142857142858,-1,Phenol,75397.8563274629,82074.2159998423,1.088548401739475,0.12240555763823179,0.507717516937397,0.7998439321266281,Upregulated
Feature0393,NA,C9 H16 N2 O3,200.1161,NA,NA,Feature0393,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,8642697.781166019,9673919.904216085,1.1193171564204505,0.16261887917799112,0.20729568102387438,0.7829565408883704,Upregulated
Feature0392,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,2114476.902739187,1171358.6958863544,0.5539709108994876,-0.8521178727697092,0.13461613576399803,0.7829565408883704,Downregulated
Feature0391,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0391,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,4775681.652696704,4828525.34492607,1.0110651622265332,0.01587598061541169,0.9444373305854878,0.9713544839041761,Upregulated
Feature0390,Anhydroecgonine methyl ester,C10 H15 N O2,181.11031,NA,NA,Anhydroecgonine methyl ester,10,15,2,1,0,0,1.5,0.2,-0.7999999999999998,83.1,4,2,0.14285714285714285,0.25,1,Lipid,1724426.7963486498,1182981.657920171,0.6860144254456321,-0.543689181317171,0.41016824330251445,0.7873878775042317,Downregulated
Feature0389,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10587,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,1764659.1056601333,5763769.883173366,3.2662228442230625,1.7076232248518153,0.029452600490684915,0.7829565408883704,Upregulated
Feature0388,NA,C14 H25 N3 O7,347.16934,NA,NA,Feature0388,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,892035.3231210996,846131.556141397,0.9485404156204351,-0.07621884927067367,0.8667901854240231,0.9379434753860953,Downregulated
Feature0387,NA,C10 H21 N O10,315.11663,NA,NA,Feature0387,10,21,10,1,0,0,2.1,1,0.20000000000000015,54.599999999999994,1,-9,10,-1.25,-10,Carbohydrate,4407883.5256380765,5664430.12255137,1.285068012710567,0.36184471662043366,0.41311358017727856,0.7873878775042317,Upregulated
Feature0386,NA,C16 H14 O3 S,286.06646,NA,NA,Feature0386,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Phenol,3745050.84004458,4475353.598801657,1.1950047649415578,0.2570163707950199,0.5210854282454954,0.8083677301524742,Upregulated
Feature0385,NA,C19 H34 N4 O5,398.25301,NA,NA,Feature0385,19,34,5,4,0,0,1.7894736842105263,0.2631578947368421,-0.6315789473684212,78.30000000000001,5,0,-0.4,-0.12,-4,Lipid,1280997.4780926933,857340.4296136957,0.669275657661879,-0.579327552135228,0.45246591040839135,0.7974180334973026,Downregulated
Feature0384,gln-phe,C14 H19 N3 O4,293.13766,NA,NA,gln-phe-peak2,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Phenol,1257826.8265141067,1078048.22336337,0.8570720552614001,-0.22251159603570259,0.2813723620255992,0.7829565408883704,Downregulated
Feature0383,lys-gln,C11 H22 N4 O4,274.16413,NA,NA,lys-gln,11,22,4,4,0,0,2,0.3636363636363637,-0.18181818181818168,65.48181818181817,3,-1,-1.6666666666666667,-0.6,-5,Protein,5987453.581593187,5701784.9941015905,0.9522888013078202,-0.07052892783628771,0.8337799982089168,0.9234957137121467,Downregulated
Feature0382,2-O-ETHYL ASCORBIC ACID,C8 H12 O6,204.06331,NA,NA,2-O-ETHYL ASCORBIC ACID,8,12,6,0,0,0,1.5,0.75,0,60.3,3,-3,-1.5,0,-3,Carbohydrate,191134.16094799433,195999.270755186,1.025453899936367,0.036262635817636064,0.9467261368626927,0.9714677168020872,Upregulated
Feature0381,4-Ethoxy-m-anisaldehyde,C10 H12 O3,180.07871,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,4-Ethoxy-m-anisaldehyde,10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Phenol,6880024.239859833,8938901.932022283,1.299254424168191,0.37768397162051004,0.3776560691937381,0.7829565408883704,Upregulated
Feature0380,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Phenol,8429388.42041347,7927593.2218407635,0.9404707466845984,-0.08854502542855033,0.5817656557031643,0.820796478981062,Downregulated
Feature0379,Gabexate,C16 H23 N3 O4,321.16895,NA,NA,Gabexate,16,23,4,3,0,0,1.4375,0.25,-0.375,70.9875,7,3,0,0.18181818181818185,0,Phenol,5208828.83693448,2266516.389574055,0.4351297499934657,-1.2004824370050782,0.06636325011335566,0.7829565408883704,Downregulated
Feature0378,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",C13 H12 N2 O2,228.08992,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",13,12,2,2,0,0,0.9230769230769232,0.15384615384615383,-0.1538461538461542,64.6846153846154,9,7,0.5555555555555556,0.6,5,Phenol,3414505.0617016465,4171892.15842494,1.2218146065204083,0.2890253927304989,0.06116125798699036,0.7829565408883704,Upregulated
Feature0377,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,1752501.177375543,294317.2863980917,0.16794127741405937,-2.5739712285097784,0.23343069869805763,0.7829565408883704,Downregulated
Feature0376,NA,C13 H17 N O5,267.11069,NA,NA,Feature0376,13,17,5,1,0,0,1.3076923076923077,0.38461538461538464,-0.3076923076923075,69.06923076923076,6,1,0,0.2631578947368421,0,Phenol,4699759.4460987765,4492000.760701806,0.9557937618340384,-0.06522874329007934,0.8163945268815211,0.9142978308596724,Downregulated
Feature0375,NA,C20 H20 N6 O5,424.14931,NA,NA,Feature0375,20,20,5,6,0,0,1,0.25,0.3999999999999999,48.9,14,9,0.3333333333333333,0.4782608695652174,3,Phenol,231355.63272933065,261836.024203248,1.1317469175672814,0.17855137725820397,0.514521045704321,0.8051500882569709,Upregulated
Feature0374,gamma-Glu-His,C11 H16 N4 O5,284.11217,NA,NA,gamma-Glu-His,11,16,5,4,0,0,1.4545454545454546,0.4545454545454546,0.5454545454545454,44.75454545454545,6,1,-1.5,-0.1111111111111111,-3,Phenol,4076380.96721636,7313782.524475167,1.7941852303047947,0.8433288406737414,0.0798749310006904,0.7829565408883704,Upregulated
Feature0373,6-methoxymellein,C11 H12 O4,208.07356,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak2,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Phenol,370896.324264279,115888.181666361,0.3124543816826447,-1.6782825231105845,0.19341374233886308,0.7829565408883704,Downregulated
Feature0372,NA,C8 H18 N2 O3,190.13174,NA,NA,Feature0372,8,18,3,2,0,0,2.25,0.375,-0.75,81.675,1,-2,-1.3333333333333333,-0.5555555555555556,-4,Protein,532735.3405007087,144226.40239570767,0.2707280546849995,-1.88508369770118,0.1440869609089988,0.7829565408883704,Downregulated
Feature0371,glutaral,C5 H8 O2,100.05243,NA,NA,glutaral,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,7266901.4185193395,9232361.172690116,1.270467375429354,0.3453593286296763,0.12597731030084772,0.7829565408883704,Upregulated
Feature0370,Pyridoxal,C8 H9 N O3,167.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak2,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Phenol,8884262.047400687,9102150.740030922,1.0245252437926438,0.03495553207564325,0.8998076617714277,0.9533372960411161,Upregulated
Feature0369,N-valeryl-Glycine,C7 H13 N O3,159.08952,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-valeryl-Glycine,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,634479.2366289264,567774.5001856233,0.8948669513635871,-0.1602548961715664,0.8513833068880714,0.931902449955211,Downregulated
Feature0368,gamma-Glutamyl-N~5~-acetylornithine,C12 H21 N3 O6,303.14309,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,gamma-Glutamyl-N~5~-acetylornithine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,1956645.5294857032,1854394.3009707166,0.9477415674049745,-0.07743437991154034,0.7162162967935437,0.8694626213961982,Downregulated
Feature0367,NA,C9 H7 N O3 S,209.01467,NA,NA,Feature0367,9,7,3,1,1,0,0.7777777777777778,0.3333333333333333,0.44444444444444464,47.633333333333326,7,4,0.5,0.6363636363636364,2,Condensed HC,2153138.435743601,1426869.9269154186,0.6626930731570166,-0.593587255259119,0.4599539099072789,0.7995347728859721,Downregulated
Feature0366,Acetylcarnitine,C9 H17 N O4,203.1157,NA,NA,Acetylcarnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,3879025.80406628,1816052.0068406034,0.46817219027955015,-1.094888854878621,0.29128552922320394,0.7829565408883704,Downregulated
Feature0365,NA,C20 H31 N O14,509.17464,NA,NA,Feature0365,20,31,14,1,0,0,1.55,0.7,0,60.3,6,-8,-1.8,-0.16666666666666666,-9,Amino Sugar,8254923.030264667,8848431.819297504,1.0718975557805785,0.10016703002168578,0.7921867214986782,0.9061342006853577,Upregulated
Feature0364,NA,C16 H28 N2 O5,328.19969,NA,NA,Feature0364,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,124412.82469717889,138170.70368656266,1.1105824823354866,0.15131654501217265,0.5851625571490037,0.820796478981062,Upregulated
Feature0363,NA,C16 H29 N3 O4,327.21588,NA,NA,Feature0363,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,4155614.12247135,3115155.455874993,0.7496257746911317,-0.41575753626086703,0.46708398368015225,0.7998439321266281,Downregulated
Feature0362,NA,C9 H22 N2 O2,190.16816,NA,NA,Feature0362,9,22,2,2,0,0,2.4444444444444446,0.2222222222222222,-1.333333333333333,98.29999999999998,0,-2,-0.8,-0.5,-4,Lipid,82172.98055802593,76025.92478293054,0.9251937104708684,-0.11217263641793901,0.03614827914462023,0.7829565408883704,Downregulated
Feature0361,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0361,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,842195.5622514903,653413.3969879206,0.77584521490604,-0.3661592388170884,0.3999832334364703,0.7873878775042317,Downregulated
Feature0360,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,C10 H12 N6 O4,280.09207,NA,NA,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,10,12,4,6,0,0,1.2,0.4,1.4,20.4,8,4,-Inf,0,-2,Phenol,7396339.85572627,9277091.72522407,1.2542814292182256,0.3268610889566478,0.2773675222521557,0.7829565408883704,Upregulated
Feature0359,tyr-his,C15 H18 N4 O4,318.13296,NA,NA,tyr-his,15,18,4,4,0,0,1.2,0.26666666666666666,0.1333333333333333,56.5,9,5,0.14285714285714285,0.3333333333333333,1,Phenol,1617090.2575549968,1855111.4602479301,1.1471910436544315,0.19810566579316705,0.17005310104102886,0.7829565408883704,Upregulated
Feature0358,NA,C16 H33 N O2,271.25118,NA,NA,Feature0358,16,33,2,1,0,0,2.0625,0.125,-1.625,106.6125,1,-1,-0.15384615384615383,-0.07142857142857142,-2,Lipid,4564451.377474864,9834056.504344344,2.154488171979328,1.1073451781542096,0.2776931356439502,0.7829565408883704,Upregulated
Feature0357,NA,C89 H119 N4 O11 P3,1512.80906,NA,NA,Feature0357,89,119,11,4,0,3,1.3370786516853932,0.12359550561797752,-1.1235955056179776,92.32247191011236,34,23,0.22535211267605632,0.28104575163398693,16,Unsaturated HC,168210.779732954,186730.88098697033,1.1101005612328665,0.1506903726299607,0.534981086522598,0.811395486596221,Upregulated
Feature0356,met-val,C10 H20 N2 O3 S,248.11947,NA,NA,met-val,10,20,3,2,1,0,2,0.3,-0.5999999999999996,77.39999999999999,2,-1,-1,-0.4545454545454546,-4,Lipid,700644.3010114203,826015.6022666337,1.1789371598031022,0.23748682123831327,0.5759860206393759,0.820796478981062,Upregulated
Feature0355,"N,N-dimethyl-9H-purin-6-amine",C7 H9 N5,163.08581,NA,NA,"N,N-dimethyl-9H-purin-6-amine",7,9,0,5,0,0,1.2857142857142858,0,0.8571428571428572,35.87142857142857,6,6,0.5,0.5,1,Unsaturated HC,1496492.7736539466,1588187.0050137567,1.0612727525144827,0.08579548389651805,0.30337278533363904,0.7829565408883704,Upregulated
Feature0354,dihomomethionine,C7 H15 N O2 S,177.08241,2-Oxocarboxylic acid metabolism;Other,NA,dihomomethionine,7,15,2,1,1,0,2.142857142857143,0.2857142857142857,-0.8571428571428568,84.72857142857141,1,-1,-1,-0.5,-3,Lipid,259494.76766930366,267415.768746983,1.0305247044047292,0.04337909051034142,0.928097774529311,0.9668497879551831,Upregulated
Feature0353,NA,C25 H34 O2,366.25594,NA,NA,Feature0353,25,34,2,0,0,0,1.36,0.08,-1.2000000000000002,94.5,9,7,0.30434782608695654,0.3333333333333333,7,Unsaturated HC,360201.44468169764,392176.885820813,1.088770996372242,0.12270054070247007,0.6270544428170941,0.8293364212030647,Upregulated
Feature0352,metharbital,C9 H14 N2 O3,198.10047,NA,NA,metharbital,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,3281134.0241894135,2914997.0539375897,0.8884114554441963,-0.1707000993392736,0.39901673125702725,0.7873878775042317,Downregulated
Feature0351,NA,C17 H31 N3 O4,341.23157,NA,NA,Feature0351,17,31,4,3,0,0,1.8235294117647056,0.2352941176470588,-0.8235294117647056,83.7705882352941,4,0,-0.3,-0.08333333333333333,-3,Lipid,5503148.91915246,5809358.490157113,1.0556426103496783,0.07812149042960448,0.861982699421239,0.9362483918205519,Upregulated
Feature0350,Lys-phe,C15 H23 N3 O3,293.17398,NA,NA,Lys-phe,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,598049.0082573036,510917.2114891697,0.8543065943340775,-0.22717417639363796,0.288660978527587,0.7829565408883704,Downregulated
Feature0349,NA,C25 H41 N5 O6,507.30589,NA,NA,Feature0349,25,41,6,5,0,0,1.64,0.24,-0.5599999999999996,76.25999999999999,8,2,-0.21428571428571427,0,-3,Lipid,86402.14918981993,96117.26779777346,1.1124407054575696,0.15372844059851623,0.46929776493969977,0.7998439321266281,Upregulated
Feature0348,NA,C14 H23 N3 O,249.18412,NA,NA,Feature0348,14,23,1,3,0,0,1.6428571428571428,0.07142857142857142,-0.8571428571428568,84.72857142857141,5,4,0.1,0.14285714285714285,1,Lipid,7428427.057799127,7594526.1931899,1.022359933549645,0.03190320305454227,0.8153459939591121,0.9142978308596724,Upregulated
Feature0347,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0347,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,4997622.914013526,5849954.584510543,1.1705474152735786,0.22718337476994432,0.5358681422172903,0.811395486596221,Upregulated
Feature0346,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0346,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1051301.5875547715,446054.10284657567,0.4242874814676686,-1.2368859821105775,0.051106050336507156,0.7829565408883704,Downregulated
Feature0345,NA,C17 H25 N3 O4,335.18463,NA,NA,Feature0345,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Phenol,105312.39300054264,155450.656969174,1.4760908240720825,0.5617814933543475,0.39450723946421656,0.7873878775042317,Upregulated
Feature0344,linatine,C10 H17 N3 O5,259.11681,Other,NA,linatine,10,17,5,3,0,0,1.7,0.5,0.20000000000000015,54.599999999999994,4,-1,-2,-0.3333333333333333,-4,Protein,357526.42592422635,249298.25160451568,0.6972862242561941,-0.5201771151894997,0.47297801153165003,0.7998439321266281,Downregulated
Feature0343,NA,C6 H9 O P S,160.01125,NA,NA,Feature0343,6,9,1,0,1,1,1.5,0.16666666666666666,-1.666666666666667,107.8,3,2,0,0.14285714285714285,0,Lipid,2508435.6796545857,188211.50284245834,0.07503142471182489,-3.7363612370901977,0.24673916060911522,0.7829565408883704,Downregulated
Feature0342,mycosporine,C11 H19 N O6,261.12129,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak1,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,193731.37647997434,255915.919410442,1.3209833330064404,0.40161226405586403,0.37841662183290575,0.7829565408883704,Upregulated
Feature0341,NA,C12 H20 N2 O5,272.13725,NA,NA,Feature0341,12,20,5,2,0,0,1.6666666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,4,-1,-0.6,-0.06666666666666667,-3,Protein,82323.27072426496,78343.55681991567,0.9516574855525478,-0.07148567346407358,0.8111873654943893,0.9142978308596724,Downregulated
Feature0340,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,C13 H14 N2 O3,246.10046,NA,Superpathway of indole-3-acetate conjugate biosynthesis,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,13,14,3,2,0,0,1.0769230769230769,0.2307692307692308,-0.1538461538461542,64.6846153846154,8,5,0.375,0.47368421052631576,3,Phenol,157305.62647279262,140765.264611911,0.8948520645334805,-0.16027889676135618,0.680226688480335,0.8450653356168011,Downregulated
Feature0339,D-PANTOTHENIC ACID,C9 H17 N O5,219.11065,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak1,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,3943388.5065538534,4170442.342667387,1.0575783582409324,0.08076455966442493,0.8550371310884288,0.9332214601957365,Upregulated
Feature0338,(−)-trans-Methyl dihydrojasmonate,C13 H22 O3,226.15687,NA,NA,(−)-trans-Methyl dihydrojasmonate,13,22,3,0,0,0,1.6923076923076923,0.2307692307692308,-1.2307692307692308,95.37692307692308,3,0,0,0.13043478260869565,0,Lipid,1079335.712286582,962964.2265936487,0.8921823077211081,-0.16458955562601815,0.852998053568629,0.931902449955211,Downregulated
Feature0337,7-hydroxyflavanone 7-O-beta-D-glucoside,C21 H22 O8,402.13151,NA,NA,7-hydroxyflavanone 7-O-beta-D-glucoside,21,22,8,0,0,0,1.0476190476190477,0.380952380952381,-0.2857142857142856,68.44285714285714,11,3,0.2307692307692308,0.4117647058823529,3,Phenol,177730.47773169866,197249.15861732635,1.1098217994726431,0.15032804625468177,0.5913146634323532,0.820796478981062,Upregulated
Feature0336,Alpha-Methyltryptamine,C11 H14 N2,174.11571,Metabolic pathways;Other,NA,Alpha-Methyltryptamine,11,14,0,2,0,0,1.2727272727272727,0,-0.7272727272727275,81.02727272727273,6,6,0.4444444444444444,0.4444444444444444,4,Unsaturated HC,2997902.415036887,3302299.50821337,1.1015366916713791,0.13951755133540303,0.5017771475317583,0.7998439321266281,Upregulated
Feature0335,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",C7 H9 N O3,155.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",7,9,3,1,0,0,1.2857142857142858,0.42857142857142855,0,60.3,4,1,0,0.3333333333333333,0,Phenol,737476.6437047997,751647.4938465627,1.0192153205972383,0.027458869111418514,0.9803598866849497,0.9900664202164838,Upregulated
Feature0334,acetoacetic acid,C4 H6 O3,102.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak1,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,3972947.1803183733,3004703.51523955,0.7562908286635633,-0.4029869710402575,0.22225696098104897,0.7829565408883704,Downregulated
Feature0333,NA,C28 H40,376.313,NA,NA,Feature0333,28,40,0,0,0,0,1.4285714285714286,0,-1.4285714285714288,101.01428571428572,9,9,0.32142857142857145,0.32142857142857145,9,Unsaturated HC,750043.8661213659,1356378.7134324994,1.8083991812993794,0.8547131696310698,0.27906100973107856,0.7829565408883704,Upregulated
Feature0332,NA,C16 H29 N3 O6,359.20566,NA,NA,Feature0332,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,1033142.634640396,649344.665477359,0.6285140538250802,-0.6699830906440228,0.010367044212873492,0.7829565408883704,Downregulated
Feature0331,2-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,6159828.726237137,6883882.952760819,1.1175445387693412,0.1603323299152669,0.6638083701456425,0.8383146233448654,Upregulated
Feature0330,orciprenaline,C11 H17 N O3,211.12082,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,orciprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,93634.33271700867,96847.146915852,1.0343123521641728,0.04867193117379592,0.9150611511137237,0.9603585751327469,Upregulated
Feature0329,GLY-MET,C7 H14 N2 O3 S,206.07248,NA,NA,GLY-MET,7,14,3,2,1,0,2,0.42857142857142855,0,60.3,2,-1,-4,-1,-4,Protein,1865481.5234918934,2901822.8393831067,1.5555355562843325,0.6374113722357181,0.07616881439646897,0.7829565408883704,Upregulated
Feature0328,NA,C11 H21 N O12,359.10644,NA,NA,Feature0328,11,21,12,1,0,0,1.9090909090909092,1.0909090909090908,0.5454545454545454,44.75454545454545,2,-10,5.5,-1.25,-11,Carbohydrate,2095120.9533763267,4302183.073042877,2.053429452896182,1.0380353833018061,0.15921855003130725,0.7829565408883704,Upregulated
Feature0327,NA,C17 H33 N O15,491.18523,NA,NA,Feature0327,17,33,15,1,0,0,1.9411764705882353,0.8823529411764706,0,60.3,2,-13,-14,-0.7647058823529411,-14,Carbohydrate,6416242.20511605,6966617.892786107,1.0857785086777443,0.11872983332419743,0.17291860838136108,0.7829565408883704,Upregulated
Feature0326,NA,C8 H19 N O4,193.13145,NA,NA,Feature0326,8,19,4,1,0,0,2.375,0.5,-1,88.8,0,-4,-1.6666666666666667,-0.6,-5,Other,1836574.5667863253,235527.670841051,0.12824291215857464,-2.963049002982895,0.21027170461774167,0.7829565408883704,Downregulated
Feature0325,NA,C16 H28 N4 O5,356.20606,NA,NA,Feature0325,16,28,5,4,0,0,1.75,0.3125,-0.375,70.9875,5,0,-0.5714285714285714,-0.15789473684210523,-4,Protein,673439.3571701413,578393.2041364469,0.8588645703258454,-0.21949743630939703,0.7613710573559531,0.8870802973555341,Downregulated
Feature0324,Chelidonic acid,C7 H4 O6,184.00082,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Chelidonic acid,7,4,6,0,0,0,0.5714285714285714,0.8571428571428571,1.1428571428571428,27.728571428571428,6,0,0,0.75,0,Condensed HC,3356690.1597186686,184839.902899995,0.05506611992912889,-4.182691232933185,0.18702174773103702,0.7829565408883704,Downregulated
Feature0323,NA,C11 H19 N3 O7,305.12233,NA,NA,Feature0323,11,19,7,3,0,0,1.7272727272727273,0.6363636363636364,0.36363636363636376,49.93636363636363,4,-3,-6,-0.5555555555555556,-6,Amino Sugar,655966.844450812,946707.7475876557,1.4432249977211236,0.5292962324642245,0.4202012059068358,0.7873878775042317,Upregulated
Feature0322,NA,C13 H18 N2 O6,298.11654,NA,NA,Feature0322,13,18,6,2,0,0,1.3846153846153846,0.4615384615384616,0,60.3,6,0,-0.4,0.125,-2,Phenol,6446528.46764552,7350803.102211247,1.1402731158489705,0.18937941709998093,0.3577231102473374,0.7829565408883704,Upregulated
Feature0321,Gly-Lys,C8 H17 N3 O3,203.12694,NA,NA,Gly-Lys,8,17,3,3,0,0,2.125,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2264493.17554906,3512632.1553526535,1.55117807078441,0.6333643131252836,0.05240033567966048,0.7829565408883704,Upregulated
Feature0320,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.1212,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak1,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,1960888.7651494402,5126994.999512327,2.614628167917315,1.3866057921914867,0.057110789276408315,0.7829565408883704,Upregulated
Feature0319,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10552,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak2",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Phenol,6213067.645839304,6927019.562160144,1.11491133800852,0.15692898610852024,0.17153316062221216,0.7829565408883704,Upregulated
Feature0318,eutypine,C12 H10 O2,186.06813,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,eutypine,12,10,2,0,0,0,0.8333333333333334,0.16666666666666666,-0.5,74.55,8,6,0.6,0.6363636363636364,6,Phenol,123615.33629907084,177896.14008865066,1.4391105943218456,0.5251774661218077,0.30218506117677696,0.7829565408883704,Upregulated
Feature0317,threonylphenylalanine,C13 H18 N2 O4,266.12661,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak1,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Phenol,202637.611008148,215717.86593520534,1.0645499858687704,0.09024369302355646,0.8138796069338814,0.9142978308596724,Upregulated
Feature0316,NA,C19 H34 N4 O7,430.24288,NA,NA,Feature0316,19,34,7,4,0,0,1.7894736842105263,0.3684210526315789,-0.4210526315789478,72.30000000000001,5,-2,-0.75,-0.21739130434782608,-6,Protein,565664.512093837,1157384.827872392,2.046062291566199,1.032850068038098,0.4203187185694793,0.7873878775042317,Upregulated
Feature0315,NA,C13 H25 N3 O5,303.17947,NA,NA,Feature0315,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,526253.2525124854,218898.76813612532,0.41595708357343014,-1.2654934090924745,0.03464739776125053,0.7829565408883704,Downregulated
Feature0314,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08989,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak1,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,1025352.264860328,1055048.3452354416,1.0289618323310172,0.04118946879358055,0.8861083540415862,0.9487246486135,Upregulated
Feature0313,2'-Deoxycytidine-5'-monophosphorate,C9 H14 N3 O7 P,307.05702,Metabolic pathways;Other,Other,2'-Deoxycytidine-5'-monophosphorate,9,14,7,3,0,1,1.5555555555555556,0.7777777777777778,0.44444444444444464,47.633333333333326,5,-2,3,-1.6666666666666667,-6,Carbohydrate,528397.4591517963,210139.28270931065,0.39769169792495634,-1.3302776496351392,0.1656908339341607,0.7829565408883704,Downregulated
Feature0312,NA,C12 H18 N4 O6,314.12269,NA,NA,Feature0312,12,18,6,4,0,0,1.5,0.5,0.5,46.05,6,0,-2,-0.2,-4,Protein,774806.8515744103,424828.0818480923,0.5483019167742775,-0.8669575778167372,0.3560708437777406,0.7829565408883704,Downregulated
Feature0311,NA,C8 H18 N O9 P,303.07198,NA,NA,Feature0311,8,18,9,1,0,1,2.25,1.125,-0.25,67.425,1,-8,3.3333333333333335,-3.6666666666666665,-10,Carbohydrate,2012152.2850399048,303053.9543596023,0.15061183818579227,-2.731092923677573,0.3167977577882758,0.7829565408883704,Downregulated
Feature0310,TC2700000,C2 H7 O4 P,126.00817,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,TC2700000,2,7,4,0,0,1,3.5,2,-2,117.3,0,-4,1.6666666666666667,3,-5,Other,250850.70003442367,247974.670730777,0.9885348962420595,-0.016636199497626566,0.8477576499527733,0.9297987128514287,Downregulated
Feature0309,dictyoquinazol B,C18 H20 N2 O4,328.14238,NA,NA,dictyoquinazol B,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Phenol,250726.23422737568,187890.965060594,0.7493869384653288,-0.41621726263735737,0.5057424088458758,0.7998439321266281,Downregulated
Feature0308,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",C20 H20 O7,372.12097,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",20,20,7,0,0,0,1,0.35,-0.2999999999999998,68.85,11,4,0.3076923076923077,0.4545454545454546,4,Phenol,170268.11029108067,189073.712508628,1.1104470014108827,0.15114053865139812,0.5894136090656857,0.820796478981062,Upregulated
Feature0307,NA,C7 H16 O6,196.09463,NA,NA,Feature0307,7,16,6,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,422190.27220287966,392934.69224138634,0.9307052249005046,-0.10360378844963912,0.6800136300754142,0.8450653356168011,Downregulated
Feature0306,"4,5,7-Trihydroxycoumarin",C9 H6 O5,194.02152,Biosynthesis of various plant secondary metabolites,NA,"4,5,7-Trihydroxycoumarin",9,6,5,0,0,0,0.6666666666666666,0.5555555555555556,0.44444444444444464,47.633333333333326,7,2,0.5,0.6923076923076923,2,Condensed HC,76161.32733040793,85865.81280440083,1.1274201200813148,0.17302521933872217,0.41857952625450856,0.7873878775042317,Upregulated
Feature0305,Clavamycin D,C13 H21 N3 O6,315.14297,NA,NA,Clavamycin D,13,21,6,3,0,0,1.6153846153846154,0.4615384615384616,0,60.3,5,-1,-1,-0.14285714285714285,-4,Protein,1789893.9399690933,1390270.26797631,0.7767333230930523,-0.3645087336921441,0.3599846125247613,0.7829565408883704,Downregulated
Feature0304,NA,C21 H38 N4 O7,458.27426,NA,NA,Feature0304,21,38,7,4,0,0,1.8095238095238095,0.3333333333333333,-0.5714285714285712,76.58571428571427,5,-2,-0.6,-0.18518518518518515,-6,Protein,395909.7765801,95594.75588398047,0.24145591126780333,-2.050168311217953,0.052566065998520733,0.7829565408883704,Downregulated
Feature0303,pro-gln,C10 H17 N3 O4,243.1219,NA,NA,pro-gln,10,17,4,3,0,0,1.7,0.4,0,60.3,4,0,-1,-0.2,-3,Protein,3332154.95319974,476905.11318879866,0.14312212963891283,-2.804681335108215,0.02887924216839102,0.7829565408883704,Downregulated
Feature0302,NA,C11 H15 N5 O,233.12763,NA,NA,Feature0302,11,15,1,5,0,0,1.3636363636363635,0.09090909090909093,0.18181818181818168,55.11818181818182,7,6,0.2,0.2727272727272727,1,Unsaturated HC,6291209.6227821,6940397.63496239,1.1031896965933883,0.14168088775945648,0.028916392228522513,0.7829565408883704,Upregulated
Feature0301,NA,C19 H36 N4 O6,416.26354,NA,NA,Feature0301,19,36,6,4,0,0,1.894736842105263,0.3157894736842105,-0.6315789473684212,78.30000000000001,4,-2,-0.6666666666666666,-0.25,-6,Protein,105292.71798693883,104035.78565854573,0.9880624951808251,-0.01732579939721881,0.9373945355021716,0.9691719887335095,Downregulated
Feature0300,Monoethyl malonic acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Monoethyl malonic acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,1589713.10991937,1546966.15920823,0.9731102735176487,-0.03932479343435758,0.8741397289738552,0.9403497372086917,Downregulated
Feature0299,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10595,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,814728.761896786,2006307.6178774643,2.462546692480256,1.3001510798466063,0.22340642607332362,0.7829565408883704,Upregulated
Feature0298,NA,C7 H7 O2 P S,185.99051,NA,NA,Feature0298,7,7,2,0,1,1,1,0.2857142857142857,-0.8571428571428568,84.72857142857141,5,3,0.3333333333333333,0.5,1,Phenol,7050414.138926746,8269767.469843034,1.1729477597895979,0.23013876070590916,0.32272449724094954,0.7829565408883704,Upregulated
Feature0297,gln-phe,C14 H19 N3 O4,293.13756,NA,NA,gln-phe-peak1,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Phenol,826836.8628371593,891444.5076303507,1.0781383217137905,0.1085422831449476,0.6685246617468878,0.8383146233448654,Upregulated
Feature0296,asn-tyr,C13 H17 N3 O5,295.11689,NA,NA,asn-tyr-peak2,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Phenol,568339.3433536077,493207.15163511335,0.8678039931651382,-0.20455887021428334,0.5820134673365995,0.820796478981062,Downregulated
Feature0295,6-Hydroxymelatonin,C13 H16 N2 O3,248.11602,Other,Other,6-Hydroxymelatonin-peak2,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Phenol,102953.2381940693,113164.217534628,1.0991807496264543,0.13642864301897575,0.6096664808872341,0.8271412231626079,Upregulated
Feature0294,beta-Aspartylaspartic acid,C8 H12 N2 O7,248.0644,NA,NA,beta-Aspartylaspartic acid,8,12,7,2,0,0,1.5,0.875,1,31.799999999999997,4,-3,5,-0.6,-5,Carbohydrate,5286325.068503137,4934842.694138753,0.9335110176143768,-0.09926104515808745,0.6913892297607034,0.8533979271633765,Downregulated
Feature0293,Asp-Trp,C15 H17 N3 O5,319.11688,NA,NA,Asp-Trp,15,17,5,3,0,0,1.1333333333333333,0.3333333333333333,0.1333333333333333,56.5,9,4,0.14285714285714285,0.3684210526315789,1,Phenol,487573.3534719033,332593.3962995503,0.6821402234786323,-0.55185975897656,0.04118654663246685,0.7829565408883704,Downregulated
Feature0292,asn-val,C9 H17 N3 O4,231.12194,NA,NA,asn-val-peak1,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,3053319.7334756833,5056986.113155589,1.6562255363276595,0.7278991450510949,0.13431748267285984,0.7829565408883704,Upregulated
Feature0291,NA,C26 H43 N5 O5,505.32642,NA,NA,Feature0291,26,43,5,5,0,0,1.6538461538461535,0.19230769230769232,-0.6923076923076925,80.03076923076924,8,3,-0.125,0.02702702702702703,-2,Lipid,171362.771979607,204750.010097794,1.1948336720542794,0.25680980046239105,0.31363499544316475,0.7829565408883704,Upregulated
Feature0290,cis-acetylacrylic acid,C5 H6 O3,114.03164,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Phenol,4556931.751015847,2572803.564356167,0.5645911997217489,-0.8247214531998945,0.376832981364853,0.7829565408883704,Downregulated
Feature0289,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,C14 H19 N O6,297.12132,NA,NA,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,14,19,6,1,0,0,1.3571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,6,0,-0.14285714285714285,0.2,-1,Phenol,1619609.30764591,4047038.838190263,2.4987747471472637,1.3212208550778923,0.08084415818076023,0.7829565408883704,Upregulated
Feature0288,NA,C8 H19 N O7,241.11608,NA,NA,Feature0288,8,19,7,1,0,0,2.375,0.875,-0.25,67.425,0,-7,-Inf,-1.2857142857142858,-8,Carbohydrate,510540.3849592857,360516.653084415,0.7061471799398696,-0.5019591838560529,0.4625543129283981,0.7995347728859721,Downregulated
Feature0287,Kyotorphin,C15 H23 N5 O4,337.17513,NA,NA,Kyotorphin,15,23,4,5,0,0,1.5333333333333334,0.26666666666666666,0,60.3,7,3,-0.3333333333333333,0,-2,Lipid,644975.5384150697,415348.900775189,0.6439762069052206,-0.6349207090536274,0.01623326279348676,0.7829565408883704,Downregulated
Feature0286,NA,C17 H25 N3 O4,335.18464,NA,NA,Feature0286,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Phenol,2663727.3992910935,1332625.9438225976,0.5002861569758429,-0.99917456168248,0.1603139221570684,0.7829565408883704,Downregulated
Feature0285,S-Allyl-L-cysteine,C6 H11 N O2 S,161.05105,NA,Other,S-Allyl-L-cysteine,6,11,2,1,1,0,1.8333333333333333,0.3333333333333333,-0.33333333333333304,69.79999999999998,2,0,-1,-0.3333333333333333,-2,Protein,237094.83120873355,207247.38626472754,0.8741117856013955,-0.1941103046120785,0.8356791798576824,0.9237754086702655,Downregulated
Feature0284,?-Ribazole,C14 H18 N2 O4,278.12667,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak2,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Phenol,3693112.9977902602,3929400.8324555233,1.0639806674766366,0.08947193731563277,0.4377471650687736,0.7974180334973026,Upregulated
Feature0283,Pheneturide,C11 H14 N2 O2,206.10554,Other,NA,Pheneturide,11,14,2,2,0,0,1.2727272727272727,0.18181818181818185,-0.3636363636363633,70.66363636363636,6,4,0.2857142857142857,0.375,2,Phenol,2836920.12565454,2284582.769103497,0.8053038745940699,-0.31239482017370285,0.660362151032341,0.8369886314710402,Downregulated
Feature0282,pyricarbate,C11 H15 N3 O4,253.10625,NA,NA,pyricarbate,11,15,4,3,0,0,1.3636363636363635,0.3636363636363637,0.18181818181818168,55.11818181818182,6,2,-0.25,0.16666666666666666,-1,Phenol,7172753.99677277,7674954.930125593,1.0700150783895248,0.097631126873636,0.5606655076814115,0.820796478981062,Upregulated
Feature0281,NA,C31 H37 N O11,599.23689,NA,NA,Feature0281,31,37,11,1,0,0,1.1935483870967742,0.3548387096774194,-0.387096774193548,71.33225806451611,14,3,0.10526315789473684,0.30612244897959184,2,Phenol,168866.77259980867,187517.60122799667,1.1104470011539092,0.15114053831753757,0.5894136097660269,0.820796478981062,Upregulated
Feature0280,NA,C7 H14 N2 O2,158.10555,NA,NA,Feature0280,7,14,2,2,0,0,2,0.2857142857142857,-0.5714285714285712,76.58571428571427,2,0,-0.6666666666666666,-0.25,-2,Lipid,124672.37834995372,124554.05516859793,0.999050927054398,-0.0013698729896322553,0.9969095881077115,0.9991408892032351,Downregulated
Feature0279,NA,C15 H27 N3 O6,345.19011,NA,NA,Feature0279,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,971773.7872852724,684256.7316095973,0.7041317028329434,-0.5060827949266102,0.20543927661736505,0.7829565408883704,Downregulated
Feature0278,arg-gln,C11 H22 N6 O4,302.17037,NA,NA,arg-gln,11,22,4,6,0,0,2,0.3636363636363637,0.36363636363636376,49.93636363636363,4,0,-6,-1.3333333333333333,-6,Protein,542006.2333020524,441071.36985343735,0.8137754563564854,-0.29729732581359825,0.6000582207936327,0.8224870011764158,Downregulated
Feature0277,NA,C18 H31 N6 O4 P3,488.16202,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0277,18,31,4,6,0,3,1.7222222222222223,0.2222222222222222,-1.1111111111111107,91.96666666666664,8,4,-1,-0.42857142857142855,-5,Lipid,1126087.5930729522,939558.392906461,0.8343564023669985,-0.2612643202178481,0.5027412192014831,0.7998439321266281,Downregulated
Feature0276,L-Hydroxyproline,C5 H9 N O3,131.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,L-Hydroxyproline,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1265677.661432221,1083920.8874708344,0.8563956846992832,-0.22365056875598727,0.6182989613291512,0.8293364212030647,Downregulated
Feature0275,Penicillic acid,C8 H10 O4,170.05799,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak1,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Phenol,575281.0960507314,749659.7376824267,1.3031190192564883,0.38196885723639545,0.6957019918391321,0.8562617001735352,Upregulated
Feature0274,Desthiobiotin,C10 H18 N2 O3,214.13169,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,2658227.2584713465,7391189.392694967,2.7804956740024482,1.4753420925462895,0.03242981381147912,0.7829565408883704,Upregulated
Feature0273,NA,C13 H17 N5 O7,355.11296,NA,NA,Feature0273,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Phenol,4124026.6026954,4143633.1623242935,1.0047542272438492,0.006842647176114405,0.9472243156697713,0.9714677168020872,Upregulated
Feature0272,Aniflorine,C20 H21 N3 O3,351.15844,NA,NA,Aniflorine,20,21,3,3,0,0,1.05,0.15,-0.2999999999999998,68.85,12,9,0.42857142857142855,0.4838709677419355,6,Phenol,1227971.1473371033,1141786.448783,0.9298153716876837,-0.10498381823001375,0.8022842550362776,0.9129441522826608,Downregulated
Feature0271,N6-Methyladenine,C6 H7 N5,149.07016,NA,NA,N6-Methyladenine,6,7,0,5,0,0,1.1666666666666667,0,1.3333333333333337,22.29999999999999,6,6,1,1,1,Unsaturated HC,87072.6396807853,91565.41506582423,1.0515980151917959,0.07258332409821269,0.6726158090997933,0.8394604425027455,Upregulated
Feature0270,NA,C43 H57 N6 O4 P3,814.36502,NA,NA,Feature0270,43,57,4,6,0,3,1.3255813953488371,0.09302325581395347,-1.0697674418604652,90.78837209302326,20,16,0.23333333333333336,0.28125,7,Unsaturated HC,199103.111052055,252886.10189283866,1.2701263207621212,0.3449719877646004,0.3824398480392519,0.7829565408883704,Upregulated
Feature0269,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",C11 H11 N O4,221.06882,NA,NA,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",11,11,4,1,0,0,1,0.3636363636363637,0,60.3,7,3,0.3333333333333333,0.5,2,Phenol,341301.80240054964,424127.9961275943,1.2426772819378211,0.31345168319832356,0.4072694218925284,0.7873878775042317,Upregulated
Feature0268,NA,C13 H25 N3 O5,303.17954,NA,NA,Feature0268,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,1303549.4186364,616215.0983858381,0.4727209337643987,-1.0809393411081456,0.3115716168761086,0.7829565408883704,Downregulated
Feature0267,Phosphonoacetic acid,C2 H5 O5 P,139.98747,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of L-lysine degradation;Other,Phosphonoacetic acid,2,5,5,0,0,1,2.5,2.5,0,60.3,1,-4,1.25,1.6666666666666667,-5,Other,479195.16049507365,548308.0052155927,1.1442269255163513,0.19437319883935134,0.3786835281163908,0.7829565408883704,Upregulated
Feature0266,"Hydroxy-1,4-benzoquinone",C6 H4 O3,124.01601,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,"Hydroxy-1,4-benzoquinone",6,4,3,0,0,0,0.6666666666666666,0.5,0.3333333333333335,50.8,5,2,0.6666666666666666,0.7777777777777778,2,Condensed HC,6014571.100083251,6807660.014741,1.1318612585104817,0.17869712607958502,0.2964078318930681,0.7829565408883704,Upregulated
Feature0265,Leu-Gly-Pro,C13 H23 N3 O4,285.16889,NA,NA,Leu-Gly-Pro-peak2,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,5066233.69003474,3101344.0862397184,0.6121596981086855,-0.7080200275667998,0.2500775216319305,0.7829565408883704,Downregulated
Feature0264,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak2,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,1968641.4456926694,1638042.69104584,0.8320675634610001,-0.26522741566447444,0.668348354195617,0.8383146233448654,Downregulated
Feature0263,NA,C22 H41 N5 O5,455.31091,NA,NA,Feature0263,22,41,5,5,0,0,1.8636363636363635,0.2272727272727273,-0.7272727272727275,81.02727272727273,5,0,-0.4166666666666667,-0.1724137931034483,-5,Lipid,113299.84526447963,132687.82974935067,1.1711210146811146,0.22789016060407385,0.31616705911878284,0.7829565408883704,Upregulated
Feature0262,Bicine,C6 H13 N O4,163.08447,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,Bicine,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,4818204.365344574,5787864.885758073,1.2012493549231498,0.2645356562648549,0.6110142259390667,0.8278735941197176,Upregulated
Feature0261,Ethyl L-tyrosinate,C11 H15 N O3,209.1052,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Ethyl L-tyrosinate,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,156472.56142368176,353111.726793718,2.2567006226580206,1.17421504110206,0.13967007762161227,0.7829565408883704,Upregulated
Feature0260,Gly-Ser,C5 H10 N2 O4,162.06409,NA,NA,Gly-Ser,5,10,4,2,0,0,2,0.8,0.7999999999999998,37.5,2,-2,4,-2,-4,Carbohydrate,2653979.0238414602,4806906.109481803,1.811207272664922,0.8569516562465186,0.18449480237199198,0.7829565408883704,Upregulated
Feature0259,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23296,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak1,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,87755.8046773801,63333.70406414,0.7217038724330092,-0.47052109906109296,0.52767600453667,0.8098418097030804,Downregulated
Feature0258,Oglufanide,C16 H19 N3 O5,333.13251,NA,NA,Oglufanide,16,19,5,3,0,0,1.1875,0.3125,0,60.3,9,4,0.125,0.3333333333333333,1,Phenol,2176220.5798323466,4221852.091168163,1.9399927242179695,0.9560512417142909,0.030165035308471918,0.7829565408883704,Upregulated
Feature0257,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",C13 H14 N2 O4,262.09538,NA,NA,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",13,14,4,2,0,0,1.0769230769230769,0.3076923076923077,0,60.3,8,4,0.2857142857142857,0.4444444444444444,2,Phenol,5409207.5649380665,5511408.944114297,1.018893965141713,0.02700392007690412,0.8304511386663371,0.9216282666504749,Upregulated
Feature0256,ophthalmic acid,C11 H19 N3 O6,289.12729,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,ophthalmic acid,11,19,6,3,0,0,1.7272727272727273,0.5454545454545454,0.18181818181818168,55.11818181818182,4,-2,-2.5,-0.4,-5,Protein,288777.1706745307,152324.97081476034,0.5274827316126031,-0.9228042303085828,0.33372331098671093,0.7829565408883704,Downregulated
Feature0255,Leu-Glu,C11 H20 N2 O5,260.13726,NA,NA,Leu-Glu-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,1881887.5769353868,3010673.3954826836,1.5998157554052725,0.6779057650697501,0.21714568553012464,0.7829565408883704,Upregulated
Feature0254,N-Acetyl-L-leucine,C8 H15 N O3,173.10526,Other,NA,N-Acetyl-L-leucine-peak2,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,3710696.935693307,3781131.7490086234,1.0189815591345663,0.027127942783564594,0.8931925671442938,0.9508178940568289,Upregulated
Feature0253,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak2,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,1867190.67893936,686415.4881588423,0.36761938451232745,-1.4437152531720794,0.07765812817987065,0.7829565408883704,Downregulated
Feature0252,N-Acetylvanilalanine,C12 H15 N O5,253.09505,NA,NA,N-Acetylvanilalanine-peak1,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Phenol,5257045.8125884,5901871.794526894,1.1226593803680402,0.16692027431527257,0.2560871979938783,0.7829565408883704,Upregulated
Feature0251,tyr-thr,C13 H18 N2 O5,282.12167,NA,NA,tyr-thr,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Phenol,2202370.0298784566,2958712.84970545,1.3434222267675582,0.4259128034467115,0.12675008231383414,0.7829565408883704,Upregulated
Feature0250,Alanyltryptophan,C14 H17 N3 O3,275.12702,NA,NA,Alanyltryptophan,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Phenol,2361454.2239150833,2474865.233345453,1.0480259190636965,0.06767439706836198,0.8400689825167789,0.9258913540116168,Upregulated
Feature0249,pre-putrebactin,C16 H30 N4 O7,390.2116,NA,NA,pre-putrebactin,16,30,7,4,0,0,1.875,0.4375,-0.25,67.425,4,-3,-1.4,-0.4117647058823529,-7,Protein,269612.75446185365,99518.62603576336,0.36911690707808786,-1.4378502744019628,0.021152975957125026,0.7829565408883704,Downregulated
Feature0248,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",C13 H10 N2 O,210.07933,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",13,10,1,2,0,0,0.7692307692307693,0.07692307692307693,-0.1538461538461542,64.6846153846154,10,9,0.7,0.7142857142857143,7,Condensed HC,4893070.848986637,5573100.26020329,1.1389780430744199,0.18773993541039913,0.22339814321673007,0.7829565408883704,Upregulated
Feature0247,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",C18 H20 N2 S,296.13484,NA,NA,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",18,20,0,2,1,0,1.1111111111111112,0,-0.666666666666667,79.30000000000001,10,10,0.4666666666666667,0.4666666666666667,7,Unsaturated HC,69111.83597244926,77673.71234562303,1.1238843716521563,0.16849361471809549,0.3845000481546275,0.7829565408883704,Upregulated
Feature0246,3-Buten-1-amine,C4 H9 N,71.07351,NA,NA,3-Buten-1-amine,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,2807182.8075733334,1920161.46296341,0.6840172495297133,-0.5478953874703594,0.3742493662994105,0.7829565408883704,Downregulated
Feature0245,NA,C14 H26 N4 O5,330.1904,NA,NA,Feature0245,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,1573595.5993091266,1192821.812287503,0.7580230986990564,-0.3996862836007059,0.44703979723541276,0.7974180334973026,Downregulated
Feature0244,Bis(methylbenzylidene)sorbitol,C22 H26 O6,386.17299,NA,NA,Bis(methylbenzylidene)sorbitol,22,26,6,0,0,0,1.181818181818182,0.2727272727272727,-0.6363636363636367,78.43636363636364,10,4,0.25,0.3684210526315789,4,Phenol,1423324.053218596,1519676.636920298,1.0676954650515584,0.09450021096628965,0.8457026786817461,0.9293618075229374,Upregulated
Feature0243,6-Quinolinecarboxylic acid,C10 H7 N O2,173.04768,Other,NA,6-Quinolinecarboxylic acid,10,7,2,1,0,0,0.7,0.2,0,60.3,8,6,0.7142857142857143,0.75,5,Condensed HC,441198.17126031534,572999.5948236317,1.298735199166433,0.37710730777367485,0.4060683123732166,0.7873878775042317,Upregulated
Feature0242,Asp-tyr,C13 H16 N2 O6,296.10088,NA,NA,Asp-tyr,13,16,6,2,0,0,1.2307692307692308,0.4615384615384616,0.15384615384615374,55.91538461538462,7,1,-0.2,0.25,-1,Phenol,986921.9595555214,1334868.3478355613,1.3525571448797673,0.4356895485016635,0.39762011219485444,0.7873878775042317,Upregulated
Feature0241,4-Amino-3-hydroxybenzoic acid,C7 H7 N O3,153.04263,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,4-Amino-3-hydroxybenzoic acid,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Phenol,233873.2218865147,88478.7316312053,0.3783192060959376,-1.4023240754759823,0.11424005696668925,0.7829565408883704,Downregulated
Feature0240,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13725,NA,NA,L-gamma-Glutamyl-L-leucine,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,826045.735486224,1409572.3641719199,1.7064095892247693,0.7709639780860994,0.0180030524447613,0.7829565408883704,Upregulated
Feature0239,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07399,NA,NA,Phenyl D-glucopyranosiduronic acid-peak1,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Phenol,1760075.5789240394,778620.933292334,0.4423792606498845,-1.176644343263455,0.16404408591197586,0.7829565408883704,Downregulated
Feature0238,NA,C13 H23 N3 O6,317.15873,NA,NA,Feature0238,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1094952.0914864487,989018.7325731297,0.9032529735894568,-0.14679799574090693,0.4621401381763422,0.7995347728859721,Downregulated
Feature0237,Leu-Gly-Pro,C13 H23 N3 O4,285.16893,NA,NA,Leu-Gly-Pro-peak1,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,889960.3576131014,793070.9678867881,0.8911306679028116,-0.16629110296770105,0.6128405589218435,0.8278735941197176,Downregulated
Feature0236,2-Methoxy-5-methylaniline,C8 H11 N O,137.08405,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,2-Methoxy-5-methylaniline,8,11,1,1,0,0,1.375,0.125,-0.75,81.675,4,3,0.3333333333333333,0.38461538461538464,2,Unsaturated HC,4076584.10113168,3613195.435945743,0.8863291781329133,-0.17408548700931945,0.41801484133694466,0.7873878775042317,Downregulated
Feature0235,Salsolinol,C10 H13 N O2,179.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Salsolinol,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Phenol,1277709.5069391236,533786.4536221713,0.41776824131246254,-1.2592252718038213,0.2646948841517842,0.7829565408883704,Downregulated
Feature0234,L-Phenylalanine,C9 H11 N O2,165.079,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak1,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Phenol,538607.3977437296,486432.08482245734,0.9031292307906669,-0.14699565393528716,0.585787838915229,0.820796478981062,Downregulated
Feature0233,(E)-5-(methylsulfanyl)pentanal oxime,C6 H13 N O S,147.0718,2-Oxocarboxylic acid metabolism;Other,NA,(E)-5-(methylsulfanyl)pentanal oxime,6,13,1,1,1,0,2.1666666666666665,0.16666666666666666,-1,88.8,1,0,-0.6666666666666666,-0.42857142857142855,-2,Lipid,88399.68900091623,96638.8790074437,1.0932038347605733,0.12856242569490528,0.5061372293037861,0.7998439321266281,Upregulated
Feature0232,NA,C16 H31 N3 O5,345.2265,NA,NA,Feature0232,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1939358.64634459,693305.0510096804,0.35749192255721235,-1.4840174499706105,0.0657050773502275,0.7829565408883704,Downregulated
Feature0231,NA,C9 H15 N O5,217.09502,NA,NA,Feature0231,9,15,5,1,0,0,1.6666666666666667,0.5555555555555556,-0.22222222222222232,66.63333333333333,3,-2,-1,-0.09090909090909093,-3,Amino Sugar,319699.702192894,754223.393163892,2.3591620135724236,1.2382744979124691,0.12892773183954237,0.7829565408883704,Upregulated
Feature0230,ser-trp,C14 H17 N3 O4,291.12193,NA,NA,ser-trp,14,17,4,3,0,0,1.2142857142857142,0.2857142857142857,0,60.3,8,4,0.14285714285714285,0.3333333333333333,1,Phenol,1572575.7949790333,1318366.55670827,0.8383484986336366,-0.25437800283073064,0.442957735560462,0.7974180334973026,Downregulated
Feature0229,Caffeic acid,C9 H8 O4,180.04231,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak1,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Phenol,2555668.734735267,2797600.0359334233,1.0946645775760986,0.13048887311489185,0.30709552880690383,0.7829565408883704,Upregulated
Feature0228,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,177883.665338103,176629.57311488432,0.9929499303894204,-0.01020712335736405,0.9655570182863242,0.9833412914850813,Downregulated
Feature0227,Adenylsuccinic acid,C14 H18 N5 O11 P,463.07418,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of purine nucleotide salvage;Other,Adenylsuccinic acid,14,18,11,5,0,1,1.2857142857142858,0.7857142857142857,1,31.799999999999997,9,-2,2.6666666666666665,-1,-8,Tannin,1629153.9465030986,726946.869964375,0.4462112813369982,-1.1642011059059427,0.26727606647221414,0.7829565408883704,Downregulated
Feature0226,NA,C16 H21 N5 O9,427.13397,NA,NA,Feature0226,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,4288815.7895054,5276762.269922663,1.2303541417737591,0.2990736367376972,0.17408790505816146,0.7829565408883704,Upregulated
Feature0225,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.07946,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak1",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,146319.59145147007,232435.52529014065,1.5885468445094224,0.6677076341779162,0.5185685224378878,0.8069818060683912,Upregulated
Feature0224,Succinyladenosine,C14 H17 N5 O8,383.10785,NA,NA,Succinyladenosine,14,17,8,5,0,0,1.2142857142857142,0.5714285714285714,1,31.799999999999997,9,1,-4,0,-4,Phenol,4462475.001911427,4123924.3713494,0.9241338874913553,-0.11382621204817031,0.6119984296582147,0.8278735941197176,Downregulated
Feature0223,NA,C14 H28 N6 O4,344.21736,NA,NA,Feature0223,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,92926.6074543551,106795.307618727,1.1492435863558683,0.20068461485308364,0.27373071999286247,0.7829565408883704,Upregulated
Feature0222,cys-val,C8 H16 N2 O3 S,220.08817,NA,NA,cys-val-peak1,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,412806.9333521393,325340.4360829233,0.7881176642093753,-0.3435170579737178,0.22813836119476494,0.7829565408883704,Downregulated
Feature0221,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.29814,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak1,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,207436.81723470666,555579.2028882833,2.678305665766493,1.421320619855886,0.14846307600962108,0.7829565408883704,Upregulated
Feature0220,Deoxyadenosine monophosphate,C10 H14 N5 O6 P,331.06822,Metabolic pathways;Other,NA,Deoxyadenosine monophosphate,10,14,6,5,0,1,1.4,0.6,0.7999999999999998,37.5,7,1,2.5,-2,-5,Phenol,151974.10583316983,173553.41886592231,1.141993354160223,0.19155425494945336,0.7397085961387851,0.8810541877576613,Upregulated
Feature0219,PYRIDOXAMINE,C8 H12 N2 O2,168.08993,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,1700523.95368064,1657306.6781831167,0.97458590606502,-0.037138735682729684,0.8414984185270621,0.9265566492515834,Downregulated
Feature0218,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,C9 H15 N O2,169.11033,NA,NA,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,9,15,2,1,0,0,1.6666666666666667,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,1,0,0.14285714285714285,0,Lipid,342741.9855831017,289088.9328692427,0.8434593514343453,-0.2456095520380186,0.8069097364006329,0.9140326627977811,Downregulated
Feature0217,NA,C13 H22 N2 O10,366.12745,NA,NA,Feature0217,13,22,10,2,0,0,1.6923076923076923,0.7692307692307693,0.3076923076923075,51.53076923076924,4,-6,-8,-0.5,-8,Carbohydrate,4132230.5003930735,3876481.03230933,0.9381086151754081,-0.09217312576801565,0.44938343905041644,0.7974180334973026,Downregulated
Feature0216,NA,C19 H41 N O,299.31886,NA,NA,Feature0216,19,41,1,1,0,0,2.1578947368421053,0.05263157894736842,-1.8947368421052628,114.29999999999998,0,-1,-0.1176470588235294,-0.08571428571428572,-2,Lipid,2151644.4788210066,3844745.6049856935,1.786887026565105,0.8374484248850249,0.15858653420481672,0.7829565408883704,Upregulated
Feature0215,NA,C16 H35 N O,257.27187,NA,NA,Feature0215,16,35,1,1,0,0,2.1875,0.0625,-1.875,113.7375,0,-1,-0.14285714285714285,-0.10344827586206896,-2,Lipid,4016782.1016340987,2337527.12429694,0.5819402360277378,-0.7810570957290907,0.601366809446922,0.8228458051212763,Downregulated
Feature0214,NA,C19 H29 N3 O4,363.21589,NA,NA,Feature0214,19,29,4,3,0,0,1.5263157894736843,0.21052631578947367,-0.6315789473684212,78.30000000000001,7,3,0,0.14285714285714285,0,Lipid,127959.74366763256,107049.81816177734,0.8365898140577129,-0.2574076624061136,0.5493070117225609,0.8163211485466402,Downregulated
Feature0213,Trigonelline,C7 H7 N O2,137.04766,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak2,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,2232376.4468029365,2796344.4360932736,1.252631221807601,0.3249617436478759,0.5410794839811583,0.8116192259717375,Upregulated
Feature0212,N-(5-acetamidopentyl)acetamide,C9 H18 N2 O2,186.13687,NA,NA,N-(5-acetamidopentyl)acetamide,9,18,2,2,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,2,0,-0.4,-0.16666666666666666,-2,Lipid,105503.10608488474,135302.39994424768,1.2824494459469968,0.35890195603188224,0.2042332921049918,0.7829565408883704,Upregulated
Feature0211,Prolylaspartic acid,C9 H14 N2 O5,230.09029,Biosynthesis of secondary metabolites;Other,NA,Prolylaspartic acid,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,135159.32667407434,303608.57819442067,2.2463013516377446,1.1675514848843773,0.061306519083975254,0.7829565408883704,Upregulated
Feature0210,NA,C12 H22 N4 O3,270.16921,NA,NA,Feature0210,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,100113.91518426784,1644461.7390176076,16.4259057893285,4.037901023531845,0.19436411749997676,0.7829565408883704,Upregulated
Feature0209,NA,C19 H29 N3 O5,379.21071,NA,NA,Feature0209,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,689533.3242165013,317188.20862603735,0.4600041759931618,-1.1202811366366712,0.23047738653507044,0.7829565408883704,Downregulated
Feature0208,Enicoflavine,C10 H13 N O4,211.0845,NA,NA,Enicoflavine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Phenol,353203.55045307166,505199.5199468803,1.430335338642083,0.5163534230034276,0.6310968111314236,0.8293364212030647,Upregulated
Feature0207,Phenethylamine,C8 H11 N,121.0891,Metabolic pathways;Phenylalanine metabolism;Other,Other,Phenethylamine,8,11,0,1,0,0,1.375,0,-1,88.8,4,4,0.42857142857142855,0.42857142857142855,3,Unsaturated HC,854212.5735198354,678583.0641594393,0.7943960147569545,-0.3320697095648823,0.6574603577839231,0.8363589828247083,Downregulated
Feature0206,Norsolorinic acid,C20 H18 O7,370.10536,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Norsolorinic acid,20,18,7,0,0,0,0.9,0.35,-0.20000000000000015,66,12,5,0.38461538461538464,0.5151515151515151,5,Phenol,121347.01880396494,129305.79237433399,1.0655868899690597,0.09164823799762721,0.7538532213698681,0.8847091047453014,Upregulated
Feature0205,NA,C7 H16 N2 O3,176.11612,NA,NA,Feature0205,7,16,3,2,0,0,2.2857142857142856,0.42857142857142855,-0.5714285714285712,76.58571428571427,1,-2,-2,-0.7142857142857143,-4,Protein,110627.07339107667,130341.23833146832,1.1782038007161257,0.2365891120475347,0.12336099354504344,0.7829565408883704,Upregulated
Feature0204,NP-003800,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,NP-003800,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,1814501.089458727,328861.42350761965,0.1812406867199624,-2.464021232549513,0.4459093438436027,0.7974180334973026,Downregulated
Feature0203,asn-leu,C10 H19 N3 O4,245.13756,NA,NA,asn-leu,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,1862289.8951603868,2125417.374419627,1.141292437843883,0.1906685064120019,0.21965639635208378,0.7829565408883704,Upregulated
Feature0202,Isovalerylglutamic acid,C10 H17 N O5,231.11066,NA,NA,Isovalerylglutamic acid-peak2,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,288037.58412831766,1382939.41244579,4.801246395087473,2.2634089755402242,0.04413315117947086,0.7829565408883704,Upregulated
Feature0201,NA,C13 H24 N4 O6,332.1696,NA,NA,Feature0201,13,24,6,4,0,0,1.8461538461538465,0.4615384615384616,0,60.3,4,-2,-2,-0.5,-6,Protein,2328946.405090473,2069367.2045082499,0.8885422180541165,-0.17048776902135973,0.3657407463495807,0.7829565408883704,Downregulated
Feature0200,NA,C8 H10 N2 O2,166.07426,NA,NA,Feature0200,8,10,2,2,0,0,1.25,0.25,0,60.3,5,3,0.25,0.4,1,Phenol,2439527.3982307566,1627561.3321050666,0.6671625550446532,-0.5838897760798426,0.5001777771139405,0.7998439321266281,Downregulated
Feature0199,Isovalerylglutamic acid,C10 H17 N O5,231.11064,NA,NA,Isovalerylglutamic acid-peak1,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,2980198.2402525763,5023108.46785791,1.685494743273251,0.7531721278469299,0.4069871932864116,0.7873878775042317,Upregulated
Feature0198,L-dihydroanticapsin,C9 H15 N O4,201.10006,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,L-dihydroanticapsin,9,15,4,1,0,0,1.6666666666666667,0.4444444444444444,-0.44444444444444464,72.96666666666667,3,-1,-0.5,0,-2,Protein,209698.87035509024,315709.05816224834,1.5055353308658623,0.5902765646330861,0.3258037302240428,0.7829565408883704,Upregulated
Feature0197,NA,C14 H25 N3 O4,299.18456,NA,NA,Feature0197,14,25,4,3,0,0,1.7857142857142858,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,0,-0.42857142857142855,-0.1111111111111111,-3,Lipid,4954246.081334863,3930178.051024,0.7932948800890125,-0.3340708569981214,0.5071165837765051,0.7998439321266281,Downregulated
Feature0196,SLH,C15 H25 N5 O5,355.18569,NA,NA,SLH,15,25,5,5,0,0,1.6666666666666667,0.3333333333333333,0,60.3,6,1,-0.8,-0.2,-4,Protein,184554.871172703,198765.468143383,1.076999305845371,0.10701732002718688,0.6689999450830391,0.8383146233448654,Upregulated
Feature0195,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16894,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak1,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,278599.8573050823,118550.0052858621,0.4255206963585888,-1.2326987918650476,0.06677953686334798,0.7829565408883704,Downregulated
Feature0194,asn-lys,C10 H20 N4 O4,260.14846,NA,NA,asn-lys,10,20,4,4,0,0,2,0.4,0,60.3,3,-1,-2.5,-0.75,-5,Protein,2031367.0723145732,1962777.8798112466,0.9662349589898713,-0.049554043557112834,0.8098234948313574,0.9142978308596724,Downregulated
Feature0193,Tyrosyltyrosine,C18 H20 N2 O5,344.13731,NA,NA,Tyrosyltyrosine,18,20,5,2,0,0,1.1111111111111112,0.2777777777777778,-0.22222222222222232,66.63333333333333,10,5,0.2727272727272727,0.4074074074074074,3,Phenol,1022615.7045186233,784788.6036217368,0.7674325752616531,-0.3818880904744074,0.3722885532073567,0.7829565408883704,Downregulated
Feature0192,7-Methylguanine,C6 H7 N5 O,165.06507,NA,NA,7-Methylguanine,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Phenol,239208.30047965332,227213.54338845433,0.9498564344667494,-0.0742186203223994,0.6169015004108024,0.8293364212030647,Downregulated
Feature0191,Leonurine,C14 H21 N3 O5,311.14813,NA,NA,Leonurine-peak1,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,3239508.5193082,2986862.2386646867,0.9220109226020908,-0.11714425324518811,0.5265934620396823,0.8098418097030804,Downregulated
Feature0190,Neostigmine,C12 H18 N2 O2,222.13678,Other,NA,Neostigmine,12,18,2,2,0,0,1.5,0.16666666666666666,-0.666666666666667,79.30000000000001,5,3,0.125,0.2222222222222222,1,Lipid,5355037.14947899,5999475.277878613,1.1203424197462988,0.16393974279036286,0.2056817578323357,0.7829565408883704,Upregulated
Feature0189,NA,C14 H21 N O10,363.11672,NA,NA,Feature0189,14,21,10,1,0,0,1.5,0.7142857142857143,0.1428571428571428,56.22857142857143,5,-5,-2,-0.125,-6,Carbohydrate,69406.30283277243,73658.0723729712,1.0612591272934244,0.08577696164105597,0.708437526365915,0.8632131886285471,Upregulated
Feature0188,NA,C20 H36 N4 O7,444.25844,NA,NA,Feature0188,20,36,7,4,0,0,1.8,0.35,-0.5,74.55,5,-2,-0.6666666666666666,-0.2,-6,Protein,179018.66774305367,170382.21677093458,0.9517567017953958,-0.07133527132604857,0.916854219640861,0.9603585751327469,Downregulated
Feature0187,NA,C19 H37 N O2,311.28246,NA,NA,Feature0187,19,37,2,1,0,0,1.9473684210526316,0.10526315789473684,-1.5789473684210522,105.29999999999998,2,0,-0.0625,0,-1,Lipid,2976415.979744726,4393226.08060526,1.4760121268338466,0.5617045745495162,0.6080727073134591,0.8271340789476043,Upregulated
Feature0186,NA,C13 H25 N O9,339.15309,NA,NA,Feature0186,13,25,9,1,0,0,1.9230769230769231,0.6923076923076923,-0.3076923076923075,69.06923076923076,2,-7,-2.6666666666666665,-0.4666666666666667,-8,Amino Sugar,81663.5169810122,91122.72360570153,1.1158314872342407,0.15811916794848127,0.4831395220809764,0.7998439321266281,Upregulated
Feature0185,NA,C47 H83 N10 O10 P3,1040.55075,NA,NA,Feature0185,47,83,10,10,0,3,1.7659574468085106,0.2127659574468085,-1.0212765957446803,89.4063829787234,13,3,-0.4166666666666667,-0.1724137931034483,-10,Lipid,2627861.0210694834,2656035.69197553,1.01072152243979,0.015385555562441894,0.9701982962718312,0.9859603162880705,Upregulated
Feature0184,NA,C20 H29 N3 O4,375.2159,NA,NA,Feature0184,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Phenol,3377758.289366577,2837427.105557878,0.8400326081621353,-0.2514827637570005,0.741543884521754,0.8823035402263076,Downregulated
Feature0183,NA,C9 H21 N O7,255.13179,NA,NA,Feature0183,9,21,7,1,0,0,2.3333333333333335,0.7777777777777778,-0.44444444444444464,72.96666666666667,0,-7,-8,-1,-8,Carbohydrate,166852.47797317166,210443.060855535,1.2612522355788585,0.3348568265214634,0.0668441635011812,0.7829565408883704,Upregulated
Feature0182,NA,C18 H32 N4 O7,416.22724,NA,NA,Feature0182,18,32,7,4,0,0,1.7777777777777777,0.3888888888888889,-0.33333333333333304,69.79999999999998,5,-2,-0.8571428571428571,-0.23809523809523808,-6,Protein,2177143.0810249834,1249791.154691389,0.574050996273059,-0.8007491893413944,0.1471684484875673,0.7829565408883704,Downregulated
Feature0181,Succinyl proline,C9 H13 N O5,215.07938,Other,NA,Succinyl proline-peak1,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Phenol,354017.7132497333,937513.5895268987,2.6482109635727524,1.4050180556711827,0.2620382192780507,0.7829565408883704,Upregulated
Feature0180,NA,C17 H31 N O9,393.19997,NA,NA,Feature0180,17,31,9,1,0,0,1.8235294117647056,0.5294117647058824,-0.5882352941176467,77.06470588235292,3,-6,-1,-0.21739130434782608,-7,Protein,803363.1321210493,151707.34294423266,0.1888403100397364,-2.404761338201051,0.34301451444493125,0.7829565408883704,Downregulated
Feature0179,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.2629,NA,NA,Leucyl-leucyl-norleucine-peak1,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,704937.0227090303,521149.3859734327,0.7392850271513435,-0.43579740036944203,0.381316644753723,0.7829565408883704,Downregulated
Feature0178,NA,C10 H23 N O6,253.15257,NA,NA,Feature0178,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,208606.4165918182,1356806.4738565665,6.504145443001594,2.7013595187215276,0.2338135573290345,0.7829565408883704,Upregulated
Feature0177,Tryptophyl-tyrosine,C20 H21 N3 O4,367.15331,NA,NA,Tryptophyl-tyrosine,20,21,4,3,0,0,1.05,0.2,-0.20000000000000015,66,12,8,0.38461538461538464,0.4666666666666667,5,Phenol,907775.5199186109,584779.244821763,0.6441892648462177,-0.6344434758961767,0.5432634982510463,0.8127221933835652,Downregulated
Feature0176,Arachidonoyl Serinol,C23 H39 N O3,377.29295,NA,NA,Arachidonoyl Serinol,23,39,3,1,0,0,1.6956521739130437,0.13043478260869565,-1.304347826086956,97.47391304347823,5,2,0.05263157894736842,0.12195121951219512,1,Lipid,162099.14794199166,206905.341673375,1.2764122717499882,0.3520943842310718,0.3019370012612224,0.7829565408883704,Upregulated
Feature0175,Amino-levulinic acid,C5 H9 N O3,131.05828,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,Amino-levulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,1333485.4993645267,1639314.9286080366,1.2293458979413372,0.29789090027794723,0.07138551326783821,0.7829565408883704,Upregulated
Feature0174,NA,C16 H21 N5 O9,427.13399,NA,NA,Feature0174,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,4129206.2148598568,4596625.8286666265,1.1131984186511823,0.15471076436990716,0.29053238948927373,0.7829565408883704,Upregulated
Feature0173,NA,C20 H33 N O11,463.2054,NA,NA,Feature0173,20,33,11,1,0,0,1.65,0.55,-0.4000000000000003,71.7,5,-6,-0.875,-0.1111111111111111,-7,Protein,78427.4999812049,87420.77282201404,1.1146698905736427,0.15661651934226922,0.5441071143939531,0.8129003759654,Upregulated
Feature0172,2-Keto-glutaramic acid,C5 H7 N O4,145.03751,Metabolic pathways;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Keto-glutaramic acid,5,7,4,1,0,0,1.4,0.8,0.7999999999999998,37.5,3,-1,-Inf,0,-2,Tannin,134654.91866755165,149854.20722867968,1.1128758511870882,0.1542926592865654,0.4414771601300352,0.7974180334973026,Upregulated
Feature0171,NA,C14 H28 N6 O4,344.21733,NA,NA,Feature0171,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,71547.088549571,78060.987007235,1.0910435153926759,0.1257086435398386,0.3782747091769234,0.7829565408883704,Upregulated
Feature0170,Diacetin,C7 H12 O5,176.0685,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,Diacetin,7,12,5,0,0,0,1.7142857142857142,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-3,-1.5,-0.1111111111111111,-3,Carbohydrate,2858935.4534904,2653759.5598441,0.9282334641742939,-0.10744038517495491,0.7022466373606756,0.8601754662867663,Downregulated
Feature0169,Marimastat,C15 H29 N3 O5,331.21071,NA,NA,Marimastat-peak2,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1103446.225362564,796282.418841405,0.721632283059165,-0.47066421421041826,0.4114716681023136,0.7873878775042317,Downregulated
Feature0168,melanostatin,C13 H24 N4 O3,284.18484,NA,NA,melanostatin,13,24,3,4,0,0,1.8461538461538465,0.2307692307692308,-0.4615384615384617,73.45384615384616,4,1,-0.5,-0.2,-3,Lipid,53418.3206392855,1848972.3521605425,34.6130752527018,5.113245220578123,0.2156432618448269,0.7829565408883704,Upregulated
Feature0167,NA,C17 H31 N5 O6,401.22757,NA,NA,Feature0167,17,31,6,5,0,0,1.8235294117647056,0.35294117647058826,-0.23529411764705888,67.00588235294117,5,-1,-1,-0.3333333333333333,-6,Protein,893270.40741559,183123.3292749297,0.20500324174483978,-2.2862813714384647,0.12816422322368834,0.7829565408883704,Downregulated
Feature0166,NA,C17 H32 N4 O5,372.2374,NA,NA,Feature0166,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,1686699.3319397133,693148.0860492659,0.4109494045107268,-1.2829673125490906,0.08507756664730298,0.7829565408883704,Downregulated
Feature0165,N-Acetyl-L-leucine,C8 H15 N O3,173.10521,Other,NA,N-Acetyl-L-leucine-peak1,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,360811.14223298465,325412.657997477,0.9018919315616645,-0.14897352076432274,0.7643560697665087,0.8895423245833387,Downregulated
Feature0164,NA,C15 H20 N2 O3,276.14743,NA,NA,Feature0164,15,20,3,2,0,0,1.3333333333333333,0.2,-0.5333333333333332,75.5,7,4,0.2,0.30434782608695654,2,Phenol,83979.34044139613,185900.448172751,2.2136450131146144,1.1464238856782163,0.27726338159085623,0.7829565408883704,Upregulated
Feature0163,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0163,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1993611.55188236,697867.5391141666,0.35005191380198564,-1.514359200741863,0.41678741575310224,0.7873878775042317,Downregulated
Feature0162,NA,C14 H25 N3 O7,347.1693,NA,NA,Feature0162,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,1039420.0653410123,837500.3204730724,0.8057380729881386,-0.3116171670703903,0.5491573146672245,0.8163211485466402,Downregulated
Feature0161,Methionylphenylalanine,C14 H20 N2 O3 S,296.11939,NA,NA,Methionylphenylalanine-peak2,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Phenol,578198.0473955794,246374.2089927203,0.42610695436015744,-1.2307124973983639,0.28460280603812893,0.7829565408883704,Downregulated
Feature0160,NA,C18 H26 N4 O5,378.19035,NA,NA,Feature0160,18,26,5,4,0,0,1.4444444444444444,0.2777777777777778,-0.22222222222222232,66.63333333333333,8,3,-0.1111111111111111,0.13043478260869565,-1,Phenol,120210.39751280927,72300.90837364251,0.6014530345924389,-0.7334760082024853,0.38250782610331874,0.7829565408883704,Downregulated
Feature0159,glu-tyr,C14 H18 N2 O6,310.11656,NA,NA,glu-tyr,14,18,6,2,0,0,1.2857142857142858,0.42857142857142855,0,60.3,7,1,-0.16666666666666666,0.2222222222222222,-1,Phenol,1404868.85409018,1727120.7091840534,1.229382162011535,0.2979334572366389,0.40860589291923927,0.7873878775042317,Upregulated
Feature0158,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03171,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak2",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,67578.9544065766,91084.35815357657,1.347821358785517,0.43062929334989497,0.15324058879069663,0.7829565408883704,Upregulated
Feature0157,DLK,C16 H30 N4 O6,374.21636,NA,NA,DLK,16,30,6,4,0,0,1.875,0.375,-0.375,70.9875,4,-2,-1,-0.3333333333333333,-6,Protein,903124.9999058163,355237.967068599,0.3933430777640366,-1.3461399002839156,0.03530507177530796,0.7829565408883704,Downregulated
Feature0156,NP-007065,C8 H10 O3,154.06303,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak1,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Phenol,2149988.631257573,5314906.72744596,2.4720627124140466,1.305715342652131,0.02002111423403411,0.7829565408883704,Upregulated
Feature0155,NA,C12 H22 N2 O3,242.16305,NA,NA,Feature0155,12,22,3,2,0,0,1.8333333333333333,0.25,-0.833333333333333,84.04999999999998,3,0,-0.2857142857142857,-0.0588235294117647,-2,Lipid,436282.94623267034,765369.348814407,1.754295819773424,0.8108920440968973,0.11398353691998879,0.7829565408883704,Upregulated
Feature0154,NA,C9 H9 O P S,196.01126,NA,NA,Feature0154,9,9,1,0,1,1,1,0.1111111111111111,-1.1111111111111107,91.96666666666664,6,5,0.5,0.5384615384615384,3,Unsaturated HC,124699.00108029896,135716.69217760602,1.0883542851334655,0.1221482644966732,0.6304217508703109,0.8293364212030647,Upregulated
Feature0153,DH2090000,C9 H10 O5,198.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak1,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Phenol,139166.7073104232,249323.09445460467,1.7915426704640518,0.8412024056662931,0.26646049540493594,0.7829565408883704,Upregulated
Feature0152,NA,C8 H11 N O7,233.05354,NA,NA,Feature0152,8,11,7,1,0,0,1.375,0.875,0.75,38.925,4,-3,-Inf,-0.14285714285714285,-4,Tannin,1176411.7044207894,1509712.8183231533,1.2833201273413597,0.35988109912496075,0.4527733468952809,0.7974180334973026,Upregulated
Feature0151,NA,C23 H32,308.25044,NA,NA,Feature0151,23,32,0,0,0,0,1.391304347826087,0,-1.391304347826087,99.95217391304348,8,8,0.34782608695652173,0.34782608695652173,8,Unsaturated HC,364094.928104267,1361088.8709431516,3.738280228263362,1.902374720172574,0.08086231867190441,0.7829565408883704,Upregulated
Feature0150,NA,C15 H27 N3 O5,329.19521,NA,NA,Feature0150,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,3786767.27394052,3838639.2522699665,1.013698221880815,0.01962822571897475,0.9380755612875147,0.9691719887335095,Upregulated
Feature0149,NA,C13 H26 N2 O6,306.17912,NA,NA,Feature0149,13,26,6,2,0,0,2,0.4615384615384616,-0.615384615384615,77.83846153846153,2,-4,-1.2,-0.375,-6,Protein,40531.3431425271,46210.23134944394,1.1401110293075465,0.18917432757557098,0.3431379535865269,0.7829565408883704,Upregulated
Feature0148,NA,C20 H29 N3 O6,407.20564,NA,NA,Feature0148,20,29,6,3,0,0,1.45,0.3,-0.4000000000000003,71.7,8,2,-0.09090909090909093,0.14285714285714285,-1,Phenol,1728289.2806014833,1726607.4057721535,0.9990268557190006,-0.0014046339949409354,0.998174483639996,0.9991408892032351,Downregulated
Feature0147,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",C13 H18 N2 O3,250.13174,NA,NA,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Phenol,2309583.66870215,3088020.32944415,1.3370463132775074,0.4190494390876398,0.4937701592256637,0.7998439321266281,Upregulated
Feature0146,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0146,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,677060.7595947568,776287.4397305123,1.1465550598370906,0.19730563764578032,0.6285154009023546,0.8293364212030647,Upregulated
Feature0145,NA,C16 H32 N6 O4,372.24864,NA,NA,Feature0145,16,32,4,6,0,0,2,0.25,-0.375,70.9875,4,0,-1,-0.5,-6,Lipid,110161.9202833763,73461.5038411174,0.6668502478183737,-0.5845652779848495,0.528589297494345,0.8098418097030804,Downregulated
Feature0144,Etilevodopa,C11 H15 N O4,225.10013,NA,NA,Etilevodopa,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Phenol,610941.2454146267,694391.675111104,1.1365932163244965,0.1847160099051762,0.6444006722236448,0.8329695325287205,Upregulated
Feature0143,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10555,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak1",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Phenol,3596334.129489727,4176409.68323023,1.1612963459051033,0.21573617393686706,0.3499030776315678,0.7829565408883704,Upregulated
Feature0142,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",C12 H11 N O3,217.07394,Metabolic pathways;Other,NA,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",12,11,3,1,0,0,0.9166666666666666,0.25,-0.16666666666666696,65.05000000000001,8,5,0.5,0.5789473684210527,4,Phenol,3351092.0659034066,3674906.20843397,1.0966294378555868,0.13307610688726879,0.24233755891141592,0.7829565408883704,Upregulated
Feature0141,N-(2-Acetylphenyl)formamide,C9 H9 N O2,163.06336,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N-(2-Acetylphenyl)formamide,9,9,2,1,0,0,1,0.2222222222222222,-0.22222222222222232,66.63333333333333,6,4,0.5,0.5714285714285714,3,Phenol,4175650.600352453,4948736.4555475,1.1851414136828866,0.2450592149435025,0.04856362220704054,0.7829565408883704,Upregulated
Feature0140,NA,C17 H32 N4 O5,372.23738,NA,NA,Feature0140,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,466913.925640039,356910.0748477287,0.7644022918324431,-0.38759599107442144,0.6131577154309138,0.8278735941197176,Downregulated
Feature0139,Ser-met,C8 H16 N2 O4 S,236.08315,Microbial metabolism in diverse environments;Other,NA,Ser-met,8,16,4,2,1,0,2,0.5,0,60.3,2,-2,-5,-1,-5,Protein,385171.990961938,311720.949708187,0.8093032645745799,-0.3052476798544943,0.49155556474168854,0.7998439321266281,Downregulated
Feature0138,DL-TYROSINE,C9 H11 N O3,181.07393,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,DL-TYROSINE,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Phenol,1896855.6014650166,1809843.0493092,0.9541280042146522,-0.0677452661224471,0.7742412301168914,0.8964898453985058,Downregulated
Feature0137,NA,C9 H19 N O8,269.11107,NA,NA,Feature0137,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,1516261.1864592184,705796.950822714,0.46548507415855905,-1.1031931865719518,0.3455511573365057,0.7829565408883704,Downregulated
Feature0136,LLK,C18 H36 N4 O4,372.27367,NA,NA,LLK,18,36,4,4,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,-1,-0.5,-0.25,-5,Lipid,67969.46753576084,75254.37820612943,1.107179163446231,0.1468886975492924,0.47768583340107545,0.7998439321266281,Upregulated
Feature0135,Paracetamol,C8 H9 N O2,151.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak1,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Phenol,4371737.864185894,5120436.020426643,1.1712587029460815,0.2280597677568256,0.2222348657797457,0.7829565408883704,Upregulated
Feature0134,Leucylasparagine,C10 H19 N3 O4,245.13751,NA,NA,Leucylasparagine,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,1102841.9739153148,720279.7502687214,0.6531123835553527,-0.6145968316798651,0.17744532654533554,0.7829565408883704,Downregulated
Feature0133,2-Pentadecylfuran,C19 H34 O,278.26093,NA,NA,2-Pentadecylfuran,19,34,1,0,0,0,1.7894736842105263,0.05263157894736842,-1.6842105263157894,108.3,3,2,0.1111111111111111,0.13513513513513514,2,Lipid,468735.60500182497,589691.8358683754,1.2580478836594449,0.33118683493844064,0.5922573279438053,0.820796478981062,Upregulated
Feature0132,Maclurin,C13 H10 O6,262.04778,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Maclurin,13,10,6,0,0,0,0.7692307692307693,0.4615384615384616,0.15384615384615374,55.91538461538462,9,3,0.42857142857142855,0.6,3,Condensed HC,109949.92909087184,122676.73085525034,1.1157508865136239,0.1580149528754958,0.4900622152970248,0.7998439321266281,Upregulated
Feature0131,NA,C17 H32 N4 O6,388.23229,NA,NA,Feature0131,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,393526.02164240467,205313.72341473034,0.5217284553581516,-0.9386289739913989,0.13669420095262763,0.7829565408883704,Downregulated
Feature0130,2-Aminooctanedioic acid,C8 H15 N O4,189.10016,NA,NA,2-Aminooctanedioic acid-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,238877.28837700668,160084.97063011667,0.670155675819057,-0.5774318252215804,0.12347844997499414,0.7829565408883704,Downregulated
Feature0129,NP-019811,C6 H7 N O2,125.04763,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak1,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Phenol,3618790.4522591066,3679705.4957415964,1.016832984469842,0.024082734982695635,0.8731918057752672,0.9403497372086917,Upregulated
Feature0128,nitrilotriacetic acid,C6 H9 N O6,191.04305,NA,NA,nitrilotriacetic acid,6,9,6,1,0,0,1.5,1,1,31.799999999999997,3,-3,4,-0.5,-4,Carbohydrate,1904700.6443001232,2165568.36967233,1.1369599606913883,0.18518144901548753,0.26067773896602076,0.7829565408883704,Upregulated
Feature0127,NA,C9 H20 N2 O3,204.14739,NA,NA,Feature0127,9,20,3,2,0,0,2.2222222222222223,0.3333333333333333,-0.8888888888888893,85.63333333333334,1,-2,-1,-0.4545454545454546,-4,Protein,384026.00364028104,426304.913884157,1.1100938734437338,0.15068168110270924,0.8181417310009904,0.9142978308596724,Upregulated
Feature0126,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,C9 H12 O6 S,248.0355,NA,NA,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,9,12,6,0,1,0,1.3333333333333333,0.6666666666666666,0.22222222222222232,53.96666666666666,4,-2,-1.5,0,-3,Tannin,3229096.9641933106,1436437.7241856663,0.44484192952828083,-1.1686353161075314,0.3388654659975095,0.7829565408883704,Downregulated
Feature0125,2H-Pyran,C5 H6 O,82.04189,NA,NA,2H-Pyran,5,6,1,0,0,0,1.2,0.2,-0.7999999999999998,83.1,3,2,0.5,0.5555555555555556,2,Phenol,249790.28984010735,257820.60956572634,1.0321482461578442,0.04565019812239799,0.9029854452339674,0.955173734959754,Upregulated
Feature0124,Pivagabine,C9 H17 N O3,187.12087,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak1,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,3030426.3581366865,3449139.035191897,1.1381695601778832,0.1867155008829043,0.37800785558503036,0.7829565408883704,Upregulated
Feature0123,NA,C16 H32 N4 O4,344.24234,NA,NA,Feature0123,16,32,4,4,0,0,2,0.25,-0.75,81.675,3,-1,-0.625,-0.3,-5,Lipid,161494.913851433,189187.447665549,1.1714761979413897,0.22832764181456208,0.18078121632758126,0.7829565408883704,Upregulated
Feature0122,VLH,C17 H29 N5 O4,367.22207,NA,NA,VLH,17,29,4,5,0,0,1.7058823529411764,0.2352941176470588,-0.35294117647058787,70.35882352941175,6,2,-0.375,-0.1,-3,Lipid,213081.384669788,155726.36153700092,0.730830437291976,-0.4523913749671559,0.30818341674760596,0.7829565408883704,Downregulated
Feature0121,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17443,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak2,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,580393.8955104966,195232.40177432544,0.33637914403390656,-1.5718398355832766,0.026455440374492403,0.7829565408883704,Downregulated
Feature0120,NA,C9 H13 N O4 S,231.05654,NA,NA,Feature0120,9,13,4,1,1,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Phenol,459462.6239685038,213200.98767198628,0.4640224831141025,-1.1077333854582323,0.4951765012704229,0.7998439321266281,Downregulated
Feature0119,NA,C17 H25 N3 O5,351.17943,NA,NA,Feature0119,17,25,5,3,0,0,1.4705882352941178,0.29411764705882354,-0.35294117647058787,70.35882352941175,7,2,-0.1111111111111111,0.13043478260869565,-1,Phenol,1991769.20903301,1198170.0651199163,0.6015606927178172,-0.7332177936194205,0.1441350930244246,0.7829565408883704,Downregulated
Feature0118,6-methoxymellein,C11 H12 O4,208.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak1,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Phenol,72286.51369902426,84728.86025377827,1.1721254203316485,0.22912694997301047,0.31623235982847436,0.7829565408883704,Upregulated
Feature0117,Isobutyric acid,C4 H8 O2,88.05244,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-lysine degradation;Other,Isobutyric acid,4,8,2,0,0,0,2,0.5,-1,88.8,1,-1,-0.5,0,-1,Protein,640356.3810100884,667114.8877055977,1.0417868978728702,0.05906019813070339,0.8107207139350665,0.9142978308596724,Upregulated
Feature0116,6-Hydroxymelatonin,C13 H16 N2 O3,248.11607,Other,Other,6-Hydroxymelatonin-peak1,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Phenol,163748.81188679504,189956.67007044266,1.1600491501688939,0.214185932251756,0.6762462820312132,0.8430536982655791,Upregulated
Feature0115,NA,C15 H27 N3 O5,329.19515,NA,NA,Feature0115,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,3516043.6922580334,2739431.36714174,0.7791232438816633,-0.36007653903502523,0.3735566568586288,0.7829565408883704,Downregulated
Feature0114,Metalaxyl,C15 H21 N O4,279.14696,NA,NA,Metalaxyl,15,21,4,1,0,0,1.4,0.26666666666666666,-0.666666666666667,79.30000000000001,6,2,0.1,0.25,1,Phenol,219594.46201656034,124712.59192488233,0.5679222999507034,-0.8162345333682002,0.04194786077021334,0.7829565408883704,Downregulated
Feature0113,Icacine,C22 H31 N O6,405.21514,NA,NA,Icacine-peak1,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Phenol,113764.53901035526,146948.10510512232,1.291686375943092,0.3692558232851431,0.257055487487525,0.7829565408883704,Upregulated
Feature0112,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",C20 H34 O,290.261,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",20,34,1,0,0,0,1.7,0.05,-1.5999999999999996,105.89999999999998,4,3,0.15789473684210523,0.1794871794871795,3,Lipid,4147423.255634873,4539206.70406181,1.0944643033224648,0.13022490083270927,0.41074204028638966,0.7873878775042317,Upregulated
Feature0111,lamifiban,C24 H28 N4 O6,468.20092,NA,NA,lamifiban-peak1,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Phenol,4049638.9916023565,4805852.412027803,1.1867360083191587,0.24699904041612672,0.1913955871365874,0.7829565408883704,Upregulated
Feature0110,N-Acetyl-L-aspartic acid,C6 H9 N O5,175.04806,Metabolic pathways;Other,NA,N-Acetyl-L-aspartic acid,6,9,5,1,0,0,1.5,0.8333333333333334,0.6666666666666665,41.3,3,-2,-Inf,-0.2,-3,Carbohydrate,2747842.986550097,1796524.3076745267,0.6537943821637545,-0.6130911143244177,0.26141960911796097,0.7829565408883704,Downregulated
Feature0109,NA,C20 H26 O7 S,410.14012,NA,NA,Feature0109,20,26,7,0,1,0,1.3,0.35,-0.5,74.55,8,1,0,0.2258064516129032,0,Phenol,155110.286751328,248722.54251891567,1.603520615738828,0.6812429019759921,0.050305141379999425,0.7829565408883704,Upregulated
Feature0108,Cyclo(leucylleucine),C12 H22 N2 O2,226.16814,Microbial metabolism in diverse environments;Other,NA,Cyclo(leucylleucine),12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,4436544.937103163,4950546.53332825,1.115856280847389,0.15815122406605103,0.4931685644719869,0.7998439321266281,Upregulated
Feature0107,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10002,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak2",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Phenol,157745.32925704034,189865.535948101,1.2036206513520404,0.26738076531295046,0.3741645365917692,0.7829565408883704,Upregulated
Feature0106,Trigonelline,C7 H7 N O2,137.04768,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak1,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Phenol,1198222.312014181,3122156.0823343,2.605656772561709,1.3816470589119065,0.1096250609249593,0.7829565408883704,Upregulated
Feature0105,Pyrazinoic acid,C5 H4 N2 O2,124.02723,NA,NA,Pyrazinoic acid,5,4,2,2,0,0,0.8,0.4,1.2000000000000002,26.09999999999999,5,3,1,1,1,Condensed HC,61104.18638425867,81667.2685954171,1.336524932708306,0.4184867511306478,0.1627257855323295,0.7829565408883704,Upregulated
Feature0104,NA,C13 H23 N3 O6,317.15875,NA,NA,Feature0104,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1299115.4129163234,2721232.7105929097,2.0946812604464,1.0667307312955674,0.11898313341560778,0.7829565408883704,Upregulated
Feature0103,NA,C13 H24 N4 O5,316.17479,NA,NA,Feature0103,13,24,5,4,0,0,1.8461538461538465,0.38461538461538464,-0.1538461538461542,64.6846153846154,4,-1,-1.25,-0.38461538461538464,-5,Protein,660310.933041641,328458.128858375,0.49742948726499664,-1.0074360628652104,0.0841270514470391,0.7829565408883704,Downregulated
Feature0102,delta-guanidinovaleric acid,C6 H13 N3 O2,159.10079,NA,NA,delta-guanidinovaleric acid,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,2352000.321741776,1157519.185648133,0.49214244358220627,-1.0228521514633222,0.28537234061898614,0.7829565408883704,Downregulated
Feature0101,NA,C14 H28 N6 O4,344.2173,NA,NA,Feature0101,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,425540.22743010835,417084.797276291,0.980130127285778,-0.028954793080900713,0.9666893444813233,0.9833412914850813,Downregulated
Feature0100,NA,C27 H39 N5 O6,529.28996,NA,NA,Feature0100,27,39,6,5,0,0,1.4444444444444444,0.2222222222222222,-0.44444444444444464,72.96666666666667,11,5,0,0.15789473684210523,0,Phenol,91188.492343987,98430.3846189471,1.0794167343796164,0.11025195894101418,0.6427557649879787,0.8329695325287205,Upregulated
Feature0099,L-Glutaminyl-L-Leucine,C11 H21 N3 O4,259.15319,NA,NA,L-Glutaminyl-L-Leucine,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1945243.1662082865,1280112.5046136337,0.6580732562648499,-0.6036799021619169,0.3779898293720171,0.7829565408883704,Downregulated
Feature0098,NA,C9 H19 N O8,269.11113,NA,NA,Feature0098,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,376875.0047136382,402900.12067572435,1.0690550331982374,0.09633612254255249,0.8903806194206912,0.9487246486135,Upregulated
Feature0097,Pyridoxal,C8 H9 N O3,167.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak1,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Phenol,467327.75147804996,396362.623646933,0.8481469854793117,-0.23761378664813523,0.5026913746003363,0.7998439321266281,Downregulated
Feature0096,Fasoracetam,C10 H16 N2 O2,196.12116,NA,NA,Fasoracetam,10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,1950210.4303669266,1910698.8909739167,0.9797398584389809,-0.02952936072205101,0.9203519013963739,0.9614849472688375,Downregulated
Feature0095,NA,C22 H42 N4 O5,442.31572,NA,NA,Feature0095,22,42,5,4,0,0,1.9090909090909092,0.2272727272727273,-0.9090909090909092,86.2090909090909,4,-1,-0.38461538461538464,-0.16129032258064516,-5,Lipid,159278.63001107232,158912.55052633566,0.9977016409250179,-0.0033196475737279295,0.9946117398394776,0.9991408892032351,Downregulated
Feature0094,DL-Ornithine,C5 H12 N2 O2,132.08986,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Other,DL-Ornithine,5,12,2,2,0,0,2.4,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Other,1336537.0748539174,281990.90357819,0.21098621870179804,-2.244779327518393,0.21997155709030108,0.7829565408883704,Downregulated
Feature0093,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,C14 H25 N3 O6 S,363.1465,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,14,25,6,3,1,0,1.7857142857142858,0.42857142857142855,-0.14285714285714324,64.37142857142858,4,-2,-1.5,-0.42857142857142855,-6,Protein,618876.1888075847,601005.784508437,0.9711244274342186,-0.042271938952784104,0.9363637074498116,0.9691719887335095,Downregulated
Feature0092,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10628,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak1,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,2649364.654610587,2812031.37220186,1.06139838746176,0.08596626203750984,0.7864594767215091,0.9031806887221425,Upregulated
Feature0091,NA,C14 H27 N3 O5,317.19514,NA,NA,Feature0091,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,601679.420898906,262626.381798391,0.4364888887275362,-1.1959831658475657,0.018155506661883015,0.7829565408883704,Downregulated
Feature0090,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14221,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak1",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Phenol,162736.21781201533,206260.716441756,1.2674542840857834,0.3419337114793708,0.45556591753277265,0.7974180334973026,Upregulated
Feature0089,NA,C14 H27 N3 O4,301.20018,NA,NA,Feature0089,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,867201.610052247,754988.8385078734,0.870603594085102,-0.1999121189172456,0.6081868227555913,0.8271340789476043,Downregulated
Feature0088,NA,C14 H27 N O10,369.16362,NA,NA,Feature0088,14,27,10,1,0,0,1.9285714285714288,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-8,-3,-0.5,-9,Carbohydrate,1825661.5169103867,2063538.89131353,1.1302965375562657,0.17670131878005838,0.2189376168223086,0.7829565408883704,Upregulated
Feature0087,NA,C15 H28 N4 O5,344.20609,NA,NA,Feature0087,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,249583.99064567467,98954.33530468453,0.3964770939381541,-1.3346905767927262,0.13012759056160353,0.7829565408883704,Downregulated
Feature0086,NP-006105,C15 H16 O5,276.09975,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,NP-006105,15,16,5,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,8,3,0.3,0.44,3,Phenol,123004.5837524213,121523.036057335,0.9879553456473761,-0.017482259624953603,0.9719002761270996,0.9859603162880705,Downregulated
Feature0085,"N,N-diacetyllegionaminic acid",C13 H22 N2 O8,334.13758,Metabolic pathways;Other,NA,"N,N-diacetyllegionaminic acid",13,22,8,2,0,0,1.6923076923076923,0.6153846153846154,0,60.3,4,-4,-2,-0.2857142857142857,-6,Amino Sugar,1778280.7305897034,1446435.6699467534,0.8133899474168483,-0.2979809340620888,0.28739007729350197,0.7829565408883704,Downregulated
Feature0084,NA,C16 H31 N3 O9,409.20616,NA,NA,Feature0084,16,31,9,3,0,0,1.9375,0.5625,-0.25,67.425,3,-6,-2.25,-0.5294117647058824,-9,Amino Sugar,4322708.98830849,4203182.585818277,0.9723491905623318,-0.0404535865874702,0.7326427353726621,0.8779932381898025,Downregulated
Feature0083,NA,C14 H27 N3 O4,301.20024,NA,NA,Feature0083,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2016746.06000934,1522236.487705474,0.7547982950805537,-0.40583693066867566,0.429539162156751,0.7926693091116359,Downregulated
Feature0082,imazamox,C15 H19 N3 O4,305.13767,NA,NA,imazamox,15,19,4,3,0,0,1.2666666666666666,0.26666666666666666,-0.13333333333333375,64.10000000000001,8,4,0.125,0.3,1,Phenol,2097990.251011743,3106418.67537018,1.4806640182775532,0.5662443116901282,0.17663406489776576,0.7829565408883704,Upregulated
Feature0081,Proglumide,C18 H26 N2 O4,334.18921,NA,NA,Proglumide,18,26,4,2,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,7,3,0.08333333333333333,0.21428571428571427,1,Phenol,284586.02225683467,272621.62769151,0.9579586008109457,-0.0619647851631683,0.8863041047701664,0.9487246486135,Downregulated
Feature0080,3477,C12 H20 N2 O3,240.14735,NA,NA,3477,12,20,3,2,0,0,1.6666666666666667,0.25,-0.666666666666667,79.30000000000001,4,1,-0.14285714285714285,0.0588235294117647,-1,Lipid,148818.68025339633,127211.09681814999,0.8548059732927701,-0.2263311054556801,0.6518611942573656,0.8362522505118077,Downregulated
Feature0079,NA,C14 H27 N3 O5,317.19523,NA,NA,Feature0079,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,304085.84350340464,138910.87685589588,0.45681467856408314,-1.130319086149441,0.07010053985855053,0.7829565408883704,Downregulated
Feature0078,NA,C14 H25 N3 O5,315.17946,NA,NA,Feature0078,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,606088.380457633,533035.6915124523,0.8794685869245316,-0.18529604680644676,0.6472556055378356,0.8347365395556914,Downregulated
Feature0077,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,C25 H30 N4 O7,498.21169,NA,NA,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,25,30,7,4,0,0,1.2,0.28,-0.16000000000000014,64.86,13,6,0.14285714285714285,0.3142857142857143,2,Phenol,4196079.998231627,4519977.71420697,1.077190548347945,0.10727347628960567,0.6220002922740568,0.8293364212030647,Upregulated
Feature0076,NA,C19 H34 N4 O8,446.2376,NA,NA,Feature0076,19,34,8,4,0,0,1.7894736842105263,0.42105263157894735,-0.3157894736842106,69.3,5,-3,-1,-0.2727272727272727,-7,Protein,2943645.879598563,1217374.0792861716,0.41355996240016135,-1.2738315727806415,0.042804202346123546,0.7829565408883704,Downregulated
Feature0075,HC blue 2,C12 H19 N3 O5,285.13253,NA,NA,HC blue 2-peak1,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,212704.16493327112,140341.96803469834,0.6597988717274341,-0.5999017840269971,0.4605615521626196,0.7995347728859721,Downregulated
Feature0074,NA,C10 H15 N O5,229.09499,NA,NA,Feature0074,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,179558.49032032865,230453.907497014,1.2834475667838874,0.3600243580979642,0.31677421009611173,0.7829565408883704,Upregulated
Feature0073,NA,C15 H27 N3 O7,361.18494,NA,NA,Feature0073,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,131011.49099736006,251832.97456650768,1.9222205063797206,0.9427738435066363,0.2168032767099302,0.7829565408883704,Upregulated
Feature0072,NA,C19 H29 N3 O6,395.20574,NA,NA,Feature0072,19,29,6,3,0,0,1.5263157894736843,0.3157894736842105,-0.4210526315789478,72.30000000000001,7,1,-0.2,0.07692307692307693,-2,Protein,439549.92812079773,243621.38873443945,0.5542519134879419,-0.8513862490554037,0.5481974268972156,0.8163211485466402,Downregulated
Feature0071,(+)-sesamin monocatechol,C19 H18 O6,342.11027,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak1,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Phenol,254180.66503266568,265928.5374712957,1.0462185919496285,0.06518431293699815,0.7827258037887436,0.901638149577507,Upregulated
Feature0070,S-methyl D-thioglycerate,C4 H8 O3 S,136.0194,NA,NA,S-methyl D-thioglycerate,4,8,3,0,1,0,2,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,3537821.6043932335,4737554.485330047,1.339116274106924,0.4212812338470888,0.26049418475855696,0.7829565408883704,Upregulated
Feature0069,NA,C15 H25 N3 O6,343.17444,NA,NA,Feature0069,15,25,6,3,0,0,1.6666666666666667,0.4,-0.2666666666666666,67.89999999999999,5,-1,-0.6666666666666666,-0.1111111111111111,-4,Protein,1741787.5139304532,2325298.935026847,1.335007236203952,0.4168475618433634,0.02477205886258718,0.7829565408883704,Upregulated
Feature0068,Deferiprone,C7 H9 N O2,139.06334,NA,NA,Deferiprone,7,9,2,1,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,4,2,0.25,0.4,1,Phenol,3285904.92256315,3543527.59851335,1.078402352478672,0.1088955488000762,0.353356463463413,0.7829565408883704,Upregulated
Feature0067,NA,C15 H21 N3 O7,355.13805,NA,NA,Feature0067,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Phenol,369796.98744327936,579135.1546114457,1.5660894335984155,0.6471666019806585,0.34009616128594455,0.7829565408883704,Upregulated
Feature0066,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0066,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,372799.4728006227,346050.685616111,0.9282488599472423,-0.10741645668935047,0.8244478552374546,0.9177535783715587,Downregulated
Feature0065,Tiglic acid,C5 H8 O2,100.0524,NA,NA,Tiglic acid-peak1,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,791401.0765918894,511409.5462194483,0.6462077969640829,-0.6299299370207699,0.3391216173192137,0.7829565408883704,Downregulated
Feature0064,Anhydroecgonine,C9 H13 N O2,167.09465,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak1,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Phenol,254739.1543490304,280930.50370093464,1.1028163472507182,0.14119255795470823,0.9289341099961562,0.9668497879551831,Upregulated
Feature0063,NA,C17 H30 N4 O8,418.20647,NA,NA,Feature0063,17,30,8,4,0,0,1.7647058823529411,0.4705882352941176,-0.117647058823529,63.65294117647058,5,-3,-1.4,-0.3333333333333333,-7,Protein,366854.6910166356,490360.96454978466,1.3366626529727228,0.41863540388045417,0.5613556874454944,0.820796478981062,Upregulated
Feature0062,NA,C18 H27 N3 O5,365.19518,NA,NA,Feature0062,18,27,5,3,0,0,1.5,0.2777777777777778,-0.44444444444444464,72.96666666666667,7,2,-0.1,0.12,-1,Lipid,413358.0972828087,384945.8640267141,0.9312648441076609,-0.10273657807639104,0.898123021195256,0.952451823989676,Downregulated
Feature0061,NP-016455,C11 H18 N2 O4,242.12667,NA,NA,NP-016455,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,181710.22737401834,177890.65614018633,0.9789798775279165,-0.030648888673344386,0.9491559883917476,0.9725598346808593,Downregulated
Feature0060,Methionylphenylalanine,C14 H20 N2 O3 S,296.11937,NA,NA,Methionylphenylalanine-peak1,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Phenol,81928.76652026213,91402.8546964534,1.1156381156287543,0.15786912980624132,0.3269462364833766,0.7829565408883704,Upregulated
Feature0059,NA,C14 H25 N3 O5,315.17952,NA,NA,Feature0059,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,3048872.743335103,2272838.902155306,0.7454686021657603,-0.423780504891944,0.4194765707471293,0.7873878775042317,Downregulated
Feature0058,NA,C19 H29 N3 O5,379.21082,NA,NA,Feature0058,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,475316.316679178,256455.17957657867,0.5395463411993008,-0.890181217941031,0.02237283666640334,0.7829565408883704,Downregulated
Feature0057,NA,C11 H13 N3 O3,235.09569,NA,NA,Feature0057,11,13,3,3,0,0,1.181818181818182,0.2727272727272727,0.18181818181818168,55.11818181818182,7,4,0.2,0.38461538461538464,1,Phenol,2930336.5734404633,939127.1627739451,0.32048440144584833,-1.641673954905639,0.13538567312888314,0.7829565408883704,Downregulated
Feature0056,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",C16 H23 N O3,277.16771,NA,NA,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",16,23,3,1,0,0,1.4375,0.1875,-0.875,85.2375,6,3,0.16666666666666666,0.25925925925925924,2,Phenol,172680.74134565,2196605.1053745262,12.720614286555824,3.6690964358531186,0.3102781930606985,0.7829565408883704,Upregulated
Feature0055,allobarbital,C10 H12 N2 O3,208.08478,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,allobarbital,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Phenol,367524.44341187866,311606.013405114,0.8478511266144609,-0.2381171293327871,0.6665359712098252,0.8383146233448654,Downregulated
Feature0054,Glu-Lys,C11 H21 N3 O5,275.14821,Metabolic pathways;Other,NA,Glu-Lys,11,21,5,3,0,0,1.9090909090909092,0.4545454545454546,-0.18181818181818168,65.48181818181817,3,-2,-1.6666666666666667,-0.4545454545454546,-5,Protein,1709552.7511866868,1841811.7259299734,1.0773646643260812,0.10750665319522962,0.7272304925891067,0.8768172749450367,Upregulated
Feature0053,NA,C16 H31 N3 O5,345.22649,NA,NA,Feature0053,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1241971.0422098967,625520.8156839621,0.5036516910820592,-0.9895017366899874,0.2184962913472914,0.7829565408883704,Downregulated
Feature0052,Acetyl-L-methionine,C7 H13 N O3 S,191.0617,NA,NA,Acetyl-L-methionine-peak1,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,590940.461982223,944288.8394618874,1.5979424328034828,0.6762154349211325,0.03619940157823833,0.7829565408883704,Upregulated
Feature0051,Ajmaline,C20 H26 N2 O2,326.19951,Biosynthesis of secondary metabolites;Other,NA,Ajmaline,20,26,2,2,0,0,1.3,0.1,-0.7999999999999998,83.1,9,7,0.3125,0.35294117647058826,5,Unsaturated HC,152817.79662760042,240204.81518646734,1.571837969708588,0.6524525074528331,0.5690901033290888,0.820796478981062,Upregulated
Feature0050,Uric acid,C5 H4 N4 O3,168.02837,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Uric acid,5,4,3,4,0,0,0.8,0.6,2.8,-19.5,6,3,0.5,-1,-1,Condensed HC,47083.27539294307,53121.63333787643,1.1282484681564529,0.17408481977832924,0.3616913963046072,0.7829565408883704,Upregulated
Feature0049,NA,C21 H33 N3 O4,391.24697,NA,NA,Feature0049,21,33,4,3,0,0,1.5714285714285714,0.1904761904761905,-0.7619047619047619,82.0142857142857,7,3,0,0.125,0,Lipid,303357.63060391,149583.53543924436,0.49309303722296527,-1.0200682136460193,0.03029269864170299,0.7829565408883704,Downregulated
Feature0048,NA,C16 H30 N4 O5,358.22173,NA,NA,Feature0048,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1091425.0812140533,734110.025094637,0.6726160482568764,-0.5721448936850694,0.6865488807987397,0.8502294086712869,Downregulated
Feature0047,NA,C25 H54 N2 O5 P2 S,556.32268,NA,NA,Feature0047,25,54,5,2,1,2,2.16,0.2,-1.84,112.74,1,-4,-0.6,-0.37142857142857144,-9,Lipid,1766132.9846941477,3549351.23552034,2.009673827667628,1.0069613693688224,0.18175299354950764,0.7829565408883704,Upregulated
Feature0046,NA,C19 H30 N4 O6,410.21666,NA,NA,Feature0046,19,30,6,4,0,0,1.5789473684210529,0.3157894736842105,-0.3157894736842106,69.3,7,1,-0.3333333333333333,0,-3,Protein,104755.2853996725,118866.293668621,1.134704499301499,0.18231663857482008,0.49714844127100083,0.7998439321266281,Upregulated
Feature0045,NA,C15 H33 N O,243.2562,NA,NA,Feature0045,15,33,1,1,0,0,2.2,0.06666666666666667,-1.8666666666666665,113.5,0,-1,-0.15384615384615383,-0.1111111111111111,-2,Lipid,1895845.2846623831,800797.9749681363,0.4223962690661988,-1.2433310031442735,0.38977377123695206,0.7873878775042317,Downregulated
Feature0044,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10007,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak1",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Phenol,157690.94151944498,111040.494716644,0.7041653353496625,-0.506013886928117,0.14794869871774788,0.7829565408883704,Downregulated
Feature0043,NA,C27 H42 N2 O2,426.32469,NA,NA,Feature0043,27,42,2,2,0,0,1.5555555555555556,0.07407407407407407,-1.1851851851851851,94.07777777777778,8,6,0.17391304347826086,0.20833333333333337,4,Lipid,1696706.7993108449,3887881.8780524167,2.291428241833867,1.1962471071080802,0.20989102990739772,0.7829565408883704,Upregulated
Feature0042,NA,C14 H27 N3 O5,317.19516,NA,NA,Feature0042,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,572138.739297132,538599.4933712987,0.9413791732280948,-0.08715215923104166,0.8504717146897286,0.931864515509644,Downregulated
Feature0041,asn-tyr,C13 H17 N3 O5,295.11678,NA,NA,asn-tyr-peak1,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Phenol,686454.7896298197,984661.2906454244,1.4344153548355554,0.520462836867826,0.1339704345382542,0.7829565408883704,Upregulated
Feature0040,NA,C7 H9 N O3 S,187.03034,NA,NA,Feature0040,7,9,3,1,1,0,1.2857142857142858,0.42857142857142855,0.2857142857142856,52.15714285714286,4,1,-0.5,0.14285714285714285,-1,Phenol,3090985.67660225,3166622.4381485265,1.0244701106571998,0.03487789373357473,0.47772002438078925,0.7998439321266281,Upregulated
Feature0039,Vinylbital,C11 H16 N2 O3,224.11608,NA,NA,Vinylbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Phenol,974563.809393726,1135119.437625084,1.1647461425139922,0.2200155524380859,0.593635184479233,0.820796478981062,Upregulated
Feature0038,NA,C12 H17 N O4,239.11576,NA,NA,Feature0038,12,17,4,1,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Phenol,2961807.0381313134,2651677.1653663334,0.8952903181158454,-0.1595725101759212,0.5127058258521165,0.8034300790587636,Downregulated
Feature0037,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17436,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak1,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1245371.7548509466,732134.000515145,0.5878838970478908,-0.7663968338602534,0.21613638863774912,0.7829565408883704,Downregulated
Feature0036,NA,C19 H27 N3 O6,393.19014,NA,NA,Feature0036,19,27,6,3,0,0,1.4210526315789471,0.3157894736842105,-0.3157894736842106,69.3,8,2,-0.1,0.15384615384615383,-1,Phenol,2803268.7034831136,2173659.5805144575,0.7754017935610829,-0.36698402273522124,0.5248981041209033,0.8098418097030804,Downregulated
Feature0035,NA,C26 H48 N2 O6,484.35117,NA,NA,Feature0035,26,48,6,2,0,0,1.8461538461538465,0.2307692307692308,-1.1538461538461542,93.1846153846154,4,-2,-0.2222222222222222,-0.04761904761904761,-4,Lipid,558095.4322272603,522443.64132193266,0.9361188269127242,-0.09523642392815604,0.752356179377951,0.8847091047453014,Downregulated
Feature0034,NA,C14 H25 N3 O6,331.17447,NA,NA,Feature0034,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,2849922.73269686,2743661.123633567,0.9627142140226592,-0.054820503675377,0.8614322074931124,0.9362483918205519,Downregulated
Feature0033,Anhalamine,C11 H15 N O3,209.10523,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak1,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Phenol,172907.85806138432,186356.39896025334,1.0777786565032494,0.10806092210397578,0.8046250948424628,0.9140326627977811,Upregulated
Feature0032,NA,C8 H9 N5 O3,223.07052,NA,NA,Feature0032,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Phenol,2206275.72222276,2118901.4119697697,0.9603973749187781,-0.05829663467267374,0.5404111470555812,0.8116192259717375,Downregulated
Feature0031,NA,C12 H23 N3 O5,289.16377,NA,NA,Feature0031,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,584890.5097751654,355106.21782002866,0.6071328084234657,-0.7199159588080263,0.262710970297468,0.7829565408883704,Downregulated
Feature0030,Isoquinoline,C9 H7 N,129.05782,NA,NA,Isoquinoline,9,7,0,1,0,0,0.7777777777777778,0,-0.44444444444444464,72.96666666666667,7,7,0.75,0.75,6,Condensed HC,312781.44103396265,288177.9267545539,0.9213395967546002,-0.11819507727853845,0.8668871514932093,0.9379434753860953,Downregulated
Feature0029,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03174,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak1",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,115904.04591890286,132512.61454518433,1.1432958486876494,0.19319877556122603,0.3884035880080136,0.7873878775042317,Upregulated
Feature0028,NA,C14 H27 N3 O5,317.19507,NA,NA,Feature0028,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,1463578.22879057,925616.844110573,0.6324341438690693,-0.6610128368355189,0.2717313064643009,0.7829565408883704,Downregulated
Feature0027,NA,C15 H19 N3 O3 S,321.11473,NA,NA,Feature0027,15,19,3,3,1,0,1.2666666666666666,0.2,-0.13333333333333375,64.10000000000001,8,5,0.125,0.2631578947368421,1,Phenol,273938.83809228963,103396.55998845214,0.3774439605150766,-1.4056656329356843,0.1285327311561334,0.7829565408883704,Downregulated
Feature0026,MFCD08277025,C12 H19 N O4,241.13144,Other,NA,MFCD08277025,12,19,4,1,0,0,1.5833333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,4,0,-0.14285714285714285,0.1111111111111111,-1,Protein,489701.6470529157,625614.6287779624,1.277542423112088,0.35337119926248856,0.7150915929770103,0.8694626213961982,Upregulated
Feature0025,NA,C12 H23 N3 O5,289.16387,NA,NA,Feature0025,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,303513.38623245835,197042.63167285995,0.6492057372452978,-0.623252345373065,0.20382455340225988,0.7829565408883704,Downregulated
Feature0024,NA,C16 H21 N5 O9,427.13396,NA,NA,Feature0024,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Phenol,3111590.6350137265,3034577.41385056,0.9752495651913328,-0.036156644853569814,0.8220308695599439,0.9168177292706331,Downregulated
Feature0023,NA,C17 H32 N6 O6,416.23845,NA,NA,Feature0023,17,32,6,6,0,0,1.8823529411764703,0.35294117647058826,-0.117647058823529,63.65294117647058,5,-1,-1.4,-0.5,-7,Protein,2438606.6057053367,1925695.125005614,0.7896702651835189,-0.3406777277859985,0.6270084167654801,0.8293364212030647,Downregulated
Feature0022,NA,C11 H19 N3 O5,273.13255,Biosynthesis of secondary metabolites;Other,NA,Feature0022,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,884673.9988960424,1082640.3012831626,1.2237731668774672,0.29133617130833694,0.11578311389839802,0.7829565408883704,Upregulated
Feature0021,NA,C20 H38 N4 O6,430.27919,NA,NA,Feature0021,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,130224.98436507443,92194.38835520101,0.7079623683942403,-0.4982554187230115,0.2758262394369143,0.7829565408883704,Downregulated
Feature0020,NA,C16 H30 N4 O5,358.22177,NA,NA,Feature0020,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1280482.7834953,829852.0876599579,0.6480775051068884,-0.6257617361803908,0.3334207875396288,0.7829565408883704,Downregulated
Feature0019,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C19 H20 O7,360.12104,NA,NA,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",19,20,7,0,0,0,1.0526315789473684,0.3684210526315789,-0.3157894736842106,69.3,10,3,0.25,0.41935483870967744,3,Phenol,124744.71785889503,138853.011974991,1.1130973267505768,0.15457974423560647,0.5326720714696201,0.811395486596221,Upregulated
Feature0018,Crotanecine,C8 H13 N O3,171.08956,Other,NA,Crotanecine-peak1,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,1451049.2337859767,1184074.6178325317,0.8160127101567234,-0.2933364711988439,0.35057278789960805,0.7829565408883704,Downregulated
Feature0017,NA,C14 H27 N3 O4,301.20015,NA,NA,Feature0017,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,261321.688481575,102637.57462804683,0.3927633225716108,-1.3482678821762626,0.0560438962232297,0.7829565408883704,Downregulated
Feature0016,?-Ribazole,C14 H18 N2 O4,278.12676,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak1,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Phenol,1334663.543834382,2755737.12209534,2.064742934521405,1.045962173810765,0.05756417410872805,0.7829565408883704,Upregulated
Feature0015,NA,C15 H21 N3 O7,355.1381,NA,NA,Feature0015,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Phenol,214825.16012306465,231100.75278572,1.0757620413425117,0.10535898891546003,0.40958111136232445,0.7873878775042317,Upregulated
Feature0014,NA,C17 H31 N3 O6,373.22133,NA,NA,Feature0014,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,852045.722270269,433205.55388714926,0.5084299381644409,-0.9758791110242141,0.18151930526640012,0.7829565408883704,Downregulated
Feature0013,Marimastat,C15 H29 N3 O5,331.21086,NA,NA,Marimastat-peak1,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2044680.3472333835,1021690.7256024024,0.4996823718606343,-1.0009167723065415,0.33809896147198304,0.7829565408883704,Downregulated
Feature0012,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,C10 H14 N2 O3,210.10041,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,10,14,3,2,0,0,1.4,0.3,-0.20000000000000015,66,5,2,0,0.2307692307692308,0,Phenol,1333560.12614189,1700342.4841036634,1.2750399856532213,0.35054249116182484,0.25582607108242345,0.7829565408883704,Upregulated
Feature0011,Pentoxifylline,C13 H18 N4 O3,278.13793,NA,NA,Pentoxifylline,13,18,3,4,0,0,1.3846153846153846,0.2307692307692308,0,60.3,7,4,0,0.2,0,Phenol,80013.17316562496,186888.98578275007,2.3357277106845302,1.2238721006984583,0.3278070631064389,0.7829565408883704,Upregulated
Feature0010,NA,C16 H30 N4 O5,358.22167,NA,NA,Feature0010,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,544594.5627195727,458456.38624297804,0.8418306344329962,-0.2483980842100574,0.640761189724937,0.8329695325287205,Downregulated
Feature0009,NA,C16 H30 N6 O6,402.22286,NA,NA,Feature0009,16,30,6,6,0,0,1.875,0.375,0,60.3,5,-1,-1.75,-0.5714285714285714,-7,Protein,1025803.048159556,924521.72904718,0.901266311019362,-0.1499746305601924,0.6384189955799683,0.8329695325287205,Downregulated
Feature0008,APM,C7 H13 N O4,175.08446,NA,NA,APM-peak1,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,195882.65396950766,146701.966097002,0.7489278051125372,-0.41710144192578974,0.521620531756142,0.8083677301524742,Downregulated
Feature0007,NA,C15 H27 N3 O7,361.18502,NA,NA,Feature0007,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,902934.8689776587,1188774.2752781387,1.316567026173349,0.3967809705798832,0.28292848175150626,0.7829565408883704,Upregulated
Feature0006,(Z)-dehydrobutyrine,C4 H7 N O2,101.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak1,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,281114.9137817087,396149.20645086037,1.4092073633577409,0.4948839183019884,0.3393910462670281,0.7829565408883704,Upregulated
Feature0005,NA,C14 H27 N3 O6,333.19005,NA,NA,Feature0005,14,27,6,3,0,0,1.9285714285714288,0.42857142857142855,-0.4285714285714288,72.51428571428572,3,-3,-1.2,-0.375,-6,Protein,366566.055609247,266223.358260047,0.7262629864011098,-0.4614360391254814,0.1961449905117013,0.7829565408883704,Downregulated
Feature0004,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",C16 H19 N O5,305.12642,NA,NA,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",16,19,5,1,0,0,1.1875,0.3125,-0.375,70.9875,8,3,0.2,0.36,2,Phenol,1836263.9194603635,1072295.9637425698,0.5839552541323654,-0.7760702687864185,0.3684200890925313,0.7829565408883704,Downregulated
Feature0003,NA,C15 H28 N4 O5,344.20604,NA,NA,Feature0003,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,237269.5491988153,100242.6172522719,0.4224841223442271,-1.2430309713521226,0.035724182760438615,0.7829565408883704,Downregulated
Feature0002,NA,C21 H21 O6 P S,432.07976,NA,NA,Feature0002,21,21,6,0,1,1,1,0.2857142857142857,-0.5714285714285712,76.58571428571427,12,6,0.3076923076923077,0.4375,4,Phenol,298225.9010841767,221874.97182072795,0.7439829036113866,-0.4266586256487616,0.79881547376209,0.9108444731311635,Downregulated
Feature0001,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,C12 H24 N4 O4,288.17983,NA,NA,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,12,24,4,4,0,0,2,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,-1,-1.25,-0.5,-5,Protein,80804.19015878683,86964.44273862457,1.0762367962321302,0.10599553808457936,0.4492499307777307,0.7974180334973026,Upregulated
